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 Smaller
My world got smaller
My handwriting
My voice
My walk
My spirit
My balance
The space in the world I take up
It crept up on me in micro increments
Those are big words for small and slow
Until it arrived with a name
    Then it became big
And scary
And I didn’t want it
But now I had a face
A reason for the smallness
So it became what it is
I may be smaller, slower
But I’m still me 
Smaller: A poem about Parkinson's disease 
by Andy McDowell, New Zealand. 
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General introduction
This thesis offers a viewpoint on the definition, measurement and improvement of 
patient-centered care for patients with Parkinson’s disease (PD). In this chapter, I will 
first describe the clinical presentation and epidemiology of PD. Then, I will present 
how Parkinson care is currently managed by a neurologist, and I will outline why this 
medical management should be preferably accompanied by a multidisciplinary team 
of allied health experts, psychosocial caregivers and nurses. Furthermore, the 
concept of patient-centered care will be introduced. Lastly, I will describe the aims 
and outline of this thesis.
1. Parkinson’s disease
1.1 Etiology and epidemiology
PD is the second most common neurodegenerative disorder after Alzheimer’s 
disease, caused by the degeneration of dopamine-producing cells in the substantia 
nigra, a region in the midbrain. Although environmental factors and genetic predisposition 
are known as etiological risk factors, the exact pathogenetic mechanisms underlying 
the selective dopaminergic cell loss are not yet fully understood.1,2 The incidence of 
the disease rises steeply with age, from 0.3 per 1,000 person-years in subjects aged 
55 to 65 years, to 4.4 per 1,000 person years for those aged ≥85 years.3 In a Dutch 
population-based door-to-door study, including 6,839 persons aged 55 years or 
more, a prevalence rate of 1.4% was found.4 In The Netherlands, an estimated 30,000 
to 50,000 persons have PD or an atypical form of parkinsonism. Due to ageing of the 
population these numbers will have doubled by the year 2020, imposing an increasing 
social and economic burden on our society.3
1.2 Brief history of PD
The characteristics of PD were described first by the English surgeon James 
Parkinson in 1817. In his Essay on the Shaking Palsy he described the course of the 
disease (which he called ‘paralysis agitans’) in six cases showing the characteristic 
resting tremor, abnormal posture and gait, paralysis and diminished muscle strength.5 
The nomenclature Parkinson’s disease was introduced in 1876 by the French 
neurologist Jean-Martin Charcot in honor of James Parkinson’s early work. Charcot 
distinguished rigidity, weakness and bradykinesia as key clinical features of PD.6 
Later milestones were the discovery of Lewy bodies in affected neurons in 1912, the 
introduction of oral levodopa treatment in the 1960s and the description of the Hoehn 
and Yahr disease stages by Margaret Hoehn and Melvin Yahr in 1967.7-8  In the last 
two decades, environmental and genetic factors associated with PD were discovered, 
12
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Braak et al described the six stages of brain pathology and deep brain stimulation 
was introduced to treat the cardinal motor manifestations of PD.9-13 Due to the diversity 
of clinical manifestations, it is now clear that the key features described by Charcot 
cover only a small aspect of a multifaceted disorder, known as the ‘Parkinson’s 
complex’ including both motor and non-motor symptoms.14 
1.3 Motor symptoms 
PD is diagnosed based on the patient’s medical history and a neurological examination. 
The criteria of the United Kingdom Parkinson’s Disease Society (UKPDS) are used 
to make the diagnosis [box 1]. Early PD manifests as a hypokinetic rigid syndrome, 
meaning that the diagnosis is primarily made on the appearance of motor symptoms, 
including bradykinesia in combination with at least one of the following features; 
rigidity, resting tremor or postural instability.15 Supporting signs are a clear and 
sustained improvement with dopaminergic treatment and a unilateral start of the 
symptoms. Other motor symptoms include dysphagia, dysarthria, gait disturbances, 
micrographia and a masked face. Parkinsonian syndromes that do not meet the 
UKPDS criteria are collectively known as atypical parkinsonisms, a group of disorders 
that are characterized by a much more rapid progression, a poor or absent response 
to dopaminergic treatment and the presence of additional symptoms, like early 
dementia, cerebellar ataxia or spasticity.1 To date, the Hoehn and Yahr Rating Scale 
remains the standard to grossly classify the severity of the disease on an ordinal scale 
[Box 1].16 Additionally, physicians and scientists use the Unified Parkinson’s Disease 
Rating Scale (MDS-UPDRS) for longitudinal clinical assessment on a continuous 
scale [Box 1].17
1.4 Non-motor symptoms
PD is traditionally classified as a movement disorder characterized by a set of specific 
motor symptoms. However, patients with Parkinson’s disease also display a wide 
variety of non-motor symptoms (NMS). 14,18-20 NMS include cognitive impairment, 
neuro psychiatric disorders (i.e. hallucinations, psychosis), autonomic dysfunction 
(i.e. orthostatic hypotension, constipation, erectile dysfunction), sleep disorders 
(i.e. rapid eye movement sleep behavior disorder, insomnia), pain and olfactory 
dysfunction.14,18 The considerable impact of NMS on the patients’ quality of life has 
received increased awareness in recent years.18 Novel discoveries show that NMS, 
like loss of sense of smell, autonomic dysfunction, REM sleep behavioral disorders 
and cognitive impairment, often precede the motor symptoms. This stage is described 
as the pre-motor phase of PD.21 
13
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1.5 Quality of life (QoL)
The impact of PD on QoL gradually increases with the progression of the disease. 
QoL is influenced by many interacting factors related to health, personal relations, 
care, communication and society.22 The most important factor contributing to a 
decline in QoL is deterioration in physical mobility.23 Overall, NMS have a greater 
impact on health status and QoL compared to the motor symptoms.24-25 In the 
advanced stages, depressive symptoms, social isolation and insomnia are important 
predictors of poor QoL.23,26 The debilitating and progressive character of the disease 
imposes a heavy burden upon the caregiver.27,28 Caregiver burden aggravates with 
increased disability and symptoms, particularly mental health problems such as 
depression and hallucinations.29-30 
Box 1  Diagnostic criteria, disease classification and clinical assessment
UKPDS Brain bank criteria for the diagnosis15
Bradykinesia accompanied by at least one of the following symptoms:
- Rigidity
- Resting tremor (4-6 Hz)
-  Postural instability, which is not caused by primary visual, vestibular or cerebellar 
dysfunction
Modified Hoehn and Yahr Disease Rating Scale16
1.0 Unilateral involvement only
1.5 Unilateral and axial involvement
2.0 Bilateral involvement without impairment of balance
2.5 Mild bilateral disease with recovery on pull test
3.0 Mild to moderate bilateral disease; some postural instability; physically independent
4.0 Severe disability; still able to walk or stand unassisted
5.0 Wheelchair bound or bedridden unless aided
Unified Parkinson’s Disease Rating Scale (UPDRS)17
Part I:  Evaluation of mentation, behavior, and mood;
Part II:  Self-evaluation of the activities of everyday life;
Part III:  Clinician-scored motor evaluation;
Part IV: Hoehn and Yahr staging of severity;
Part V:  Schwab and England ADL scale.
14
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2. Management of PD
2.1 Pharmacotherapy and deep brain surgery
PD is an incurable and chronic disease. Therefore, disease management aims to 
alleviate the symptoms and to improve or maintain functional capacity and QoL.1 In 
the early stages, the motor symptoms can be treated by oral levodopa therapy or 
dopamine agonists.1 During the course of the disease, a variety of other drug 
treatments may be considered, tailored to the progression of the disease and the 
occurrence of specific symptoms.15 Advanced treatment options include deep brain 
stimulation, subcutaneous apomorphine injections and intraduodenal levodopa 
infusion.31-33  Unfortunately, advanced therapies offer only partial and temporary 
relief, and not all patients are good candidates to receive these treatments.34
2.2 Allied healthcare professionals and specialized nurses
Allied healthcare includes physical therapy (PT), occupational therapy (OT) and 
speech-language therapy (SLT), as well as treatment by a range of other disciplines, 
including Parkinson nurses, dieticians, social workers and sexologists. Over 20 
different professional disciplines may at a given point in time be engaged in Parkinson 
care. Allied health interventions in Parkinson care are supported by a growing body 
of evidence. PT proved to be effective; cognitive movement strategies can be utilized 
to improve transfers, auditory and visual cues to facilitate the patient’s ability to walk, 
and balance and fitness training to enhance muscle power and balance.35-36 SLT 
focuses on dysphagia (swallowing and saliva control) and the quality of speech 
(articulation and vocal power).37, 38 The value of OT is recently  investigated in a 
randomized controlled trial using home-based, individualized OT. This study showed 
that OT led to an improvement in self-perceived performance in daily activities in 
patients.39 A guideline for dieticians has been developed concerning constipation, 
gastroparesis and the link between medication intake, response fluctuations and 
nutrition.40 Parkinson nurses play a vital role in Parkinson care. International studies 
show that Parkinson nurses are key persons in the coordination of care, patient 
education and emotional support.41-42
2.3 Multidisciplinary care
A collaborative team approach of neurologists, allied health experts and nurses is 
thought to be the optimal way to manage the disease, but how such care should be 
delivered is under debate.43 International studies including a multidisciplinary approach 
are heterogeneous in design and outcomes. Moreover, the evidence to support a 
possible role for a specific multidisciplinary team approach remains inconclusive to 
date.44 First, an integrated care approach offered small benefits to patients with 
Parkinson’s disease in activities of everyday life and QoL compared to usual care. 
15
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However, these advantages disappeared after correction for baseline disease 
severity.45 Second, an inpatient multidisciplinary intervention program (minimum of 
3 hours per day, 5 to 7 days per week) showed a significant improvement in motor 
and cognitive scores.46 Third, an individually adapted rehabilitation program of 5 to 
10 days found significant differences in pain, emotional well-being and physical 
mobility.47 Fourth, a randomized controlled trial showed that care provided by a 
movement disorder specialist and a multidisciplinary team significantly improved 
QoL, depression and UPDRS motor scores compared to usual care provided by a 
general neurologist.48 
Insufficient expertise, poor coordination and inadequate communication are recognized 
as important barriers for the delivery of high-quality Parkinson care.34 In The Netherlands, 
ParkinsonNet has been developed to tackle these barriers.49, 50 The concept provides 
care by a restricted number of trained professionals who collaborate within regionally 
coordinated networks in the catchment areas of community hospitals.51-52 Within 
each network selected therapists are trained according to evidence-based guidelines. To 
improve the accuracy of dedicated referrals to allied health therapists, neurologists 
Parkinson care in The Netherlands
ParkinsonNet consists of 66 regional networks  
with 2970 trained health experts from 15 different 
disciplines covering the whole of The Netherlands. 
Online support
The Parkinson healthcare finder, a web-based  
search engine, allows both patients and referring 
physicians to identify ParkinsonNet professionals 
(www.ParkinsonZorgzoeker.nl). Participants are 
involved in continued education (www.parkinsonnet.nl) 
and engage in online health communities  
(www.parkinsonconnect.nl).51-52
Aims of ParkinsonNet
(1)  to improve PD-specific expertise among allied health professionals by training a selected 
number of therapists according to evidence-based guidelines; 
(2)  to enhance the accuracy of referrals by neurologists; 
(3)  to boost patient volumes per therapist by stimulating preferred referral to ParkinsonNet 
therapists; 
(4)  to stimulate collaboration between therapists, neurologists and patients.
Figure 1  ParkinsonNet regions distributed across The Netherlands
16
CHAPTER 1
and nurse specialists receive standardized referral forms with referral criteria. An 
online search engine, the ‘Parkinson healthcare finder’, includes information of all 
network participants facilitating neurologists and nurse specialists to direct patients 
to expert therapists in the patients’ immediate environment. Furthermore, collaboration 
is facilitated by regional multidisciplinary meetings and an annual national conference.
ParkinsonNet reduces healthcare utilization and costs.49 Furthermore, healthcare 
professionals adhere better to guideline recommendations and treat higher patient 
volumes per year.50 Analysis of Dutch medical claims data showed that patients in 
ParkinsonNet regions sustained fewer fractures than those in other areas, including 
a 55% decrease in hip fractures. Relevant differences between regions were found, 
proving the existence of unwarranted medical practice variation in Dutch Parkinson 
care.53 
3. Patient-centered care 
3.1 Definition of patient-centered care 
In 2001 the National Academy of Medicine (NAM) introduced six aims to improve the 
quality of healthcare systems. According to the NAM, healthcare has to be safe, 
effective, equitable, timely, efficient and patient-centered.54 Patient centeredness was 
defined as ‘providing care that is respectful of and responsive to individual patient 
preferences, needs and values, and ensuring that patient values guide all clinical 
decisions’. Several other definitions were introduced ever since, briefly worded by the 
terms ‘personalized medicine’ and ‘partnerships’ between healthcare professionals 
and patients.55-57
Harvey Picker (1915-2008), founder of the Picker Institute and advocate of patient- 
centered care, believed that the United States healthcare system was technologically 
and scientifically outstanding. However, he also claimed that the United States system is 
characterized by a provider-centered model with an emphasis on the evaluation and 
treatment of diseases, which is not adequately sensitive to the needs of individual 
patients.58-61 The disease-centered approach is a legacy of past efforts to treat infectious 
diseases and acute illnesses, but does not focus on today’s growing problem; the 
increasing numbers of people with chronic conditions, who require continuous care 
and coordination across healthcare settings and providers.
In the 1980s, the Picker Institute conducted interviews with different patient groups 
to better understand care experiences, resulting in a theoretical model of patient- 
centered care.62 To date, the Picker Institute principles of patient-centered care still 
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provide a powerful framework to investigate and improve the quality of care from a 
patient’s perspective. A corresponding multidimensional framework of patient- centered 
care is provided by the World Health Organization (Table 1).63
3.2 Benefits of patient-centered care
Patient-centered care reflects an ethical norm inherent to medicine, such as respect 
for patient values and shared decision making.66 The concept increases treatment 
adherence among chronically ill patients.67-70 For example, women with breast cancer 
who experienced higher levels of patient centeredness were more compliant to their 
ongoing cancer treatment with Tamoxifen.70 Moreover, patient centeredness contributes 
to better collaboration between patients and health professionals, which increases 
job satisfaction and reduces misunderstandings, litigations and complaints.71 
In addition to the intrinsic value, several studies showed significant correlations 
between patient centeredness and clinical outcomes.67,72,73 For example, patients 
who experienced higher levels of patient centeredness during their hospitalization for 
acute myocardial infarction showed a lower hazard ratio of death over a one-year 
study period.73 Other studies indicated an association between patient centeredness 
and improved patient satisfaction, healthcare experiences, self-management and 
QoL67,68,72,74,75 Moreover, hospital units adopting a patient-centered approach are 
associated with significantly better outcomes, albeit with higher total costs compared 
to less patient-centered units.76 On the other hand, patient centeredness may lower 
the cost per patient by a shortened length of stay in the hospital, decreased adverse 
events or reduced healthcare utilization.66,77-79 
Table 1  Two theoretical models of patient-centered care  
Picker Institute concept WHO responsiveness model 
1. Accessibility 1. Confidentiality of information 
2. Information & communication 2. Communication 
3. Partner & family involvement 3. Access to family & community support 
4. Respect & autonomy 4. Autonomy 
5. Organization of healthcare 5. Freedom to choose a healthcare provider 
6. Continuity of care 6. Dignity 
7. Physical comfort 7. Prompt attention 
8. Emotional support 8. Quality of basic amenities 
18
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3.3 Measurement of patient-centered care
Patient centeredness is recognized as a quality indicator on which healthcare 
organizations should be evaluated.80, 81 A common way for eliciting the patient’s voice 
is to collect care experiences.82 Patient experience surveys have replaced patient- 
satisfaction measures, since experiences better reflect the quality of care from the 
patient’s perspective and might discriminate more effectively between practices.71, 82 
Moreover, patient experiences provide relevant feedback for quality improvement.83
In the 1980s, the Commonwealth Fund started to collect patient experiences to 
evaluate hospital care in the United States84 These efforts were followed up by a national 
standard called the Consumer Assessment of Health Plans Survey (CAHPS).85 
To date, the CAHPS still measures patient’s perceptions of their hospital experience. 
The questionnaire allows consumers to compare hospitals on the responsiveness of 
staff, communication with nurses and physicians, cleanliness, noise levels and pain 
management.86 Additionally, the Patient Assessment of Chronic Illness Care (PACIC) 
survey was designed to assess the extent to which patients with chronic illnesses 
receive care that aligns with the Chronic Care Model, measuring patient involvement, 
collaborative goal setting and self-management support.87 Since the introduction of 
regulated competition in The Netherlands, the Consumer Quality Index is recognized 
as the Dutch standard for measuring patient experiences.88
Applications include feedback to drive improvement, public reporting, benchmarking 
across institutions, their use as an outcome measure for clinical trials and an indicator 
to contract healthcare providers.71 So far, a suitable instrument to assess the level of 
patient centeredness for patients with Parkinson’s disease is lacking.
3.4 Improving patient-centered care 
Despite the advantages of patient-centered care and the best intentions of healthcare 
professionals, patient centeredness remains far from being implemented in clinical 
practice.54 Although many organizations believe they provide patient-centered care, 
they continue to deliver care in a disease-oriented or physician-centered manner.92 
Patients increasingly wish to participate in making treatment decisions and express a 
desire to have open communication channels with their healthcare professionals.64, 65 
To date, patients assume a passive role, partially because this is the traditional 
approach to medicine, but also because they lack the tools and support to gain a 
central position within the healthcare team. 
The implementation of patient-centered care requires more than a respectful attitude 
or a personalized style of clinical interviewing. It is about engaging patients to become 
active participants in their care.59, 68, 89, 90 Accordingly, patients and professionals both 
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have to be recognized as disease experts; doctors are experts in the cause and the 
prognosis of diseases and in diagnostic and therapeutic procedures, while patients 
know best about their day-to-day experiences with the disease. Both types of 
expertise are equally important in patient-centered care.59 Moreover, the role of 
healthcare professionals should change from ‘experts who care for patients’ to 
‘enablers who support patients to make decisions’.91 Patients on their behalf have to 
learn to become active participants in managing their disease and how to interact 
with their healthcare team. 
4. Conclusions
PD is an illustrative example of a debilitating chronic disorder in which each patient 
displays a unique set of cognitive, emotional and motor symptoms. Given the 
complex nature of the disease, delivering patient-centered care to PD patients is 
particularly challenging. Preferably, Parkinson care requires a collaborative team 
approach of physicians, nurses, psychosocial caregivers and allied health experts. 
‘Patient centeredness’ means that patients are invited to participate within this team 
to ensure that decisions respect patients’ needs, wants and preferences. Patient- 
centered care refers to multiple different aspects and processes in the medical 
consultation. Therefore, it is necessary to operationalize the concept in measurable 
and concrete elements. This thesis provides a starting point in the definition, 
measurement and improvement of patient-centeredness in Parkinson care.
5. Aims and outline of the thesis
These conclusions helped to formulate the aims and research questions of this thesis. 
In Part 1, I aim to define, measure and improve patient centeredness in Parkinson 
care. First, I will elaborate on patient-centered care initiatives that have thus far been 
tested in PD (chapter 2). Second, I will describe a focus group study that aimed to 
define patient centeredness according to PD patients and caregivers (chapter 3). 
Third, I will outline the development of a patient experience questionnaire to assess 
the quality of care from a patient’s perspective (chapter 4). Fourth, I will explore the 
level of patient centeredness in North American Parkinson centers and I will provide 
feedback on patients’ experiences to healthcare professionals (chapter 5). In chapter 6, 
I will present a viewpoint on the outdated nomenclature in healthcare with respect to 
the word ‘patient’.
20
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In Part 2 I will explore, measure and implement strategies to improve the coordination 
of Parkinson care. First, I will provide a viewpoint on multidisciplinary teamwork in 
Parkinson care (chapter 7). Thereafter, I will explore social network analysis as a method 
to measure the quality of multidisciplinary collaboration (chapter 8). In chapter 9 I will 
investigate whether ParkinsonNet enhances multidisciplinary collaboration between 
healthcare professionals involved in Parkinson care. In the final two chapters the 
concept of online (chapter 10) and personal (chapter 11) health communities will be 
introduced as a strategy to improve patient-centered care. 
6. Research questions
Part 1 Patient centeredness in Parkinson care
1.  Which patient-centered care initiatives have thus far been tested in Parkinson care? 
(chapter 2)
2.  How should patient centeredness in Parkinson care be defined? (chapter 3)
3.  How should patient centeredness in Parkinson care be measured? (chapter 4)
4.  What is the level of patient centeredness in Dutch and American Parkinson 
care?(chapter 3-5)
5.  Does feedback on care experiences improve patient centeredness in Parkinson 
care? (chapter 5)
Part 2 Multidisciplinary collaboration in Parkinson care
6.  How should multidisciplinary collaboration between health professionals involved 
in Parkinson care be measured? (chapter 8-9)
7.  Does the implementation of ParkinsonNet improve multidisciplinary collaboration 
between health professionals involved in Parkinson care? (chapter 9)
8.  Does the implementation of online health communities improve collaborative, 
patient- centered care? (chapter 10-11)
21
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Abstract 
Today’s society is changing rapidly and individuals increasingly favor an active role in 
designing their own lives. Contemporary patients are no exception, but the present 
healthcare system - which is organized primarily from the provider’s perspective - is 
not yet prepared for this development. Here, we argue that an alternative way to 
organize healthcare, namely more from the patient’s perspective, may help to contain 
costs, while improving the quality, safety and access to care. This involves a redefinition 
of the patient-doctor relationship, such that patients are no longer regarded as passive 
objects, but rather as active subjects who work as partners with healthcare professionals 
to optimize health (‘participatory medicine’). The opportunities that come with such 
a collaborative and patient-centered care model are reviewed within the context of 
patients with Parkinson’s disease. We also discuss societal and Parkinson-specific 
barriers that could impede implementation of this alternative care model to the 
management of PD and other chronic conditions.
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Physician-centered care
Today’s society is changing rapidly and individuals increasingly favor an active role in 
designing their own lives. Internet technology has greatly facilitated this development, 
with readily available knowledge and interactive communication platforms.1 Contemporary 
patients are no exception. They search the internet for medical information, they wish 
to have open communication channels with their healthcare professionals, and they 
prefer to actively participate in making important medical decisions.2 Moreover, they 
want to be regarded as humans with a health problem, and not as carriers of a disease.3 
Terms that have been coined to describe this alternative healthcare approach include 
patient-centered care2, collaborative care4, participatory medicine5 and health 2.0.6 
This chapter reviews the opportunities that come with such a collaborative and 
patient- centered care model in the context of patients with Parkinson’s disease.
The pace of the aforementioned societal developments do not match concurrent 
healthcare system reforms. Specifically, the present healthcare is organized primarily 
from the ‘provider perspective’, with professionals taking the lead in deciding about 
the quality of care, and with a somewhat paternalistic approach to patients.7 Here, we 
argue that organizing healthcare more from the patient’s perspective may help to 
contain costs, while improving the quality, safety and access to care.8-10  It is interesting 
to consider that healthcare is meant to be organized this way; patients already had a 
central position within the healthcare team during the times of Hippocrates, the 
ancient Greek doctor who lived 400 years BC. However, in the centuries following his 
oath, we inadvertently seem to have lost this view of patients as partners in the 
healthcare process.11 The current challenge is to ‘reestablish’ a level playing field, in 
which patients and healthcare professionals are equal members of the healthcare 
team. If we want patients to regain their central role, a shift is needed from the classical 
model of professionalism (‘Trust us, we know best what will help you’) towards a more 
consumerist model (‘Let us know what you need and want, and that is what we will offer’).12-13
Drawbacks of the current healthcare system
Our current healthcare system has several drawbacks. First, patients with complex 
healthcare needs and chronic conditions such as PD, often receive care that is 
fragmented, incomplete, inefficient, and ineffective.14 Particularly in elderly patients, 
this complexity is compounded by co-morbidities and most patients acquire 
relationships with multiple professionals and institutions.15-16 Healthcare – which 
initially involved individual consultations for a specific health problem – has gradually 
evolved into complex multidisciplinary teamwork, with care given by multiple 
professionals from different backgrounds, and who typically work in different 
departments and institutions.17 To manage patients with complicated health problems, 
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professionals must collaborate to make coordinated decisions and share responsi-
bilities.18 Indeed, for chronic patients, delivery of coordinated and integrated care 
centered around an individual patient positively affects the clinical outcome, patient 
functioning and quality of life.17 However, current multidisciplinary collaboration in 
healthcare can still be improved considerably.19
Second, most chronic patients currently assume a passive role, partially because this 
is the traditional approach to medicine, but also because patients lack the tools to 
self-manage their condition.20 Moreover, patients with Parkinson’s disease are increasingly 
willing to assume a more active role in managing their own care processes.21 However, 
physicians are not fully responsive to patient preferences regarding either the degree 
of communication or the patient’s participation in decision making.22 
Third, for complex disorders such as PD, healthcare professionals often lack sufficient 
experience to address the complex needs of affected patients.15 This gap between 
available and required knowledge continues to increase, as our understanding of PD 
improves. A further problem is the fact that patients with Parkinson’s disease are 
often not referred to professionals who do have adequate expertise, likely because 
referring physicians are unaware where experts can be found.14 Put simply, there are 
no ‘yellow pages for PD’.
Patient-centered care
An alternative way to organize the care for chronically affected patients is patient- 
centered care.4, 19, 23 Central elements of this approach are collaborative goal-setting, 
practical care planning, self-management and monitoring of outcomes within a team 
of professionals that also involves the patient.24 Accumulating evidence suggests that 
collaborative care programs are  a cost-effective way to improve the quality of care 
and lead to better medical outcomes for elderly patients with multiple chronic 
conditions.24-26
Patient centeredness is a crucial element of quality of care and is defined by the 
National Academy of Medicine as: ‘providing care that is respectful of and responsive 
to individual patient preferences, needs, and values, and ensuring that patient values 
guide all clinical decisions’.27 Contrary to common belief, patient centeredness 
requires more than a respectful attitude towards patients or a personalized style of 
clinical interviewing. It really is about engaging patients to become active participants 
in their own care, and about improving patient-professional communication.9,28 
Patient- centered care lowers the cost per patient by i.e. a shortened length of stay in 
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the hospital, decreased adverse events or reduced healthcare utilization.8-10 Patient 
centeredness increases treatment adherence among chronically ill patients and improves 
job satisfaction among healthcare professionals. Moreover, patient centeredness is 
associated with improved quality of life and improved physical health outcomes.9,29 
Despite these apparent advantages, the concept of patient centeredness remains far 
from being implemented in everyday clinical practice, even in developed Western 
countries.30
Recently, we explored the concept of patient-centered care for PD. These studies 
showed that patient-centered Parkinson care involves six subscales, each representing 
a separate dimension of patient centeredness: patient involvement; provision of 
tailored information; healthcare accessibility; empathy and PD expertise; collaboration 
and continuity of care and emotional support.31-32 Independent of age, patients with 
Parkinson’s disease expressed a desire to be actively involved in the healthcare 
process, and were in need of much more medical information, particularly about 
medication and the various treatment options offered by therapists. Patients wished 
to be emotionally supported, especially when it comes to disease acceptance and 
changes in personal relationships.31-32 Finally, the qualitative study identified a lack 
of multidisciplinary collaboration among healthcare professionals as an important 
bottleneck.31
Delivering patient-centered care to patients with Parkinson’s disease is particularly 
challenging, given the complex and debilitating nature of the disease, which includes 
a mixture of cognitive, emotional and motor symptoms.33 In current clinical practice, 
the primary focus of physicians is on assessing disease severity and evaluating drug 
effectiveness, but less so on patient involvement or on the specific needs of patients 
which affect their quality of life.34 Interestingly, patients with Parkinson’s disease  who 
did perceive greater involvement in their care were more satisfied with their 
consultations and tended to be more compliant.21 A Swedish study demonstrated 
that neurologists provided only a small proportion of patients with advanced therapy 
information, despite patients’ interest in this issue.35 Importantly, there are enormous 
variations in patients ’ expectations of treatment success, and also great inter-individ-
ual differences in what patients perceive to be their most troublesome symptoms.36 
These considerations highlight the importance of providing care tailored to each 
patient’s individual preferences.
Implementation of patient-centered care for PD
The implementation of patient-centered care for patients with Parkinson’s disease 
could include several targets that together enclose the whole spectrum of this approach: 
a broad focus on providing better emotional support and tailored information; 
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implementation of tools that allow better access to healthcare; active patient 
involvement and self-management; and reduction of healthcare fragmentation. Table 1 
shows all patient-centered care initiatives that have thus far been tested for PD, 
classified by a taxonomy of ‘patient focused quality interventions’.37 In the next 
paragraphs, we will elaborate on shared decision making, as a promising example of 
the implementation of patient-centered care which illustrates how patients with 
Parkinson’s disease  can become actively involved in their own healthcare process.
Shared Decision Making
Shared Decision Making (SDM) is considered especially applicable to specific 
medical decisions for which – based on the available scientific evidence – there is no 
distinct preference or obvious superiority for one particular treatment over other 
treatments. Under such circumstances, it is often the personal preference of the 
physician that drives the ultimate treatment decision. This is not necessarily wrong, 
because it is important that physicians feel comfortable with and have experience in 
the treatments which they prescribe. Ideally, however, the treatment choice should 
also depend at least on how patients themselves value the risks and benefits of the 
various treatment options51 In other words, a key feature is the process of really 
making a shared decision, with involvement of both the patient and the physician. 
This SDM process involves information sharing, consensus building about the 
preferred treatment and reaching an agreement about which treatment to implement.52 
This process does require that patients receive access to unbiased medical 
information – in layman’s terminology, and presented in a comparative and easy to 
understand format. This information is normally only available to physicians. 
Depending on the specific context and the patient’s wishes and cognitive abilities, 
SDM can involve a ‘continuum’, ranging from fully patient-driven decisions on the one 
end to fully physician-driven decisions on the other end.53 The latter situation – i.e. 
physicians driving the medical decisions largely by themselves – is most common in 
current clinical practice. However, true SDM with greater patient involvement offers 
interesting advantages, including improved patient-physician communication, 
increased treatment compliance, better clinical outcomes and reduced healthcare 
costs.54
We feel that SDM might well apply to PD and other chronic conditions, although we 
anticipate specific challenges that need to be studied and addressed. In every stage 
of PD, treatment decisions must be made. However, each patient with Parkinson’s 
disease has a different disease presentation and expresses unique individual needs. 
For example, complex treatment decisions must be made in the advanced phase of 
PD when debilitating response fluctuations and dyskinesias can no longer be 
managed with oral pharmacotherapy alone. Three treatment options are then available: 
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deep brain stimulation (DBS), intraduodenal levodopa infusion, or subcutaneous 
apomorphine infusion. Each of these treatments has its own specific risks and 
benefits, indications and contra-indications, costs and impact on daily life. There is a 
variable amount of scientific evidence to support the choice for each of these three 
individual treatment strategies, but back-to-back comparisons between them are not 
available. To determine which of these three treatments fits best for each individual 
patient, it would appear best to accommodate both scientific, medical, personal and 
financial factors. We are currently developing a decision aid to facilitate this specific 
decision and to increase the likelihood that the right treatment is given to the right 
person at the right time by using an SDM approach.
Barriers to patient-centered care in PD
Patient-centered care offers several promising opportunities. However, its uptake into 
routine clinical care is lagging behind. Which societal and PD-specific barriers might 
impede the clinical implementation of patient-centered care, and what can be done 
about it?
First, although the evidence to support patient-centered care is growing, this is still a 
young field, and the ideological base of this concept is better developed than its 
evidence base. Terminology might be a hampering factor, because ‘patient 
centeredness’ is a container concept for multiple different elements that refer to 
different processes in the medical consultation. Hence, patient centeredness is 
difficult to operationalize in measurable elements.7 An additional challenge is the fact 
that evidence-based medicine is wrongly assumed to only rely on randomized 
controlled trials (RCTs) as the ‘gold standard’ for finding the best treatment. RCTs are 
typically performed on homogeneous patient groups, which are artificially constructed 
by strictly defined inclusion criteria. As such, evidence-based medicine is considered 
by most as essentially physician-centered, because it focuses on the physicians’ 
interpretation of the evidence, and in most professionals’ views it neglects the much 
broader variety that exists among individual patients that form everyday clinical 
populations.7 Moreover, individual patient preferences may well differ from what is put 
down in guidelines and standards of practice, as these are based on average findings 
in large groups. In other words, medical guidelines address the risk across a patient 
population, but usually do not account well for the heterogeneity within the population.54
Second, patients with Parkinson’s disease  vary in their wishes and abilities to be 
involved in making decisions about their care. Age and cognitive capacity play a 
major role in the ability to understand information and make treatment decisions. 
Even in newly diagnosed patients with PD, cognitive measures are impaired, in 
particular immediate memory and executive function.55 Moreover, impairment in 
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Table 1  Patient-centered care initiatives that have thus far been tested in PD  
Patient focused 
quality 
interventiona
Example of 
intervention
Goal Outcomes of interesta Reference
To improve  
self care and 
health literacy
The Patient Education 
Program Parkinson, 
The Netherlands.
To provide psychosocial education and enhance patient 
participation. Improve health-related quality of life of 
patients with Parkinson’s disease  and caregivers. 
Self care knowledge, quality of life, psychosocial well-being,  
self-efficacy.
A’Campo et al., PRD 201038
Group education 
program, China.
To increase health related quality of life. The program 
includes group lectures on health education  followed by 
individualized and tailored rehabilitation, 24 half-hour 
sessions over eight weeks. 
Quality of life, psychological wellbeing. Guo et al., CJNS 200939
Patient support 
groups, US. 
Support groups help physicians in understanding patients’ 
needs that are not adequately addressed and can help 
patients cope with and accept their condition.
Knowledge of condition and treatment options, self care 
knowledge, psychosocial wellbeing, patients’ satisfaction.
Dorsey et al., MDS 201040
Professionally 
facilitated online 
support group, US.
Reduce depression symptoms and increase quality of life. Quality of life, psychological wellbeing Lieberman et al., SWHC 200541
Parkinson’s disease 
Research, Education 
and Clinical Centers. 
(VA), US. 
To provide patient education and support to Patients with 
Parkinson’s disease  in VA medical centers. 
Self care knowledge, patients’ satisfaction. Pogoda et al., MDS 200942
Psycho-educational 
support group with 
women with young 
onset PD, Israel.
To provide health-related information and the acquisition of 
coping skills for young women with Parkinson’s disease in 
coping with psycho-social and physical difficulties. 
Doctor-patient communication, involvement and empowerment  
of patients, providing individualized care.
Posen et al., SWHC 200043
EduPark patient 
education program, 
Seven European 
countries.
Empowering people with PD and their caregivers to deal 
with psychosocial problems. Eight sessions covering 
information, empowerment and self management 
strategies, anxiety and depression and social support.
Knowledge of condition and treatment options, psychological 
wellbeing, 
self efficacy, involvement and empowerment of patients.
Simons et al., PRD 200644
Interdisciplinary home 
healthcare program, 
Sweden.
Psychosocial support, manage daily life activities and 
mobility patterns. Ten sessions. Each session consisted of 
one hour of dialogue, followed by one hour of physical 
performance.
Psychological wellbeing, 
physical functioning
Sunvisson et al., SJCS 200145
To improve  
self care and 
patient safety
Patient education and 
health promotion 
program (Propath), US.
To improve health confidence, provide information and 
support, improve physical function through exercise, and 
work with the physician to optimize medical treatment and 
compliance.
Self-efficacy, hospital admission rates, number of visits to 
physicians, days lost from work or school, physical functioning, 
severity of disease or symptoms.
Montgomery et al., AJM 199446
Telemedicine for PD 
patients residing in a 
remote community, US.
To improve accessibility to an academic movement 
disorders specialist.
Quality of life, physical functioning, clinical indicators. Dorsey et al., MDS 201047
To improve 
clinical decision 
making
Patients with Parkinson’s 
disease perceptions of 
their most troublesome 
symptoms, United 
Kingdom.
To find out patients’ most troublesome symptoms and to 
incorporate these priorities in an individual treatment plan. 
Doctor-patient communication, involvement and empowerment of 
patients, providing individualized care.
Politis et al., 
MDS 201048
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strategies, anxiety and depression and social support.
Knowledge of condition and treatment options, psychological 
wellbeing, 
self efficacy, involvement and empowerment of patients.
Simons et al., PRD 200644
Interdisciplinary home 
healthcare program, 
Sweden.
Psychosocial support, manage daily life activities and 
mobility patterns. Ten sessions. Each session consisted of 
one hour of dialogue, followed by one hour of physical 
performance.
Psychological wellbeing, 
physical functioning
Sunvisson et al., SJCS 200145
To improve  
self care and 
patient safety
Patient education and 
health promotion 
program (Propath), US.
To improve health confidence, provide information and 
support, improve physical function through exercise, and 
work with the physician to optimize medical treatment and 
compliance.
Self-efficacy, hospital admission rates, number of visits to 
physicians, days lost from work or school, physical functioning, 
severity of disease or symptoms.
Montgomery et al., AJM 199446
Telemedicine for PD 
patients residing in a 
remote community, US.
To improve accessibility to an academic movement 
disorders specialist.
Quality of life, physical functioning, clinical indicators. Dorsey et al., MDS 201047
To improve 
clinical decision 
making
Patients with Parkinson’s 
disease perceptions of 
their most troublesome 
symptoms, United 
Kingdom.
To find out patients’ most troublesome symptoms and to 
incorporate these priorities in an individual treatment plan. 
Doctor-patient communication, involvement and empowerment of 
patients, providing individualized care.
Politis et al., 
MDS 201048
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understanding treatment consent as well as impairment in organizing information 
necessary to make complex decisions are present even in patients with Parkinson’s 
disease  without dementia.56 Moreover, it may be difficult for clinicians to judge the 
extent to which patients wish to be involved in understanding their health problems, 
in knowing each option available to them, and in making shared decisions.57 
Therefore, healthcare professionals should be supported to develop competencies 
how to carefully explore patients’ decision making capacity and desired degree of 
control and to facilitate greater participation by chronically ill elders who wish to 
become more involved in their care. In a review on barriers and facilitators of SDM, 
Table 1  Patient-centered care initiatives that have thus far been tested in PD  
Patient focused 
quality 
interventiona
Example of 
intervention
Goal Outcomes of interesta Reference
Define treatment 
success from the 
patient’s perspective, 
US.
To evaluate treatment success and expectations from the 
patient’s perspective across 10 motor and non-motor 
functional domains.
Patients’ satisfaction, doctor-patient communication, patient 
involvement, providing individualized care.
Nisenzon et al., PRD 201036
Patient-centered 
questionnaire for PD 
(PCQ-PD), 
The Netherlands.
Quality of care from a patient’s perspective; incorporate 
the patient experience to improve the quality of care. 
Patients’ satisfaction, providing individualized care. Van der Eijk et al., PRD 201232
To improve 
clinical decision 
making and 
patient safety
Patient-perceived 
involvement in therapy 
decisions, United 
Kingdom. 
To involve patients in PD therapy decisions. Patients’ satisfaction, doctor-patient communication, quality of life, 
involvement and empowerment of patients, treatment adherence.
Grosset et al., MDS 200521
Decision aid on deep 
brain stimulation 
(DBS), intraduodenal 
Levodopa gel and 
subcutaneous 
Apomorphine, The 
Netherlands.
To stimulate active patient-involvement and increase the 
likelihood that the right treatment is given to the right 
person at the right time.
Knowledge of treatment options and outcomes, patients’ 
satisfaction, doctor-patient communication, involvement of patients, 
cost effectiveness, treatment adherence.
Currently under study  
by the authors
To improve  
self care,  
health literacy 
and clinical 
decision making
Online Health 
Communities, The 
Netherlands.
To stimulate active patient involvement, self-management 
and reduction of healthcare fragmentation.
Self care knowledge, doctor-patient communication, self efficacy, 
involvement and empowerment of patients, self care activities. 
Currently under study  
by the authors
PD nurse specialists, 
United Kingdom.
To provide patient education and emotional support, 
information, continuity of care, liaison with hospital team 
and primary care professionals
Comprehension of information, self care knowledge, psychological 
wellbeing, cost effectiveness. 
Hurwitz et al., JECP 200549
Jahanshahi et al., BN 199450
aClassification according to taxonomy Coulter & Ellins, BMJ, 200737 
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Légaré and colleagues expressed it in a distinct way; ‘be careful not to assume, 
based on patients’ sociodemographics or the type of clinical situation, that they are 
not fit for shared decision making. Healthcare professionals would gain by asking one 
simple question to their patients: what role do you want to play in making decisions 
about your health?’.58  
Third, the way healthcare is currently reimbursed may penalize physicians for 
providing patient-centered care. For instance, pay-for-performance systems rarely 
account for individual patients’ preferences and physicians are penalized for failing to 
Table 1  Patient-centered care initiatives that have thus far been tested in PD  
Patient focused 
quality 
interventiona
Example of 
intervention
Goal Outcomes of interesta Reference
Define treatment 
success from the 
patient’s perspective, 
US.
To evaluate treatment success and expectations from the 
patient’s perspective across 10 motor and non-motor 
functional domains.
Patients’ satisfaction, doctor-patient communication, patient 
involvement, providing individualized care.
Nisenzon et al., PRD 201036
Patient-centered 
questionnaire for PD 
(PCQ-PD), 
The Netherlands.
Quality of care from a patient’s perspective; incorporate 
the patient experience to improve the quality of care. 
Patients’ satisfaction, providing individualized care. Van der Eijk et al., PRD 201232
To improve 
clinical decision 
making and 
patient safety
Patient-perceived 
involvement in therapy 
decisions, United 
Kingdom. 
To involve patients in PD therapy decisions. Patients’ satisfaction, doctor-patient communication, quality of life, 
involvement and empowerment of patients, treatment adherence.
Grosset et al., MDS 200521
Decision aid on deep 
brain stimulation 
(DBS), intraduodenal 
Levodopa gel and 
subcutaneous 
Apomorphine, The 
Netherlands.
To stimulate active patient-involvement and increase the 
likelihood that the right treatment is given to the right 
person at the right time.
Knowledge of treatment options and outcomes, patients’ 
satisfaction, doctor-patient communication, involvement of patients, 
cost effectiveness, treatment adherence.
Currently under study  
by the authors
To improve  
self care,  
health literacy 
and clinical 
decision making
Online Health 
Communities, The 
Netherlands.
To stimulate active patient involvement, self-management 
and reduction of healthcare fragmentation.
Self care knowledge, doctor-patient communication, self efficacy, 
involvement and empowerment of patients, self care activities. 
Currently under study  
by the authors
PD nurse specialists, 
United Kingdom.
To provide patient education and emotional support, 
information, continuity of care, liaison with hospital team 
and primary care professionals
Comprehension of information, self care knowledge, psychological 
wellbeing, cost effectiveness. 
Hurwitz et al., JECP 200549
Jahanshahi et al., BN 199450
aClassification according to taxonomy Coulter & Ellins, BMJ, 200737 
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meet treatment targets.54 Although time constraints are commonly perceived  as a 
barrier for the adoption of SDM in clinical practice, there is no evidence for a negative 
impact of SDM on the length of consultation or increased healthcare costs.58 
Additionally, patient-centered care involves communication and collaboration across 
different primary and secondary care settings to manage complex patients with 
multiple co-morbidities. To date, these care services are reimbursed separately. 
Innovative solutions are needed to reimburse the integrated care pathway of individual 
patients across these traditional echelons.
Future perspective
The implementation of patient-centered care does not aim to turn the patient-doctor 
relationship upside down. Moreover, it involves a ‘redefinition’ where patients are no 
longer regarded as passive objects, but rather as active subjects who can contribute 
to their own health, and who work as partners with their healthcare professionals to 
optimize health. This approach calls for the development and implementation of tools 
for self-management, such as web-based shared decision facilities. Changing the 
way we provide care from a ‘provider-focus’ to a ‘patient-focus’ takes time and 
requires a change in the mindset of both professionals and patients. Once 
implemented, we expect that this approach may help to improve the quality and 
safety of care and ascertain an affordable healthcare system for the next generations.
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I fear to become a patient
 "What chills my bones is indignity. 
It is the loss of influence on what happens to me. 
It is the image of myself in a hospital gown, homogenized, 
anonymous, powerless, no longer myself. That’s what scares me: 
to be made helpless before my time, 
to be made ignorant when I want to know, 
to be made to sit when I wish to stand,
 to be alone when I need to hold my wife’s hand, 
to eat what I do not wish to eat, 
to be named what I do not wish to be named, 
to be told when I wish to be asked, 
to be awoken when I wish to sleep. 
Call it patient centeredness, but, I suggest, this is the core: 
It is that property of care that welcomes me to assert my humanity 
and my individuality. If we be healers, then I suggest that that is not a 
route to the point, it is the point.”
Berwick DM. 
What ‘patient-centered’ should mean: 
confessions of an extremist.
Health Affairs 2009;28(4):555-65
Published as: 
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Abstract
Introduction
Quality of care is becoming increasingly important in the field of movement disorders.
Patient centeredness is a crucial element of quality of care, but has thus far received 
limited attention regarding the treatment of movement disorder syndromes. As a first 
step towards patient-centered care in Parkinson’s disease, we explored the unmet 
needs of patients and their caregivers.
Methods
Eight focus group discussions involving 40 patients with Parkinson’s disease (mean 
age 62 years, Hoehn & Yahr stage 1-3) and 20 caregivers (mean age 63 years) were 
organized to explore the experiences in relation to patient-centered care. The key 
elements of patient centeredness e as defined by the Picker Institute and the World 
Health Organization e were used as a framework for discussion and qualitative analysis.
Results
Patients and caregivers desired more emotional support from healthcare professionals, 
and wanted more active involvement in clinical decision making, but currently lacked 
sufficient information to do so. Participants also missed the tools to find professionals 
with PD expertise. Finally, they identified a lack of multidisciplinary collaboration as a 
major bottleneck in the current healthcare system.
Conclusions
We identified various unmet needs among patients and caregivers. These joint experiences 
represent a disease-specific model of patient centeredness for PD, which can assist 
healthcare professionals in implementing patient-centered care tailored to the 
preferences of each individual patient. The present findings will be used to construct 
a patient centeredness questionnaire for PD that will clarify the quality of care from a 
patient’s perspective.
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1. Introduction
In 2001, the National Academy of Medicine (NAM) introduced six distinct aims to 
improve the quality of healthcare. These aims were built around the core needs for 
healthcare, which had to be safe, effective, equitable, timely, efficient and patient- 
centered.1 Quality of care, as described by the NAM, is becoming increasingly 
important in the field of movement disorders, resulting in new clinical guidelines and 
quality indicators.2,3 Patient centeredness is one of the six NAM quality dimensions 
and represents a crucial element of quality of care, particularly in this era of 
individualism and globalization. Several definitions of patient-centered care have 
evolved. The NAM definition is: “Providing care that is respectful of and responsive to 
individual patient preferences, needs, and values, and ensuring that patient values 
guide all clinical decisions”. Patient centeredness holds great promise to improve the 
quality of care. It increases treatment adherence among chronically ill patients and 
job satisfaction among healthcare professionals. Moreover, patient centeredness is 
associated with greater patient well-being and improved physical health outcomes, 
without significant increases in resource utilization4-6 Despite the advantages of 
patient- centered care and the best of intentions of professional caregivers, patient 
centeredness remains far from being implemented in current clinical practice, even in 
developed Western countries.7
There are hardly any studies regarding patient centeredness in the field of movement 
disorders. Grosset found that patients with Parkinson’s disease who perceived higher 
involvement in their care were more satisfied with the consultation and intended to be 
more compliant.8 Findley stated that a single-minded focus of doctors on disease 
severity and drug effectiveness does not adequately address experienced changes 
in patients’ quality of life.9 The author speculated that what patients need, is apparently 
not what doctors presently focus on. Others advocate the inclusion of patients’ 
expectations of treatment success as part of a set of criteria to evaluate treatment 
outcome.10 Finally, Politis et al. identified an enormous variety in what patients with 
Parkinson’s disease  perceive to be their most troublesome symptoms, depending in 
part on their disease severity, thus highlighting the importance of providing care 
tailored to each patient’s individual preferences.11
Delivering individualized and patient-centered care to patients with Parkinson’s 
disease is particularly challenging, given the complex and debilitating nature of this 
disease. Most patients become progressively handicapped by a mixture of cognitive, 
emotional and motor symptoms. As a first step towards developing patient-centered 
care for this population, we here explore the experiences of patients and their 
caregivers concerning received healthcare.
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2. Methods
2.1. Participants
Five focus group discussions involving 40 patients (Hoehn & Yahr 1-3, all living 
independently) and three separate group meetings involving 20 caregivers were 
conducted in June 2009 (Table 1). Patients and caregivers who were able and willing 
to give their opinion about the received healthcare in a group setting were included. 
No other specific in- or exclusion criteria were adopted. Participants were recruited 
from Neurology departments of six Dutch hospitals and by an online request on the 
website of the Dutch Parkinson’s Disease Patients Association. All participants 
completed a brief demographic questionnaire. The research protocol was approved 
by the local Ethics Committee, and signed consent was obtained from all participants.
2.2. Focus groups
Patients and their caregivers participated in eight focus group discussions. This 
qualitative interview technique was introduced in medical science by Kitzinger in 
1995 and has been used widely since.12 Patient experiences are best identified via 
focus groups. The interaction between group members encourages participation of 
those who are disinclined to be interviewed individually and elicits discussion about 
issues that may not arise in individual interviews. Moreover, the collective nature 
decreases the interviewer’s influence. The ideal size of a focus group ranges from 
four to ten participants.12,13 Our mean focus group size was 8 (range 4-10). Depending 
upon the nature and complexity of the subject and the level of saturation, the required 
number of focus groups can differ between one and ten meetings.13 We organized 
separate group meetings for patients and caregivers to encourage open discussion 
of problems and needs. Each focus group lasted for approximately 2 h. An 
independent moderator accompanied all focus groups by asking open-ended 
questions. Priority was given to aspects of care addressed by participants themselves.
2.3. Framework and topic list
Participants were asked to share their experiences concerning patient-centered care. 
Patient centeredness is typically presented as a multi-dimensional construct. Two 
frameworks were used to guide the discussion and qualitative analysis: the WHO 
responsiveness model14 and the Picker Institute principles of patient-centered care15, 
as listed in Table 2. The WHO responsiveness model focuses on the quality of the 
interaction between individuals and the health system.14 The Picker Institute defined 
eight universal dimensions of patient centeredness which appeared salient and 
relevant for European countries and the United States.15 Focus groups were facilitated 
by a topic list concerning aspects of Parkinson care. The written report of two panel 
discussions regarding patient preferences, conducted by the Dutch Parkinson 
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Patients Association in 2009, as well as an extensive literature search, were used to 
compose the topic list.  
2.4. Analysis
The tape-recorded focus group discussions were transcribed verbatim. We conducted 
an inductive analysis, involving the conceptualization of themes from the transcripts 
using Kwalitan 5.0. During a process called open coding, all emerging care aspects 
were labeled independently by two researchers to increase coding reliability. This 
was followed by discussion between the investigators and axial coding, which involves 
sorting and classifying codes into recurring themes. Generally, differences in interpretation 
Table 1  Background characteristics of study population 
Patients Caregivers 
Sample size(n) 40 20 
Gender (n,%)
women
10 (25)
30 (75) 
15 (75)  
5  (25) 
Age (mean, SD) 61.9 (7.6) 63.0 (1.8) 
Level of education(n,%)* 
Low education 
High education
20 (50)
20 (50)
13(65)
7 (35)
Diagnosis (n, %)
Parkinson’s disease
Multiple System Atrophy 
39 (98)
1  (2) 
- 
Years since diagnosis (mean, SD)   6  (5) - 
*‘High education’ means Bachelor, Master or PhD
Table 2  Frameworks of patient centeredness of the Picker Institute and WHO 
Picker Institute concept WHO responsiveness model 
1. Accessibility 1. Confidentiality of information 
2. Information & communication 2. Communication 
3. Partner & family involvement 3. Access to family & community support 
4. Respect & autonomy 4. Autonomy 
5. Organization of healthcare 5. Freedom to choose your own healthcare provider 
6. Continuity of care 6. Dignity 
7. Physical comfort 7. Prompt attention 
8. Emotional support 8. Quality of basic amenities 
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between researchers were small and consensus was promptly achieved. Using constant 
comparison analysis of codes and associated text fragments, a final set of codes and 
core themes were identified.12,13,16
2.5. Code selection
In this chapter, only a selection of codes is presented, based on their frequency and 
dispersion within the focus group discussions. A code was selected if it was mentioned in:
(a) All five patient focus groups OR
(b) Three patient focus groups, by a minimum of ten different participants OR
(c) One patient focus group, by a minimum of five different participants.
Thereafter additional codes were selected if the topic was mentioned in:
(d) All three caregiver focus groups OR
(e) Two caregiver focus groups, by a minimum of five different participants OR
(f) One caregiver focus group, by a minimum of three different participants.
3. Results
3.1. Care aspects, codes and core themes
From the focus group discussions, 2157 care aspects were selected and assigned to 
108 descriptive codes. These 108 descriptive codes were allocated to one of six core 
themes of patient centeredness regarding PD. Based on the criteria described in the 
last paragraph, 83 descriptive codes were selected and presented in this chapter. 
Fig. 1 shows the distribution of all 2157 care aspects among the six core themes. 
Table 3 illustrates the relationship between core themes, descriptive codes and related 
care aspects. The six core themes representing patient centeredness for people with 
PD are elaborated further in the following paragraphs.
3.1.1. Emotional support, empathy and respect
Patients and caregivers both expressed the need to be instructed how to cope with 
the disease in light of the changing roles in their relationship and maintaining their job 
as long as possible. According to patients, support to facilitate acceptance of the 
disease should be delivered directly after the diagnosis PD was first communicated 
to the patient. Participants wanted to be treated with respect and to be taken seriously. 
Paying attention to the ‘person behind the disease’ and providing customized care to 
individual preferences were greatly appreciated. Involvement and support of the 
caregiver was felt to be necessary in order to prevent overburdening. Generally, 
patients liked to share experiences with peers, provided that the contact is tailored to 
their own disease stage.
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3.1.2. Knowledge of PD treatment among caregivers
Participants desired to be treated by healthcare providers with specific, adequate 
knowledge of and experience in PD. According to patients, late recognition of early 
symptoms and delayed referrals by the general practitioner were major problems. 
Patients who were supported by a specialized Parkinson nurse endorsed their great 
importance for the treatment.
3.1.3. Provision of tailored information
Both patients and caregivers stated to be in need of reliable information about the 
disease and clear information on where to find professionals with PD expertise. 
Information about devices and home care were also being missed, mostly by 
caregivers. Patients were mainly interested in information about potential treatment 
strategies and tailored information that could support them in deciding when and 
how to start with medication.
3.1.4. Involvement in decision making and respecting patients’ preferences
Many patients and caregivers expressed a desire to be actively involved, and to be 
able to participate in shared decision making with their professional caregivers. 
Figure 1  Distribution of 2157 care aspects into six core themes
Involvement in
decisions & respect
preferences
322 (15%)
Emotional support,
empathy and respect
579 (27%)
Knowledge of
PD treatment among
caregivers
419 (19%)
Provision
of tailored information
386 (18%)
Continuity &
collaboration of
caregivers
276 (13%)
Accessibility
of healthcare
175 (8%)
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Table 3  Core themes and examples of descriptive codes and related care aspects  
Relationship between core themes, descriptive codes and care aspects 
Core theme Emotional support, empathy and respect 
↘ descriptive code Coping with and acceptance of the disease 
↘ Care aspect 
“(…) “I would like to talk with somebody about the acceptation of the 
diagnosis. Just a few conversations about learning how to cope with 
the disease.”
Woman with Parkinson’s disease, 61 years old 
Core theme Knowledge of PD treatment among caregivers
↘ descriptive code Need for and expertise of a specialized nurse
↘ Care aspect 
“(…) For me the neurologist provides the medical part of the treatment 
and the Parkinson nurse helps me to live with the disease. I can dis-
cuss everything with her. They have a separate, complementary role.”
Woman with Parkinson’s disease, 62 years old
Core theme Provision of tailored information 
↘ descriptive code Information about the disease 
↘ Care aspect 
“(…)”We have made treatment proposals by ourselves. I realize that we 
have the ability to oversee and look for information about the disease. 
Others have to depend solely on what their neurologist prescribes. 
Improvements must be made in the provision of valid information.
Caregiver, 68 years old
Core theme Involvement in decisions and respect for patient preferences
↘ descriptive code Take control of your disease
↘ Care aspect 
“(…) “Someone should organize training about ‘how to become 
a  patient’. A patient must be enabled to take control by himself. 
 Ultimately, the neurologist remains the expert who you can appeal  
to at any moment and with whom you have to collaborate.”
Man with Parkinson’s disease, 61 years old
Core theme Continuity and collaboration of caregivers
↘ descriptive code Need for interdisciplinary care 
↘ Care aspect 
“(…) They are all isolated specialists. My experience is that they do not 
employ an integrated approach.”
Caregiver, man, 45 years old 
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However, they identified a current lack of information to do so. Patients also valued 
the freedom to request a second opinion, and to self-select their professional caregiver 
or institution.
3.1.5. Continuity and collaboration of caregivers
Several patients identified the lack of multidisciplinary collaboration and communication 
between healthcare providers as an important bottleneck. They wanted therapists to 
plan multidisciplinary consultations periodically, where patients would be discussed 
in the group and be informed of the outcome afterwards.
3.1.6. Healthcare accessibility
Participants underscored the importance of a brief access time prior to consultation 
with their doctor, and the need to have easy access to interim telephone and mail 
contact. Patients also raised the suggestion for follow-up by telephone whenever 
medication was changed, to monitor for possible side-effects. The perceived access 
to hospital care increased considerably by the presence of a specialized nurse in the 
department.
Table 3  Continued  
Relationship between core themes, descriptive codes and care aspects 
Core theme Accessibility of healthcare 
↘ descriptive code Interim e-mail access 
↘ Care aspect 
“Most neurologists are very difficult to reach by phone or e-mail.  
I notice on the Internet that people often have short questions about 
their medicines, which can be answered by e-mail very easily. I do not 
have the possibility to do that.”
Woman with Parkinson’s disease, 56 years old
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Box 1 illustrates the most specific issues addressed by patients and caregivers separately.
Box 1  Diagnostic criteria, disease classification and clinical assessment
Important issues addressed by patients and caregivers
* Involvement of a specialized nurse
* Coping with the consequences of the disease
* Control who has access to the (Electronic) Health Record
* Communication between professional caregivers
* Having a neurologist who has knowledge of and experience in PD
Important issues especially addressed by patients
*Active involvement in medical decision making
* Possibility of and cooperation with a second opinion
* Time to consultation
* Information about the disease, 
   operations and (alternative) medicine
* Tailored care to individual preferences 
* Stigma and work related consequences of the disease
Important issues especially addressed by caregivers
* Active involvement of caregivers
* Paying attention to  caregivers
* Having contact with fellow caregivers
* Paying attention to the person behind the disease
* Information about disease related devices and home care
* Interim e-mail contact 
* Planning your own consult
55
DEFINITION OF PATIENT CENTEREDNESS IN PARKINSON CARE
3
4. Conclusions
We performed a series of focus group discussions that revealed various unmet needs 
and preferences among patients with Parkinson’s disease and their caregivers. Six 
core themes emerged, representing the disease-specific theoretical model of pa-
tient-centered care for people with PD. The general impression is a compelling call 
for patient centeredness in the management of PD. In the following paragraphs, we 
will highlight two key findings, and elaborate on opportunities for improvement: (a) 
patients’ desire to be emotionally supported and actively involved, and; (b) the need 
for multidisciplinary collaboration among healthcare providers with PD expertise.
4.1. Emotional support and active involvement in decision making
Our first main finding is that participants desired additional support to cope better 
with PD. Moreover, participants wanted their professionals to provide customized 
care, and to pay better attention to the ‘person behind the disease’. They demanded 
respect for individual preferences and expressed a desire to be actively involved in 
choices concerning their treatment. What can be done to improve these aspects of 
patient centeredness in Parkinson care? We will discuss ‘self-management support’ 
and ‘shared decision making’ as two promising ways to support and empower 
patients with Parkinson’s disease.
4.1.1. Self-management support
Self-management support refers to efforts to increase patient participation, collaborative 
goal-setting, treatment planning and assisting patients to gain control over their 
lives.17 Self-management among people with chronic conditions reduces healthcare 
utilization, improves communication between patients and doctors, and enhances 
health-related quality of life.18 Additionally, a patient education and health promotion 
program improved patients’ self-efficacy, and reduced the side-effects of medication.19 
Furthermore, the Patient Education Program Parkinson (PEPP) reduced the psychosocial 
problems and need for help among caregivers.20 Medical care generally does not 
meet patients’ needs for information and psychological support in coping with their 
condition. The use of self-management programs can be worthwhile for this purpose.21 
Patients with Parkinson’s disease can be encouraged to make decisions themselves 
and take action based on adequate information. Self-management programs can 
teach patients how to utilize healthcare resources and how to form partnerships with 
their care providers.
4.1.2. Shared decision making
Our findings show that patients with Parkinson’s disease wanted to participate in 
decision making with respect to their treatment. Shared decision making (SDM) can 
56
CHAPTER 3
assist doctors in situations where either evidence for the superiority of one treatment 
over another is lacking, or when it does not allow differentiation. The best choice 
depends on how individuals value the risks and benefits of the treatment.22 SDM is 
associated with positive effects on treatment compliance, anxiety and patient 
satisfaction.23 Broadly speaking, empowered patients can weigh the benefits, harms 
and scientific uncertainty of medical decisions.23 However, this is not a uniform desire, 
as patients vary in their wishes and abilities to be involved in decisions about their 
care. Active participation is more common among young, highly educated, relatively 
healthy patients and women.24 Age and cognitive capacity appear to play a major 
role in the ability to understand information and make decisions. Disease progression 
in PD is accompanied by cognitive decline and less ability to concentrate and make 
decisions. Martin et al. showed that impairment in understanding treatment consent 
and decisional capacity is already present in cognitively impaired patients without 
dementia.25 Delivering all available information to patients may therefore be 
overwhelming and paradoxically undermine their ability to choose wisely. So SDM 
can only be introduced in the treatment of progressive neurological diseases when 
accompanied by a careful exploration of patients’ decision making capacity and 
desired degree of control. Our present results suggest that SDM certainly merits 
further attention, both in clinical practice and in research.
4.2. Multidisciplinary care involving professionals with PD expertise
The second main finding is the importance attached by participants to PD expertise, 
and to the perceived lack of multidisciplinary collaboration between healthcare 
providers. In keeping with this finding, a recent review showed that adequate delivery 
of allied healthcare for people with PD is threatened by inadequate collaboration and 
communication between involved disciplines, insufficient expertise among most 
therapists, and generally low patient volumes for each individual therapist.26 The 
evidence for the benefits of allied healthcare in PD is increasing, but remains 
limited.27,28 Nevertheless, multidisciplinary collaboration is increasingly recognized to 
provide a complementary, therapeutic approach. In The Netherlands, multidisci-
plinary Parkinson care is facilitated by the ‘ParkinsonNet’ concept of healthcare. This 
approach reduces healthcare costs, increases adherence to evidence-based 
standards, and increases patient volume per professional.29 Effective multidisci-
plinary care requires that patients and their advocates are indispensable members of 
the healthcare team, with an important role in decision making. To enable patients to 
participate, they need to learn how to obtain reliable information about their condition, 
and need to get a better understanding of which healthcare professionals may 
contribute to their own healthcare team.
57
DEFINITION OF PATIENT CENTEREDNESS IN PARKINSON CARE
3
4.3. Shortcomings
This study was not without shortcomings. First, we included patients who were able 
and willing to share their healthcare experiences with others. Patients in late disease 
stages did not respond to our call to participate. With disease progression and a 
diminishing ability to communicate, patients with Parkinson’s disease tend to 
withdraw from social events. Hence, the needs we discussed in this chapter probably 
represent the relatively young and mild to mid-stage patients. Therefore, caution 
should be taken when interpreting these results for the general PD population and in 
particular those with severe PD. Second, one participant later turned out to have 
Multiple System Atrophy (MSA). His responses showed no striking differences from 
those of patients with Parkinson’s disease and he was therefore not excluded from 
the study. Future qualitative research must demonstrate whether the experiences of 
seriously affected patients with Parkinson’s disease or a form of atypical parkinsonism 
differ from those with early to mid-stage PD.
4.4. Implications
The theoretical model of patient centeredness for PD will be deployed to construct a 
‘patient centeredness questionnaire’, which can be used to evaluate current care and 
to facilitate patients in making proper choices. Such an instrument can give insight in 
the quality of care from a patient’s perspective, asking them about actual experiences 
instead of mere patient satisfaction. Measures of patients’ actual experiences discriminate 
more effectively between practices than measures of satisfaction.30 Therefore, determining 
patients’ experiences is increasingly recognized as an essential part of quality of care 
assessment. Feedback on patient-centered aspects will help healthcare professionals 
in providing care tailored to the specific preferences and needs of each individual 
patient. This study may have broader implications for the field of movement disorders. 
Many healthcare aspects identified in our study, such as respect for a patient’s 
preferences and the need for information, are generic and recognizable for all patients 
with chronic conditions. Generally, performance on patient centeredness remains a 
problem in Western countries.7 As such, our study endorses the compelling call 
made by the Commonwealth Fund for patient-centered care delivery for all chronic 
conditions.
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CHAPTER 4
Abstract 
Introduction
Patient centeredness is increasingly recognized as a crucial element of quality of care. 
A suitable instrument to assess the level of patient centeredness for Parkinson’s disease 
(PD) care is lacking. Here we describe the development and validation of the Patient- 
Centered Questionnaire for PD (PCQ-PD), and its initial application in a large patient 
sample.
Methods
Based on the outcomes of eight focus groups we composed a questionnaire that 
measures patient centeredness by assessing patients’ care experiences. The questionnaire 
was sent to 1112 Dutch patients, and face, content and construct-validity and reliability 
were assessed. The level of patient centeredness was determined by calculating scores 
for overall patient centeredness [0-3], subscale experiences [0-3], item experience, 
item priority and quality improvement.
Results
895 PD patients (net response 82.0%) completed the questionnaire. After the validation 
procedure, the PCQ-PD addressed 46 care aspects in six different subscales of patient 
centeredness. The internal consistency of the instrument, expressed in Cronbach’s a 
per subscale, ranged from 0.62 to 0.84. The overall patient centeredness score was 
1.69 (SD 0.45). ‘Emotional support’ (1.05, SD 0.90) and ‘provision of tailored information’ 
(1.18, SD 0.57) subscales received the lowest experience ratings. ‘Access to medical 
records’ obtained the highest item quality improvement score (5.44).
Conclusions
This study produced a valid instrument to measure patient centeredness in Parkinson 
care. Psychometric properties of the instrument were good. Application of the PCQ-PD 
revealed the level of patient centeredness in the care for PD patients in The Netherlands. 
The main outcome was a compelling call for the provision of tailored information and 
emotional support.
63
MEASUREMENT OF PATIENT CENTEREDNESS IN PARKINSON CARE
4
1. Introduction
Since the National Academy of Medicine (NAM) introduced their aims for improving 
the quality of healthcare systems in 2001, quality of care has received widespread 
attention of professionals and leading health organizations in Western countries.1-3 
Patient centeredness is one of the six NAM quality dimensions and represents a 
crucial element of quality of care. It has been defined as ‘providing care that is 
respectful towards and responsive to individual patient preferences’.3 
Recent studies on patient-centered care for people with neurodegenerative diseases 
have given clear insight in patients’ experiences and unmet needs.4,5 Some authors 
concluded that what patients need, is not what doctors focus on to date. The primary 
focus of physicians is on disease severity and drug effectiveness, but this does not 
adequately address experienced changes in patients’ quality of life.6 Grosset found 
that patients with Parkinson’s disease who perceived greater involvement in their 
care were more satisfied with the consultation and tended to be more compliant.7 The 
variation in patients’ expectations of treatment success and the perception of their 
most troublesome symptoms highlighted the importance of providing care tailored to 
each patient’s individual preferences.8
Surveys of patients’ experiences are increasingly recognized as an essential part of 
quality of care assessment.9 Measuring patient experiences is believed to discriminate 
effectively between practices, in contrast to patient satisfaction measures.10 In the 
United States, the Consumer Assessment of Healthcare Providers and Systems 
(CAPHS) survey is used to measure patient experiences.11 In The Netherlands, several 
Consumer Quality Indexes are developed.12 These questionnaires provide insight in 
the current state of patient-centered care, thereby providing professionals with 
tailored feedback that can be used for internal quality improvement. Other applications 
include benchmarking across care institutions, and their use as outcome measure for 
future clinical trials on patient-centered care.13
So far, a suitable instrument to assess the level of patient centeredness for people 
with PD is lacking. Therefore, the aim of this study was to build a valid questionnaire 
to measure patient experiences in Parkinson care. Here we describe the development 
and validation of the Patient-Centered Questionnaire for PD (PCQ-PD) and its initial 
application in a large sample of Dutch PD patients.
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2. Methods
2.1. Questionnaire development
A patient centeredness questionnaire was composed using the results of eight focus 
groups that focused on care experiences, preferences and needs of PD patients and 
caregivers.5 The questionnaire covers in- and out-patient care aspects and addresses 
professionals that are commonly involved in PD treatment, like neurologists, physical 
therapists and speech-language pathologists. Two researchers independently 
phrased items on patient experiences. Differences in formulation were discussed 
and consensus was promptly achieved. Subsequently, items on patients’ background 
characteristics (e.g. level of education) and items on patient priorities were added. 
The following response categories were used for the experience items: No, not at all; 
somewhat; for the most part; yes, absolutely, and: No; yes. In some cases a response 
option was added, like; ‘Not applicable’ or ‘I do not know/I haven’t tried’. For priority 
items, all starting with “How important did you find.?”, the following answer categories 
were applied: Not important; fairly important; important; and extremely important. 
After the validation process, the questionnaire was reciprocally converted from Dutch 
into English by two researchers (MF, ME) and a bilingual translator [appendix 1].
2.2. Data collection
The PCQ-PD was sent to 1112 PD patients to determine the psychometric properties 
of the instrument and the level of patient centeredness of Parkinson care in The 
Netherlands. Patients who received PD treatment during the past 12 months were 
included from five Dutch neurology clinics. Patients with severe cognitive impairment 
(Lewy Body Disease, Corticobasal Degenerative Disease, Parkinson’s disease 
Dementia, MMSE < 24) and Parkinson syndromes (Multiple System Atrophy, Progressive 
Supranuclear Palsy) were excluded. Questionnaires were sent accompanied by a 
cover letter, a refusal form and a postage-paid return envelope. In order to optimize 
the response rate, participants received a reminder card and a second questionnaire 
in the weeks after the initial mailing. Participation in this study was voluntary, anonymity 
was guaranteed. The research protocol was approved by the local ethical committee 
and Institutional ethical approval for separate clinics was thereby not required.
2.3. Data analysis
All completed questionnaires were processed electronically and data were entered 
into SPSS. Patients completing <50% of the background characteristics were excluded. 
Item Q18, 19 and 80 were negatively phrased. Thus, a positive answer indicated that 
the respondent had a negative experience for this care aspect. Data of these items 
were therefore mirrored, allowing for comparison with other items where higher scores 
indicated a better care experience. Psychometric properties of the questionnaire 
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were assessed by analysis of the content, face and construct validity (Section 2.3.1), 
item quality and internal consistency (Section 2.3.2). The level of patient centeredness 
was determined by calculating the overall patient centeredness score, subscale 
experience scores, item experience-, item priority and quality-improvement scores 
(Section 2.3.3).
2.3.1. Instrument validity
‘Content validity’ is warranted since the questionnaire items were based on the key 
elements of patient centeredness as defined by the Picker Institute and the WHO and 
a disease specific model of patient centeredness derived in our focus group study.5 
‘Face validity’ was determined by pre-testing the questionnaire within 14 cognitive 
interviews with PD patients, caregivers and professionals. Cognitive interviewing is 
used to evaluate sources of response error in questionnaires, developed during the 
1980’s by survey methodologists and psychologists.14 Consequently, some items 
were rephrased. In the absence of an external gold standard, univariate linear 
regression analysis was used to be able to comment on the ‘construct validity’ of the 
questionnaire. The following associations between patient characteristics (independent 
variable) and the overall patient centeredness score (dependent variable) were 
tested: PD patients who experience a higher level of patient centeredness,
1. Are more satisfied with healthcare15;
2. Are more often supported by a caregiver;
3. More often have access to ParkinsonNet professionals with specific PD expertise16;
4. Have a higher level of education compared to patients with lower experience scores17.
2.3.2. Item quality and instrument reliability
Items that qualified for removal of the questionnaire were: (a) extremely skewed items, 
i.e. >90% in one extreme answer category, (b) relatively unimportant items, i.e. item 
priority score (IPS) < 1.50 (c) items with a high non-response, i.e. >5% missing 
values18, (d) redundant items, i.e. Spearman’s rho between two items >0.80. When 
patients made many written comments regarding a certain item, restatement or 
exclusion of the item was considered. An exploratory factor analysis using Principal 
Component Analysis with oblique rotation was used to determine the underlying 
structure of the instrument.18-20 Items should have a factor loading >0.30 and all 
inter-factor correlations should be <0.70.18,19 The internal consistency was analyzed 
using Cronbach’s a. A subscale Cronbach’s a > 0.70 is considered appropriate. 
Subscales with Cronbach’s a < 0.60 are not reliable. Arguments for omission of 
single items were low contribution to the subscale (Item Total Correlation, ITC> 0.20) 
or an increased subscale Cronbach’s a when an item was deleted.20
66
CHAPTER 4
2.3.3. Outcomes
We first calculated item experience scores [IES, 0 ¼ most negative, 3 ¼ most 
positive], item priority scores [IPS, 0 ¼ not important, 3 ¼ extremely important] and 
quality improvement scores [QIS ¼ (3 _ IES)*IPS, 0 ¼ low priority, 9 ¼ high priority].
The proportion of negative experiences (PNE) per item represents the percentage of 
respondents with an IES of 0 or 1. As expected, most participants were unable to 
answer all survey items. In order to do so, PD patients should have consulted all 
professionals on the questionnaire and experienced all care aspects in the past year. 
Therefore, a mean IES was calculated for equal care aspects on different professionals. 
i.e. scores on“Q22 Did the neurologist listen carefully to you?” and “Q36 Did the PD 
nurse specialist listen carefully to you?” were combined into one IES ‘listen carefully’.
Next, subscale experience scores [SES, range 0-3] and an overall patient centeredness 
score [OPS, range 0-3] were calculated. Participants who answered <50% of the 
subscale items were excluded from further analysis of the subscale. A mean SES was 
calculated by adding up the subscale items and divide it by the total number of 
completed subscale items. i.e. the subscale ‘emotional support’ consists of six items 
and two of the items are about the patients’ caregiver. When the participant did not 
have a caregiver, the SES was calculated from the other four items. No data- 
imputation over the missing values was performed.
3. Results
3.1. Participants
From the 1112 questionnaires that were distributed, four packages returned unopened 
and 16 patients had deceased. Of the 1092 patients who received a package, 895 
completed the questionnaire (net response 82.0%, Table 1). 875 participants could 
be included for further analysis; 14 respondents did not receive PD treatment during 
the past 12 months and six respondents completed <50% of the background char-
acteristics. Self-reported Hoehn & Yahr disease state was between 1 and 3. 197 
patients (18.0%) did not return the questionnaire. On average, non-responders who 
returned the refusal form (n = 69) were five years older than responders (p < 0.001) 
and less satisfied with healthcare; 6.8 (1.5) vs. 7.3 (1.3) on a 1-10 scale (p < 0.05).
3.2. Psychometric properties of the instrument
3.2.1. Instrument validity
Regression analysis showed significant correlations patient centeredness and higher 
patients’ satisfaction with healthcare (r = 0.49, p < 0.001), patients’ familiarity with the 
ParkinsonNet concept (r = 0.26, p < 0.001), presence of a regional ParkinsonNet 
network nearby the clinic (r = 0.12, p = 0.001), support by a caregiver (r = 0.18, p < 0.001) 
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and higher level of education (r = 0.11, p = 0.002). These associations support the 
construct validity of the questionnaire.
3.2.2. Item quality and instrument reliability
Eight omitted experience items that did not meet the psychometric criteria are 
presented in Table 2 together with the reason for exclusion. For example, the item 
“Did your neurologist treat you in a polite manner?” was deleted since the response 
pattern was positively skewed. Exploratory factor analysis showed 46 care aspects 
in six different subscales of patient centeredness; involvement in decision making; 
provision of tailored information; accessibility of healthcare; empathy and PD expertise; 
continuity and collaboration of professionals and emotional support (Table 3). All items 
had a factor loading >0.30 on at least one of the factors and all inter-factor correlations 
were <0.70. The internal consistency of all subscales was appropriate, with Cronbach’s a 
ranging from 0.62 to 0.84. ITC’s reached the threshold of 0.20, except for two items 
Table 1  Background characteristics of responders and non-responders  
Percentage 
% (n)
Age in years 
mean (SD)
Gender 
% men
Overall satisfaction with care
mean (SD) [1-10 scale]
Non-responders 
(no refusal form)
11.7 (128) 68 (12) 52.0 Unknown
Non-responders 
(Refusal form) 
6.3 (69) 74 (9) 34.8 6.8 (1.5)
Responders 82.0 (895) 69 (10) 60.9 7.3 (1.3)
Table 2  Omitted items with reason for omission  
Nr of 
items
Item Reason for omission  
3 Collaboration with professionals not involved in  
PD treatment (i.e. cardiologist, pulmonologist)
Many missing values
2 Have you been informed about the possibilities of 
peer contact?  
Relatively unimportant
1 Did you feel free to ask questions about alternative 
medicine as an additional treatment for your illness? 
Redundant, overlap with Q10
1 Did your neurologist treat you in a polite manner? Positively skewed
1 Do you consider the internet to be a reliable source 
for PD information?
Many negative comments
68
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(Q80 and Q82). Replacement of these items caused a small increase of the subscale’s 
internal consistency. However, the items were maintained within the questionnaire 
based on high priority scores (IPS 2.17 and 2.35 respectively).
3.3. Outcomes
The overall patient centeredness score (OPS) was moderate; 1.69 (SD 0.45). Generally, 
patients experienced low levels of emotional support; SES 1.05 (SD 0.90) and they 
lacked the provision of tailored information; SES 1.18 (SD 0.57). Overall, patients 
experienced accessibility of healthcare SES 2.63 (SD 0.53) and empathy and PD 
expertise to be good; SES 2.55 (SD 0.48) (Table 3). Items with the highest QIS and PNE 
scores were mostly within the ‘provision of tailored information’, ‘emotional support’ 
and ‘involvement in decision making’ subscales. Table 4 shows that patients desired to 
have direct access to their medical records, wanted information about medication 
and treatment options and needed support with acceptance of the disease.
Table 4  Items with the highest Quality Improvement Scores (QIS)  
Item  Subscale PNE (%) n IES 
(Mean, sd)
IPS 
(mean, sd)
QIS
Q1 Access to your own medical record Involvement in decision making 88,0 668 0,36 (0,97) 2,06 (0,88) 5,44
Q9 Information About reimbursement of Parkinson medication Provision of tailored information 78,0 846 0,67 (1,03) 2,25 (0,76) 5,23
Q83 Feedback on discussions on your treatment between your professional caregivers Provision of tailored information 75,1 309 0,72 (1,03) 2,25 (0,78) 5,14
Q49 Information about possible treatment options occupational therapist Provision of tailored information 76,4 842 0,79 (1,04) 2,31 (0,81) 5,11
Q63 Information about possible treatment options psychosocial caregiver Provision of tailored information 75,4 846 0,79 (0,87) 2,31 (0,81) 5,10
Q2 Opportunity to decide who  has access to your own medical record Involvement in decision making 85,3 580 0,44 (1,06) 1,98 (0,98) 5,07
Q64 Information about where to find psychosocial caregivers with PD expertise Provision of tailored information 78,3 843 0,63 (0,93) 2,12 (0,84) 5,04
Q86 Emotional support with relationship changes Emotional support 81,6 591 0,63 (0,97) 2,03 (0,87) 4,80
Q85 Emotional support with coping with the disease Emotional support 74,9 813 0,82 (1,05) 2,13 (0,79) 4,65
Q50 Information about where to find an occupational therapist with PD expertise Provision of tailored information 72,2 837 0,84 (1,18) 2,12 (0,84) 4,58
Q10 Information about alternative medicine as an additional treatment Provision of tailored information 95,7 855 0,19 (0,57) 1,57 (1,02) 4,42
Q11 Information about complex treatment options Provision of tailored information 81,2 853 0,65 (1,02) 1,88 (1,00) 4,40
Q56 Information about possible treatment options speech-language pathologist Provision of tailored information 66,5 835 1,11 (1,12) 2,31 (0,81) 4,35
Q57 Information about where to find a speech & language pathologist with PD expertise Provision of tailored information 66,6 829 1,00 (1,22) 2,12 (0,84) 4,25
Q8 Contact after a new medication policy Provision of tailored information 52,7 837 1,38 (1,30) 2,47 (0,69) 3,99
PNE (%)  = Proportion of negative experiences. % answer category 0 and 1
QIS = (3 - IES)*IP
QIS = Quality Improvement Score [range 0-9]
IES  = Item Experience Score [range 0-3]
IPS  = Item Priority Score [range 0-3]
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4. Conclusions
4.1. Main results
This study yielded a valid instrument to measure patient centeredness in Parkinson 
care. Application of the PCQ-PD in a very large cohort of PD patients unveiled the 
level of patient centeredness of Parkinson care in The Netherlands: a compelling call 
to professionals to provide tailored information, emotional support in coping with the 
disease and access to medical records. In the following paragraph, we will elaborate 
on opportunities to improve the provision of information and emotional support to 
PD patients. 
PD is a complex and debilitating disease. Psychosocial problems such as feelings of 
stigmatization, depression and anxiety make coping with the disease difficult.21 Our 
results show that current healthcare does not adequately provide patient support, 
Table 4  Items with the highest Quality Improvement Scores (QIS)  
Item  Subscale PNE (%) n IES 
(Mean, sd)
IPS 
(mean, sd)
QIS
Q1 Access to your own medical record Involvement in decision making 88,0 668 0,36 (0,97) 2,06 (0,88) 5,44
Q9 Information About reimbursement of Parkinson medication Provision of tailored information 78,0 846 0,67 (1,03) 2,25 (0,76) 5,23
Q83 Feedback on discussions on your treatment between your professional caregivers Provision of tailored information 75,1 309 0,72 (1,03) 2,25 (0,78) 5,14
Q49 Information about possible treatment options occupational therapist Provision of tailored information 76,4 842 0,79 (1,04) 2,31 (0,81) 5,11
Q63 Information about possible treatment options psychosocial caregiver Provision of tailored information 75,4 846 0,79 (0,87) 2,31 (0,81) 5,10
Q2 Opportunity to decide who  has access to your own medical record Involvement in decision making 85,3 580 0,44 (1,06) 1,98 (0,98) 5,07
Q64 Information about where to find psychosocial caregivers with PD expertise Provision of tailored information 78,3 843 0,63 (0,93) 2,12 (0,84) 5,04
Q86 Emotional support with relationship changes Emotional support 81,6 591 0,63 (0,97) 2,03 (0,87) 4,80
Q85 Emotional support with coping with the disease Emotional support 74,9 813 0,82 (1,05) 2,13 (0,79) 4,65
Q50 Information about where to find an occupational therapist with PD expertise Provision of tailored information 72,2 837 0,84 (1,18) 2,12 (0,84) 4,58
Q10 Information about alternative medicine as an additional treatment Provision of tailored information 95,7 855 0,19 (0,57) 1,57 (1,02) 4,42
Q11 Information about complex treatment options Provision of tailored information 81,2 853 0,65 (1,02) 1,88 (1,00) 4,40
Q56 Information about possible treatment options speech-language pathologist Provision of tailored information 66,5 835 1,11 (1,12) 2,31 (0,81) 4,35
Q57 Information about where to find a speech & language pathologist with PD expertise Provision of tailored information 66,6 829 1,00 (1,22) 2,12 (0,84) 4,25
Q8 Contact after a new medication policy Provision of tailored information 52,7 837 1,38 (1,30) 2,47 (0,69) 3,99
PNE (%)  = Proportion of negative experiences. % answer category 0 and 1
QIS = (3 - IES)*IP
QIS = Quality Improvement Score [range 0-9]
IES  = Item Experience Score [range 0-3]
IPS  = Item Priority Score [range 0-3]
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especially when it comes to disease acceptance and changes in personal relation-
ships. Promising initiatives that address these needs have been implemented in recent 
years. First, the Patient Education Program Parkinson, a standardized psychosocial 
intervention aiming at improving the health-related quality of life of patients and 
caregivers, showed significant improvements in patients’ mood and caregivers’ 
psychosocial problems.22 Second, within regional allied health networks of PD 
professionals, psychosocial caregivers are now trained to provide emotional support.16 
Third, increasing evidence is found that care delivered by a PD nurse specialist has 
positive effects on patients’ well being and the level of depression and anxiety.23
Our results clarify that PD patients were in need of information, particularly about 
Parkinson medication and the various treatment options offered by all professionals 
involved. This specific information demand was confirmed by our earlier focus group 
findings and other studies on PD patient’s needs.4,5,24 A British study showed that patients 
wanted to know when to seek medical advice, and they wanted information about 
their medication and about treatments available for PD.24 The study of Buetow showed 
that patients wanted their GPs to offer information about their condition and involve 
them in decision making.4 Patients within a focus group study on self-perceived physical 
limitations and compensatory strategies voiced a lack of personalized care, individualized 
attention and information regarding their specific symptoms and limitations.25 
Similar results were found in patient centeredness studies involving other patient 
groups.13,26, indicating that the need for emotional support and information is rather 
universal, and that generic solutions should be developed. A study with patients 
facing fertility problems showed that participants lacked the information on possible 
side effects of prescribed medication, and they urged their professionals to pay 
attention to the enormous impact of fertility problems on their emotional well-being.13 
Increasingly, the Internet can provide generic solutions for different patient groups to 
acquire reliable information and emotional support. Promising examples include 
online peer support, access to Personal Health Records with integrated social 
networking tools and Internet-based medical education to instruct PD patients about 
complicated medication regimens.27,28
4.2. Strengths
First, the PCQ-PD has been developed according to state-of-the art procedures29, 
including a combination of qualitative methods (focus groups, cognitive interviews) 
and quantitative methods (questionnaire completed by 895 patients). The representative 
patient sample, together with the satisfactory response rate (82.0%), ascertained 
that the results were not affected by sampling bias and contributed to the general 
applicability of the instrument.10 Second, the questionnaire covers a wide variety of 
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in- and outpatient care aspects, addressing emotional support, collaborative care, 
accessibility of care, PD expertise, provision of information and patient involvement. 
Taken together, all items provide a disease specific model of patient centeredness. 
Moreover, the questionnaire’s multidisciplinary focus underscores that the provision 
of patient-centered care is the responsibility of all professionals involved in the 
treatment of PD patients. Third, the questionnaire can provide PD clinics with 
feedback about the quality of care through the eyes of their own patients’, by asking 
them about genuine care experiences. Feedback drawn from experience surveys 
can be easily translated into service improvement initiatives.10
4.3. Shortcomings
Some weaknesses should be mentioned. First, we do not know whether the observed 
differences in patient centeredness between the participating clinics represented 
actual discrepancies in the quality of care, or merely differences caused by case mix 
variations. For this purpose, future studies should focus on background characteris-
tics associated with care experiences, like disease duration, level of education and 
ethnicity. Interestingly, recent work has shown that many variations in the quality and 
costs of care cannot simply be attributed to case mix variations, but reflect true 
differences in professional behavior.30 Additionally, the responsiveness of the 
PCQ-PD should be evaluated. i.e. by the establishment of the test-retest reliability in 
repeated measurements within a small patient sample.29 Second, despite appropriate 
Cronbach’s a of all subscales, the internal consistency of the total scale could not be 
calculated using this dataset. Adjustments were made to prevent missing values in 
future measurements, allowing for estimation of the instrument’s internal consistency. 
Third, it would have been better to have separated the validation study from the initial
application study. Since the face validity and content validity was established before 
the psychometric property data were gathered and no items were changed afterwards, 
we used the dataset to draw some initial conclusions on the PD population at large. 
Future work should replicate these findings in an independent population. Fourth, 
since the Dutch PCQ-PD was translated into English after the validation procedures, 
future research should include validation of the English PCQ-PD. Some items may be 
specific to the country’s practice and may have to be rephrased. For PCQ-PD users 
outside The Netherlands a small pre-test with PD patients is advised to confirm the 
content- and face validity in their country. Fifth, patients who completed the questionnaire 
were more satisfied with their care compared to non-responders. Regression analysis 
demonstrated that a higher level of patient centeredness was associated with higher 
patient’s satisfaction. Therefore, our results may be slightly overestimated, and the 
actual level of patient centeredness of Dutch Parkinson care might be lower in real 
life. Hence, experience scores can be adjusted by subdividing respondents into 
different satisfaction levels and to calculate experience scores per cohort.
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4.4. Future perspective
Patient experiences should be at the core of future assessments of the quality of 
Parkinson care. The definition of patient centeredness suggests that care has to be 
respectful of and responsive to individual patient preferences and values. In this 
respect, our current application of the PCQ-PD in a group of almost 900 PD patients 
(yielding a mean experience score) is somewhat contradictory, as this only offers 
insight in the quality of care as perceived by mainstream PD patients, but it did not 
clarify patients’ individual needs, expectations and priorities. Possible future 
applications of the PCQ-PD include benchmarking of and feedback to institutions, in 
order to improve their quality of care tailored to the wishes of their customers. The 
overall patient centeredness score can be used as an outcome measure for future 
clinical trials aiming to improve patient-centered care. The results will create transparency 
and better opportunities for PD patients to choose for quality themselves.
To date, such comparisons across clinics have not been made in the field of PD.
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“I’m blessed to be under the care of a team of professionals. 
Collaboration would be ideal but very difficult to achieve. 
It is imperative that I take responsibility of my care. A few things 
that make that easier for me:
*Email and phone access to all my doctors. 
*Please do not put me in a room and say the doctor will 
be here shortly. Please let me wait in the waiting room. 
*I want a person who I can call when I can’t reach my doctors.
*Caution about what I will face as new disease progression. 
*Follow-up calls after discharge or changes in medications.
Woman with Parkinson’s disease, 54 years old 
Patient centeredness study, chapter 5
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Capturing patients’ experiences to change Parkinson’s disease care delivery:  
a multicenter study. Journal of Neurology 2015 [in press]
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Abstract
Introduction
Capturing patients’ perspectives has become an essential part of a quality of care 
assessment. The patient centeredness questionnaire for PD (PCQ-PD) has been 
validated in The Netherlands as an instrument to measure patients’ experiences. This 
study aims to assess the level of patient centeredness in North American Parkinson 
centers and to demonstrate the PCQ-PD’s potential as a quality improvement instrument.
Methods 
20 Parkinson Centers of Excellence participated in a multicenter study. Each center 
asked 50 consecutive patients to complete the questionnaire. Data analyses included 
calculating case mix-adjusted scores for overall patient centeredness [scoring range 
0-3], six subscales [0-3] and quality improvement [0-9]. Each center received a 
feedback report on their performance.
Results
The PCQ-PD was completed by 972 PD patients (median 50 per center, range 37-58). 
Significant differences between centers were found for all subscales, except for emotional 
support (p<0.05). The information subscale (mean 1.62 SD 0.62) and collaboration 
subscale (mean 2.03 SD 0.58) received the lowest experience ratings. 14 centers 
(88%) who returned the evaluation survey claimed that patient experience scores 
could help to improve the quality of care. Nine centers (56%) utilized the feedback to 
change specific elements of their care delivery process. 
Conclusions
PD patients are under-informed about critical care issues and experience a lack of 
collaboration between healthcare professionals. Feedback on patients’ experiences 
facilitated Parkinson centers to improve their delivery of care. These findings create a 
basis for collecting patients’ experiences in a repetitive fashion, intertwined with existing 
quality of care registries.
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1. Introduction
In 2001, the National Academy of Medicine introduced six areas to improve the 
quality of the US healthcare system. These areas were built around the fundamental 
needs for healthcare, which has to be safe, effective, equitable, timely, efficient and 
patient-centered.1 Patient centeredness is increasingly recognized as a critical aspect 
and deficiency in care delivery.1-3 The concept can be defined as providing care that 
is respectful of and responsive to individual preferences, and ensuring that the 
patient’s needs guide all clinical decisions. 
Patient-centered care reflects an ethical norm inherent to medicine.4 In addition to the 
intrinsic value, the approach is associated with improved physical and psychosocial 
health outcomes.5-7 Moreover, patient-centeredness increases treatment adherence 
among chronically ill patients.8 The concept may lower costs by a shortened length 
of stay in the hospital, decreased adverse events and reduced healthcare utilization.9-11
To integrate the concept into a comprehensive assessment of quality of care, we need 
validated instruments and an assessment of current levels of patient centeredness.12 
Increasingly, experience questionnaires have been recognized to provide insight into 
the level of patient centeredness.13-14 Moreover, improving care experiences has 
become a key priority for health system reform in the US.15-16 The Affordable Care Act 
mandated new payment approaches based in part on the results of patient experience 
surveys.17
The US and England have the longest tradition of measuring care experiences, 
through the Consumer Assessment of Healthcare Providers and Systems (CAPHS) 
questionnaire (US) and the Picker Institute survey (used by the NHS). The patient 
centeredness questionnaire for PD (PCQ-PD) has been developed according to 
Dutch standards for measuring patients’ experiences.18 This study aimed to validate 
the PCQ-PD for use in US based populations, to assess the level of patient 
centeredness in North American Parkinson centers, and also to demonstrate the 
PCQ-PD’s potential as a quality improvement instrument.
2. Methods
2.1 Cross-cultural validation
A cross-cultural validation procedure was applied to the Dutch version of the PCQ-PD 
to test the applicability in National Parkinson Foundation (NPF) centers in the US and 
Canada.19 Cross-cultural validation included a translation of the questionnaire from 
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Dutch into English, based on a forward-backward translation process by two 
researchers and a bilingual translator, online expert consultation with 17 movement 
disorders specialists; and pre-testing the face and content validity by conducting 15 
cognitive interviews with health professionals, patients and caregivers in the UF 
Center for Movement Disorders and Neurorestoration. Consequently, some items 
were refined, for example the word ‘tools’ was changed into ‘adaptive equipment’ 
(Q2) and ‘complementary medicine’ into ‘alternative health therapies’(Q8). Two new 
items were included (Q4-Q28) and one item was removed. ‘When to start with 
medication’ referred to the right time to take anti-Parkinson medication; immediately 
after the  diagnosis or during the course of the disease. All American interviewees 
started immediately. The PCQ-PD consists of 15 items on patient characteristics, e.g. 
gender, age, race and health status and 44 care aspects covering six subscales of 
patient centeredness (Table 1).
2.2  Multicenter study
2.2.1 Data collection 
North American NPF Centers of Excellence were invited to participate in a multicenter 
study (n = 48). These centers are recognized as leaders in Parkinson care based 
on their ongoing research, comprehensive care delivery and professional education. 
In each participating center a research coordinator was assigned to distribute the 
PCQ-PD. Patients with idiopathic PD, multiple system atrophy or progressive supranuclear 
palsy were included. Patients diagnosed with severe cognitive impairment, like Lewy 
body disease, corticobasal degenerative disease, Parkinson’s disease dementia or 
MMSE <24 were excluded. 
Consecutive patients were asked to complete the questionnaire at the clinical site 
after their consultation with a neurologist. The PCQ-PD was accompanied by an informed 
consent form, a return envelope and a cover letter signed by local neurologists. 
Neither patient names nor addresses were stated. The PCQ-PD had a center identification 
number only. Completed questionnaires were stored in a sealed envelope and returned 
to the research coordinator. All centers applied for approval by a local institutional 
review board. The protocol was exempted from review, since patients could not be 
identified from the data and the study did not involve an intervention, specimens or 
devices.
2.2.2 Sample size calculation 
The PCQ-PD’s ability to discriminate between practices can be determined by the 
Intra-class Correlation Coefficient (ICC).20 The ICC accounts for the relatedness of 
clustered data (here: patients clustered in Parkinson centers) by comparing the 
variance within centers with the variance between centers. High ICC values indicate 
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greater variation between centers, relative to variation within centers. Sample size 
calculations showed that with 20 participating centers, an estimated ICC of 5% 
(95%CI 0.01-0.14), 50 patients had to complete the PCQ-PD per center.21
2.2.3 Data processing
Completed questionnaires were processed manually and data were entered into 
SPSS. Systematic and random errors were detected and instantly corrected by 
conducting frequency analyses and by entering the data of 5% of the questionnaires 
twice (n = 50). Participants completing <50% of the experience items were excluded. 
Three items were negatively phrased (Q17-23-24). Thus, a positive answer indicated 
a negative experience on this aspect. Data of these items were mirrored, allowing for 
comparison with other items where higher scores indicated better experiences.
Table 1  The PCQ-PD consists of 44 care aspects covering six subscales  
Subscales Care aspects
Information 
12 items
 
Patient organizations (Q1), adaptive equipment, home care and facilities 
(Q2), reliable information (Q3), peer support (Q4), medication use and  
side effects (Q5), reimbursement of treatment costs (Q6), contact after 
medication regimen changes (Q7), alternative health therapies (Q8), 
advanced treatment options (Q9), ability to drive a car (Q10), find health 
professionals specialized in PD (Q11) and; treatment options allied 
healthcare professionals(Q12).
Collaboration
11 items
Leading physician (Q13), care coordinator (Q14), awareness of 
professionals of each other’s involvement (Q15), mutual agreements (Q16), 
conflicting information (Q17), informed about what professionals discussed 
regarding your treatment (Q18), cooperation second opinion (Q19), timely 
referrals (20), collaboration PD nurse specialist and neurologist (Q21), 
collaboration between physicians (Q22) and; fixed contact for questions or 
complaints (Q25).
Accessibility
4 items
Waiting period before visiting a neurologist (Q23), waiting period in waiting 
room (Q24), e-mail access (Q26) and telephone access (Q27).
Empathy
5 items
Questions answered in a timely manner (Q28), listen carefully (Q29),  
take enough time (Q30), explain things clearly (Q31), and; professional 
competence (Q32).
Patient 
involvement
6 items
Access to medical record (Q33), authorize who has access to your medical 
record (Q34), opportunity to choose your healthcare professional 
(Q35),opportunity to schedule appointments (Q36), adapt treatment to 
personal preferences (Q37) and; participation in treatment decisions (Q38).
Emotional 
support 
6 items
Attention paid to the caregiver (Q39), active involvement of the caregiver 
(Q40), support after the diagnosis was first communicated (Q41), support 
coping with the disease (Q42), support relationship changes (Q43), support 
related to employment (Q44).
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2.2.4 Data analysis 
For each item an Item Experience Score (IES) [0 = No, not at all, 1 = Yes, to some 
extent, 2 = Yes, to a moderate extent, and 3 = Yes, to a great extent], an Item Priority 
Score (IPS) [0 = Not important, 1 = Fairly important, 2 = Important, and 3 = 
Extremely important], a proportion of negative experiences [% respondents with IES 
0 or 1] and a Quality Improvement Score (QIS) were calculated at the center level. The 
latter represents those care aspects where patients report negative experiences in 
combination with high priorities, and can as such be labeled as having priority for 
quality improvement. QIS was calculated by the maximum IES of 3 minus the 
observed IES, multiplied by the observed IPS. Consequently, improvement scores 
vary from 0-9; the higher the score, the higher the need for improvement. For each 
center, case mix-adjusted subscale scores [0-3] and an Overall Patient centeredness 
Score (OPS) [0-3] were calculated using a general linear model. To determine any 
differences between centers, one-way ANOVA analysis was performed.
2.3 Discriminative power 
Multivariate multilevel regression analysis was performed to assess the discriminative 
power of the PCQ-PD between centers.22-23 First, univariate multilevel regression 
analyses were performed between patient characteristics and subscale scores. Next, 
two nested models were fitted to the data. The first model was a random-intercept 
model without explanatory variables (0-model). The second model was performed 
with patient characteristics as fixed effects (1-model). Casemix adjusters with a p value 
<0.20 in the univariate regression analysis were included in the multivariate regression 
model using a backward selection procedure.24. Discriminative power was determined by 
calculating ICCs for each subscale in both the 0 and 1-model, with a random intercept 
at the center level. To assess how much variance in each 0-model is attributable 
to differences in patient characteristics, the proportional change in variance was 
calculated.25
2.4 Feedback reports
Each center received a feedback report on their level of patient centeredness. The 
report included an Overall Patient centeredness Score (OPS) and subscale scores 
anonymously benchmarked against other centers. Additionally, Quality Improvement 
Scores (QIS) and patients’ qualitative feedback were presented. Hereby, health 
professionals could identify care aspects with the highest priority for improvement in 
their own center. Professionals were encouraged to discuss the report within their 
medical team, but were free to change aspects of care that needed improvement 
according to their patients. After three months, medical directors and research 
coordinators received a survey to evaluate the impact of the feedback report. 
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3. Results
3.1 Respondents
20 Parkinson Centers of Excellence participated in this study (center participation 
rate 41.7%). The PCQ-PD was completed by 972 PD patients (median 50 per center, 
range 37-58). 17 patients were excluded based on having another diagnosis, and this 
included depression, essential tremor, dementia or dystonia (n = 7), or because of 
completing <50% of the experience items (n = 10). Patient characteristics of all 
respondents are shown in Table 2.
3.2 Overall patient centeredness and subscale scores  
The information subscale [mean 1.62 (SD 0.62)] and collaboration subscale [mean 
2.03 (SD 0.58)] received the lowest experience ratings. Accessibility of care [mean 
2.49 (SD 0.55)] and empathy [mean 2.63 (SD 0.52)] received the highest experience 
ratings. The Overall Patient centeredness Score (OPS) and casemix-adjusted 
subscale scores for each center are shown in Figure 1. OPS ranged from 1.87 (95%CI 
= 1.74-2.00) for the worst performing center to 2.23 (2.11-2.36) for the best [δ 0.36]. 
Subscale scores ranged from 1.89 to 2.68 [δ 0.79] for patient involvement; 1.61 to 
2.29 [δ 0.68] for collaboration; 1.83 to 2.44 [δ 0.61] for emotional support; 2.15 to 2.71 
[δ 0.56] for accessibility; 1.37 to 1.88 [δ 0.51] for information; and 2.47 to 2.81 [δ 0.34] 
for empathy.
3.3 Quality improvements scores(QIS)
The item with the highest QIS 4.80 was ‘Were you informed about what your health 
professionals discussed with each other regarding your treatment?’(Table 3). 80.3% 
of the respondents indicated to have a negative experience on this item. Care aspects 
with the highest potential for improvement are all information and collaboration 
subscale items. Care aspects with the highest priority scores were all empathy 
subscale items. However, these items had low QIS, as patients experience good care 
on these aspects.
3.4 Evaluation of the feedback reports
Eight medical directors and 12 research coordinators representing 16 centers (80%) 
returned the evaluation survey. All respondents read the report and all but two 
discussed the report within their medical team. Moreover, nine centers (56%) shared 
the results with patients in the waiting room. The feedback report was perceived as a 
useful tool for internal quality improvement by 14 centers (88%). Respondents stated 
that the report easily identified areas to work on and revealed invaluable information 
from the patient’s perspective. Additionally, nine centers (56%) used the feedback to 
change specific elements within their care delivery process illustrated by the following 
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Table 2  Patient characteristics  
Net response N 955
Respondents per center Median [range] 50 [37-58]
Age (years) Median [range] 69.0 [32-93]
Gender n (%) Women 377 (38.8)
Level of education n (%) College or university degree 501 (52.5)
 n (%) Technical or community college 75 (7.9)
  n (%) College no degree 157 (16.5)
 n (%) High school 170 (17.8)
 n (%) Less than high school 51 (5.3)
Diagnosis Parkinson’s disease 928 (97.2)
Parkinsonism (MSA and PSP) 27 (2.8)
Disease duration (years) Median [range] 7.0 [1-40]
Self-reported n (%) HY1 306 (32.5)
Hoehn & Yahr disease stage n (%) HY2 190 (20.2)
 n (%) HY3 374 (39.7)
 n (%) HY4 49 (5.2)
 n (%) HY5 22 (2.3)
Self-reported n (%) Excellent 70 (7.4)
physical health status n (%) Very good 301 (31.6)
n (%) Good 387 (40.7)
n (%) Fair 165 (17.3)
n (%) Poor 29 (3.0)
Self-reported n (%) Excellent 155 (16.3)
mental health status n (%) Very good 363 (38.1)
 n (%) Good 298 (31.3)
 n (%) Fair 116 (12.2)
 n (%) Poor 20 (2.1)
Race n (%) Caucasian 671 (93.6)
n (%) African American 17 (2.4)
n (%) Asian 14 (2.0)
n (%) American Indian or Alaska native 2 (0.3)
n (%) Other 13 (1.8)
Overall quality of care n (%) Excellent 603 (62.6)
 n (%) Very good 265 (27.5)
 n (%) Good 77 (8.0)
 n (%) Fair 15 (1.6)
 n (%) Poor 3 (0.3)
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statements: “We altered the pre-appointment checklist to ask patients to provide more 
input into their care(#3); We took the top five items cited for improvement and are 
digging down into them more. We started a project that will allow for better driver 
screening(#11); We developed a center information sheet to new patients that provides 
explicit information about available resources(#13). Patients are given an email to 
contact the physician after 2-3 weeks in the medications changes(#14).We have 
changed the way we are addressing the waiting list(#17) and; We have added 
additional providers to increase accessibility and are increasing the referrals in the 
patient’s area of residence(#26). 
3.5 Discriminative power of the PCQ-PD
One-way ANOVA analysis showed significant differences between centers on overall 
patient centeredness and all subscales, except for emotional support (p <0.05). 
Table 4 demonstrates the multilevel analysis results. Regression coefficients (column 
3-9) show that gender, level of education, physical and mental health status, disease 
Figure 1  Level of patient centeredness in North American Centers of excellence
The small dots and boxes in Figure 1 represent case mix-adjusted mean scores per subscale 
for each center. The horizontal lines in each boxplot represent the minimum, first quartile, 
median, third quartile and maximum score per subscale. Dots plotted outside the boxplot are 
outliers. The OPS and subscale scores for the total study population are shown below Figure 1.
Mean (SD)   2.09 (0.44) 2.27 (0.80) 2.63 (0.53)2.40 (0.63)2.49 (0.55)2.03 (0.57)1.62 (0.62)
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stage, language and race are significantly related to patient centeredness scores. 
For example, a higher level of education is associated with more positive experiences 
towards information, patient involvement and empathy. Conversely, women perceived 
less access to healthcare compared to men. The proportional change in variance 
shows that patient characteristics explain 0.7% for emotional support to 11.8% for 
information of the total variance detected in the 0-models. ICC values demonstrate 
that differences between centers were accountable for 1 to 6% of the variance in 
patient centeredness. 
Table 3  Ten highest quality improvement scores  
Item Subscale %NE IES
[0-3]
IPS 
[0-3]
QIS 
[0-3]
Q18 Informed about what professionals 
discussed with each other regarding 
your treatment
Collaboration 80.3% 0.80 2.19 4.80
Q8 Informed about alternative health 
therapies
Information 71.0% 1.03 2.07 4.08
Q7 Being contacted after a new 
medication regimen
Information 61.1% 1.22 2.21 3.94
Q9 Informed about advanced treatment 
options
Information 62.6% 1.33 2.24 3.73
Q16 Mutual agreements about your 
treatment
Collaboration 60.9% 1.30 2.16 3.68
Q2 Informed about adaptive equipment, 
home care and facilities
Information 73.5% 1.03 1.72 3.39
Q1 Informed about Parkinson’s disease 
patient organizations
Information 75.3% 0.95 1.55 3.17
Q22 Collaboration between physicians Collaboration 46.7% 1.73 2.39 3.05
Q10 Informed about ability to drive a car Information 50.1% 1.61 2.10 2.93
Q12 Informed about treatment options 
allied healthcare professionals
Information 41.8% 1.80 2.44 2.92
%NE = the proportion of patients with a negative experience with that aspect, IES = Item Experience 
Score, IPS = Item Priority Score, QIS = Quality Improvement Score = (3-IES)*IPS.
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4. Conclusions
4.1 Main results
Application of the PCQ-PD in a large cohort showed that North American PD patients 
are under-informed about critical care issues and experience a lack of collaboration 
between members of their healthcare team. Moreover, significant differences in 
patient centeredness between the participating centers were found. Feedback on 
patients’ experiences stimulated half of the centers to change the delivery of care at 
their individual center. Here, we will discuss the potential significance of these findings.
This study showed that PD patients are under-informed about critical aspects of their 
care, as was found previously.18-26-27 A qualitative study from New Zealand on unmet 
needs showed that PD patients wanted their physicians to offer more information 
about their condition.26 Moreover, a British study demonstrated that PD patients were 
poorly informed about medication and treatment options.27 Application of the 
PCQ-PD in a large Dutch sample certified that patients were in need for information 
regarding alternative health therapies and treatment options of allied health 
professionals.18 These findings reflect the complexity of providing the right information 
to the right person at the right time. Considerable individual differences in information 
needs exist, while each disease stage induces new information requirements.28 
Stratification of patients’ needs by disease stage and online personalized information 
might facilitate healthcare providers to target information to patient subgroups.29
PD patients were not aware of mutual consultation and sound agreements between 
members of their healthcare team. Moreover, patients were not informed about what 
health professionals discussed with each other regarding their treatment. Two previous 
studies confirm that Dutch patients experience a lack of collaboration between 
professionals in the exact same way.18,30 An integrated approach including the patient 
as part of the team is thought to be the best way to manage PD.31. However, evidence 
quantifying positive and sustained effects of such an approach remains inconclusive.31-32 
Novel care models, fostering the interaction between healthcare providers and patients 
and online exchange of medical data, may facilitate multidisciplinary collaboration 
in healthcare.29
Feedback on patients’ experiences stimulated health professionals to improve the 
delivery of care at their individual center. Three months after receiving the report, half 
of the centers had changed specific elements of their care delivery process. However, 
feedback did not encourage all centers to improve; some centers discussed the 
report within their medical team, but did not know how to convert the feedback into a 
practicable action plan. Increasing the desire to change and improving the ability to 
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Table 4   Model fitting results multilevel analysis for the six subscales  
of patient- centered care  
Intercept
Mean (95% CI)
Sex
(two levels)
Education
(five levels)
 Physical Health
(five levels)
Mental Health
(five levels)
Disease stage
(five levels)
Language
(four levels)
Race
(four levels)
Var 
 patienta
Var 
 centerb
PCVc ICCd
OPS
0-model 2.15 (2.02 – 2.28) 0.191 0.005* reference 0.025
Final model 1.82 (1.58 – 2.05) 0.05 (0.03 – 0.07) 0.04 (0.01 – 0.08) 0.04 (0.00 – 0.07) 0.175 0.004* 8.8% 0.023
Information
0-model 1.83 (1.66 – 2.01) 0.367 0.012* reference 0.031
Final model 1.13 (0.81 – 1.45) 0.11 (0.08 – 0.14) 0.07 (0.01 – 0.12) 0.05 (0.01 – 0.09) -0.06 (-0.12 – 0.00) 0.329 0.006* 11.6% 0.017
Collaboration
0-model 1.94 (1.77 – 2.11) 0.318 0.012* reference 0.037
Final model 1.84 (1.52 – 2.16) 0.295 0.011* 7.3% 0.038
Accessibility
0-model 2.59 (2.43 – 2.75) 0.281 0.017* reference 0.058
Final model 2.53 (2.25 – 2.82) -0.08 (-0.15 - -0.01) 0.05 (0.01 – 0.10) -0.05 (-0.09 - -0.02) -0.08 (-0.13 - -0.02) 0.263 0.016* 7.0% 0.058
Patient involvement
0-model 2.46 (2.28 – 2.65) 0.380 0.020* reference 0.051
Final model 2.30 (1.96 – 2.63) 0.03 (0.00 – 0.07) 0.07 (0.01 – 0.12) -0.07 (-0.13 - -0.01) 0.349 0.019* 8.0% 0.052
Empathy
0-model 2.64 (2.48 – 2.80) 0.272 0.002 reference 0.007
Final model 2.24 (1.96 – 2.52) 0.03 (0.00 – 0.06) 0.07 (0.02 – 0.11) 0.07 (0.03 – 0.11) 0.248 0.003* 8.5% 0.011
Emotional support
0-model 2.22 (1.91 – 2.52) 0.628 0.007 reference 0.011
Final model 2.26 (1.68 – 2.84) 0.627 0.004 0.7% 0.006
a  Var patient = variance at the patient level. The significance of variances at the level of  
individuals is not reported
b Var center = variance at the center level. Variances with a *sign are significant (p<0.05)      
c  PCV = Proportional change in variance = (Total Var 0-model) – (Total Var Final model)/Total Var 0-model.  
E.g. for information, the PCV is ((0.367 + 0.012)-(0.329 + 0.006))/(0.367 + 0.012) = 0.116
d  ICC = Var center/(Var patients + Var center). E.g. for information, the ICC  
for the final model = 0.012/ (0.367 + 0.012) = 0.03
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translate feedback into an optimal improvement strategy are necessary future steps.33 
Furthermore, the content and timing of feedback is important.34 Long term conditions 
such as PD, require audits and feedback at regular intervals, provided to various 
levels of staff, in both verbal and written formats, and should include explicit targets 
to accomplish behavioral change.35 
 
This study uncovered significant differences in the level of patient centeredness 
between North American Parkinson centers. These differences may reflect meaningful 
variation, however, multilevel analysis revealed that differences between centers were 
accountable for only 1-6% of the variance in patient centeredness. These values 
suggest that variation in experience scores occurred mainly at the patient level and 
to a lesser extent at the center level. Casemix adjustment did not change this result. 
Limited discriminative power is a common finding in experience surveys and may 
have resulted from the homogeneity of participating centers in our study36; all of 
these were established Centers of Excellence recognized by the American NPF. 
However, NPF centers do provide different services, resources and professional 
disciplines on a center-by-center basis without standardization. Stratification for 
hospital factors might increase benchmark validity in future studies. Additionally, 
unknown confounders may have obliterated the variation between centers.36 Limited 
discriminative power suggests that patients’ experiences can be used for feedback 
and to rank the best and the worst performing centers, but should not be utilized to 
list all centers in a consecutive order. If new payment models depend in part on care 
experiences, the discriminative power of experience surveys should be raised.
4.2 Strengths
First, cross cultural validation contributed to the face and content validity of the 
PCQ-PD. We applied cognitive interviews to evaluate sources of response error in the 
questionnaire.19 The PCQ-PD was developed based on the outcomes of eight focus 
group discussions in The Netherlands.30 Some care aspects mentioned in these 
discussions were not found to be relevant for patients in the US and it was necessary 
to rephrase some items. Overall, Dutch and North American patients showed similar 
values and needs. 
Second, we applied casemix adjustment which is necessary for valid comparisons of 
care experiences across centers.22 International studies confirm that patients’ 
experiences differ significantly depending on age, education and health status.24,37-38 
Researchers agree that the effect of casemix adjustment is modest and patients’ 
characteristics only predict a small percentage of the variability.36 Nevertheless, when 
patients’ experiences are used for benchmarking, hospital ranks are substantially 
affected by casemix adjustment.22 
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4.3 Shortcomings 
Our study was not without shortcomings. First, we included 27 patients suffering from 
atypical Parkinsonism, who may have dissimilar needs and  may utilize different 
healthcare resources. However, these patients are part of the average patient 
population seen by NPF centers and data analysis showed that their experiences did 
not deviate from patients with idiopathic PD. Additionally, NPF centers are more likely 
to routinely employ best practices in PD care, and therefore most likely provide an 
overestimation of the level of patient centeredness when compared to general 
Parkinson care settings. Our patient mix analysis showed that participants were 
highly educated, English speaking, non-Hispanic, Caucasian, and all covered by 
health insurance. These features do not completely reflect the US and Canadian 
population and may demonstrate inequitable access to high qualitative Parkinson 
care.39 Future work also needs to study patient-centeredness among these 
populations, and within centers that mainly serve these populations.40
Second, patients were asked to self-rate their disease stage to facilitate the inclusion 
procedure. Normally, disease stage is classified by clinicians using the Hoehn and 
Yahr rating scale. We found that most medical records did not contain up-to-date 
disease stage ratings. Pragmatically, we therefore included self-reported medical 
data instead of performing actual physical examinations. This approach is not 
infallible, as some patients may find it hard to review whether the disease affects one 
or both sides of the body. Moreover, patients might complain about unilateral 
involvement, while the neurological evaluation shows bilateral involvement with 
regards to bradykinesia or rigidity. However, this inaccuracy was equally distributed 
among centers in our study. Ideally, future studies aimed at exploring care experiences 
should link these to up-to-date medical information stored within electronic health 
records.
Future perspective
The study provided a first step to increase awareness on patient-centered care in 
North-American Parkinson centers. Such findings create a basis for collecting 
patients’ experiences in a repetitive fashion and intertwined with existing quality of 
care registries. This will allow for comparisons of the patient’s perspective with the 
provided treatment, clinical outcomes and costs. The data should become publicly 
available enabling direct comparisons across institutions and utilized to credit health 
professionals for providing patient-centered care. 
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“My greatest disappointment after being diagnosed
with Parkinson’s disease is that no one told me 
about the benefits of exercise. I was given pills; end of treatment 
and discussion. I feel like it is up to me to discover support groups, 
holistictreatments, other experimental treatments, etc. 
I’m continually disappointed that there is no coordination 
between doctors and caretakers. 
No one is my advocate looking at the whole me.”
Woman with Parkinson’s disease, 71 years old 
Patient centeredness study, chapter 5
Published as: 
Kremer JA, van der Eijk M, Aarts JW, Bloem BR. The individual formerly known as 
patient, TIFKAP. Minerva Med. 2011;102(6):505.
The individual  
formerly known as patient 
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In 1993, the pop musician Prince changed his stage name to the Love Symbol ( ). 
Because this symbol was unpronounceable, the media referred to him as “The Artist 
Formerly Known As Prince”, or TAFKAP(1). Prince felt that his former name no longer 
applied to his new artistic interests. He switched to another record label, and started 
producing different music.
By analogy, we should consider to change the nomenclature in healthcare. Old labels 
might hamper the implementation of innovations that are needed to improve the 
quality of care. One example is patient empowerment: an altered role for patients, 
who should transform from their current passive position to become engaged subjects 
who actively contribute to self-management of their disease(2). The neologism ‘Health 2.0’ 
reflects this change in thinking. It was copied from the Internet world, where the term 
Web 2.0 was introduced to echo new opportunities for sharing and co-creation of 
information through interactive websites.
Another possibly outdated term in healthcare is the word ‘patient’. Patient is derived 
from the Latin word ‘patientia’, which means patience, suffering, endurance or 
forbearance. Those terms were applicable to the medical care that was delivered 
centuries ago. If you were ill, waiting patiently was the best option, suffering was 
inevitable, and much endurance was needed. But this – literally patient – behavior no 
longer fits 21st century medicine. The world around us is changing, and individuals 
wish to play an active role in society(3). Contemporary patients are no exception. They 
search the Internet for medical information, they request access to their medical 
records, they hope to participate in making treatment decisions (‘shared decision 
making’), and wish to have open communication channels with their physicians(4,5). 
And importantly, they want to be regarded as humans with a health problem, and not 
as mere carriers of a disease.
We therefore suggest to abandon the term patient. However, it is difficult to find good 
alternatives. ‘Citizen’ is inappropriate, because what patients currently are to physicians, 
is what citizens are to the authorities. ‘Person’ is perhaps better, but is defined too 
broadly. Some disciplines, e.g. in the field of allied healthcare, use the term ‘client’. 
This aptly reflects the need for professionals to deliver service to their customers, but 
still contains elements of passivity.
Surely, changing the nomenclature will not prevent people suffering from their 
disease. However, new active labels may underscore the importance of considering 
patients as co-pilots of their healthcare process, rather than as passive passengers. 
For the time being, we propose to consider the word TIFKAP: ‘The Individual Formerly 
Known As Patient’. We would welcome any better suggestions! 
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Part 2
Multidisciplinary collaboration  
in Parkinson care
“Dr. … spends over an hour with me during 
a very major decision making time period. 
Other movement specialists have stood up, 
after 10 minutes of examining, walked to the door, 
indicating the session was to end.”
Man with Parkinson’s disease, 70 years old
Patient centeredness study, chapter 5 
Published as: 
Post B, van der Eijk M, Munneke M, Bloem BR. Multidisciplinary care for Parkinson’s 
disease: not if, but how! Pract Neurol. 2011;11(2):58-61.
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Increasingly, many centers around the world are delivering multidisciplinary care for 
patients with Parkinson’s disease.1-2 Indeed, a multidisciplinary team approach 
currently seems inevitable for anyone who understands even a little about PD. After 
all, this really is a wretched disorder, with a complex and diverse phenotype. Patients 
become progressively incapacitated, not only because of the well-known motor 
symptoms (bradykinesia, rigidity, tremor, gait impairment and postural instability), 
but also because of a wide variety of non-motor symptoms. These include neuropsy-
chiatric disorders (cognitive disturbances, hallucinations, psychosis), sleep disorders 
(insomnia, rapid eye movement sleep behavior disorder, periodic leg movements), 
autonomic dysfunction (orthostatic hypotension, constipation, urinary incontinence, 
erectile dysfunction) and pain from various sources (e.g. central pain, painful off 
period dystonia). Not surprisingly, PD is regarded by patients as one of the most 
unbearable disorders around, ranked second on the respective lists for both motor 
and cognitive disorders.3 Perhaps even more telling is the fact that many immediate 
caregivers are on the brink of succumbing to the pressure of living with someone with 
PD.4–6 Moreover, conventional therapies— drug treatment and stereotactic deep 
brain surgery—offer only partial and temporary relief, particularly in more advanced 
disease.7 Against this background, any neurologist who still feels that a single 
discipline suffices to combat this debilitating disease must seem almost heartless, 
or at least a bit naive. And any potential critics should be consoled by the fact that 
multidisciplinary care has already won its spurs in other areas of neurology—for 
example, stroke units.8
Luckily for PD patients, help is on the way. Evidence is growing to support the 
effectiveness of various allied health disciplines. Thus far, the case is strongest for 
specific physiotherapy techniques, such as cueing.9 But there are also practice 
based guidelines—from accumulating research evidence, or sometimes merely expert 
clinical opinion—that recommend speech and language therapy, and occupational 
therapy.10-11 And a growing number of clinicians seem undisturbed by the fact that 
allied health treatments are not fully evidence-based. After all, lack of evidence of 
effect is not proof of lack of effect, and the patients are clearly in great need.12This is 
why many PD patients are currently receiving physiotherapy, and why referrals to 
other allied health disciplines seem to be rising in popularity too, albeit more 
modestly.13-14 One can reasonably argue that neurologists may need to wait for more 
evidence before referring their patients but we are being overtaken by the facts. 
Indeed, despite the relatively low level of evidence, several guidelines recommend 
that PD patients should have regular access to a broad range of medical and allied 
healthcare professionals.15-16 
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So the question really becomes how one should combine conventional medical 
management with allied health treatment in order to deliver an efficient and well- 
coordinated multidisciplinary team effort in clinical practice. Here things start to become 
somewhat problematic. Is multidisciplinary care simply the sum of a series of mono-
disciplinary interventions which can each be delivered to the patient independently? 
Or should every participating discipline be integrated into a streamlined team approach, 
working under one roof with a single, dedicated coordinator? Which disciplines 
should be part of this team and what is best for patients: a one size fits all treatment 
or an individually tailored approach? Nobody knows for sure, and perhaps as a result, 
the nature of multidisciplinary treatment varies widely across countries, and even 
between centers within a given country.1
Several additional vexing problems came to light when we recently developed a new 
multidisciplinary guideline for the management of patients with PD.16 As part of the 
process, we started out by questioning all relevant stakeholders about the perceived 
barriers in current clinical practice in The Netherlands. Regardless of the specific 
type of multidisciplinary approach that was chosen, four key problems stuck out 
(Table 1). The same shortcomings were also identified in a separate survey among 
allied healthcare professionals in The Netherlands.14 This situation is unlikely to be 
unique to our country, and we suspect that many multidisciplinary teams worldwide 
are troubled by similar problems. 
More importantly, we fear that the barriers mentioned in Table 1 may explain why the 
three trials of multidisciplinary care in PD thus far have failed to demonstrate robust 
or sustained benefits for patients and their families.17
	The first was a cross over, randomized trial that evaluated multidisciplinary 
intervention with individualized physiotherapy, occupational therapy, speech and 
language therapy, specialized nursing and group educational support.18 There 
was improvement in mobility directly after the program but worse general and 
Table 1   Barriers that obstruct the implementation of optimal multidisciplinary  
care for PD patients  
1. Insufficient expertise among healthcare professionals
2. Poor interdisciplinary collaboration
3. Inadequate communication, both across participating professionals and between 
 professionals and patients
4. Lack of financial support for a multidisciplinary team approach
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mental health. The benefits on mobility had disappeared 6 months later. Moreover, 
caregivers of treated patients unexpectedly showed a trend towards more strain. 
Extrapolating the Dutch findings, we suspect that the multidisciplinary team was 
perhaps not optimally coordinated, and this could have led to more stress on 
caregivers, rather than relief of pressure.
	The second evaluated the effect of group education combined with personal 
rehabilitation for 8 weeks, delivered by a team consisting of a movement disorders 
neurologist, physiotherapist, occupational therapist, dietician, psychologist and 
nurse.19 Directly after the intervention, quality of life, activities of daily living and 
motor signs had improved. Whether and how long these improvements then 
persisted was not studied.
	In the third study20, patients were randomized to a 6 week intervention with no 
hours of rehabilitation (control group), 16 hours of rehabilitation or 28 hours of 
rehabilitation. The rehabilitation program was a group session, followed by 
self-management and one individual home training. The multidisciplinary team 
consisted of a physiotherapist, occupational therapist and a speech-language 
pathologist. Directly after the program, 54% of the patients in the intervention 
groups experienced a clinically significant improvement in quality of life compared 
with only 18% in the control group. At 2 months, the proportion of responders was 
34% (intervention) and 20% (control), while at 6 months this was 38% (intervention) 
and 10% (control), suggesting a sustained response. 
So what should be done next? We foresee a two pronged approach. The first is to 
gather more evidence from well designed and large randomized trials. We are aware 
of two such studies, one of which is complete (preliminary positive results but 
published thus far only in abstract21) and one which is ongoing in our own centre.22This 
latter study is a large (n=299) cluster randomized trial to evaluate the effectiveness 
and costs of integrated multidisciplinary care in PD compared with usual (typically 
monodisciplinary) care. The results will be available later this year. These and any 
future studies need to accommodate the slowly progressive nature of PD, addressing 
the need for low intensity maintenance after specific treatment goals have been 
reached. New trials will also need to use sensitive clinical rating scales that can 
reliably measure relevant changes in quality of life and disability.
Pending more evidence, the second approach is to optimize the current delivery of 
multidisciplinary care in everyday clinical practice. Here the focus should be on 
eliminating the four factors identified earlier as being the main barriers (Table 1). For 
this purpose, we have developed the ParkinsonNet healthcare concept, a series of 
professional regional networks within the catchment area of community hospitals.23-24 
ParkinsonNet has several specific aims (Table 2). This new approach started in a 
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single region in The Netherlands in 2004 but has now reached complete nationwide 
coverage (Figure 1). We put this concept to the test for one specific discipline 
(physiotherapy) in a cluster randomized trial. The results showed an improved quality 
of care (e.g. better knowledge of guidelines and higher patient volumes per therapist) 
but health outcomes did not change. This lack of efficacy was likely due to the design 
of the trial which was really an implementation study. In the intervention regions, the 
choice of either a ParkinsonNet trained therapist or a regular therapist (i.e. not 
specifically trained in PD) was left to the patients, and since only 30% of patients 
opted for the experts, the study was not optimally designed to study efficacy. 
However, healthcare costs were reduced in ParkinsonNet clusters compared with 
usual care clusters. These findings demonstrate that the quality of care can be 
improved while costs can be contained. 
The challenge is now to extend this expertise to include multiple disciplines, and to 
test the merits in new clinical trials. A further challenge is to involve patients more 
closely in the healthcare process, empowering them to actively participate in the 
management of their own disease. Effective multidisciplinary care for PD comes with 
the recognition that patients and their advocates are indispensable members of the 
healthcare team, with an important role in decision making. To enable PD patients to 
Table 2   ParkinsonNet aims and goals  
Aim of ParkinsonNet Goal attained in trial
To improve PD specific expertise among 
allied health personnel, by training a selected 
number of therapists according to evidence-
based guidelines
Succeeded (improved knowledge of 
guidelines; better use of guidelines  
in clinical practice)
To enhance the accuracy of referrals by 
neurologists
Succeeded
To boost patient volumes per therapist,  
by stimulating preferred referral to 
ParkinsonNet therapists
Succeeded (case load more than doubled  
for ParkinsonNet therapists compared  
with usual care therapists)
To stimulate collaboration between  
therapists, neurologists and patients
Partially succeeded
To improve patient outcomes Failed
To contain healthcare costs Succeeded
Specific aims of the ParkinsonNet healthcare concept are shown in the first column.23 The second column 
shows the results for each of these aims, as demonstrated in a large cluster controlled trial.24
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participate, they need to learn how to obtain reliable information about their condition, 
and which healthcare professionals may potentially contribute to their specific health 
questions. 
In recent years, small steps towards greater patient centeredness have been made. 
PD patients who perceived higher involvement in their treatment were more compliant 
with their medical treatment and more satisfied.25 The perceptions of what patients 
perceive as their most troublesome symptoms shows wide inter-individual variability, 
and patients’ views often deviate from those of their clinicians.26 In addition, patients 
have diverse expectations about whether their treatment can be called successful, 
highlighting the importance of individual patient preferences in evaluating their 
clinical outcomes.27
We hope that this comprehensive approach will be supported by sound scientific 
evidence for an integrated multidisciplinary team for patients with PD and their families.
Figure 1   Distribution of ParkinsonNet across The Netherlands, currently involving 
68 community networks of health professionals specializing in the 
treatment of patients with Parkinson’s disease
114
CHAPTER 7
References
1.   van der Marck MA, Kalf JG, Sturkenboom IH, et al. Multidisciplinary care for patients with Parkinson’s 
disease. Parkinsonism Relat Disord 2009;15:S219–23.
2.  Hagell P. Nursing and multidisciplinary interventions for Parkinson’s disease: what is the evidence? 
Parkinsonism Relat Disord 2007;13:S501–8.
3.  Gage H, Hendricks A, Zhang S, et al. The relative health related quality of life of veterans with Parkinson’s 
disease. J Neurol Neurosurg Psychiatry 2003;74:163–9.
4.  Carter JH, Stewart BJ, Archbold PG, et al. Living with a person who has Parkinson’s disease: the 
spouse’s perspective by stage of disease. Parkinson’s Study Group. Mov Disord 1998;13:20–8.
5.  Cifu DX, Carne W, Brown R, et al. Caregiver distress in parkinsonism. J Rehabil Res Dev 2006;43:499–508.
6.  Schrag A, Hovris A, Morley D, et al. Caregiver burden in Parkinson’s disease is closely associated with 
psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 2006;12:35–41.
7.  Langston JW. The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 
2006;59:591–6.
8.  O’Rourke K, Walsh C. Impact of stroke units on mortality: a Bayesian analysis. Eur J Neurol 2010;17:247–51. 
9.  Keus SH, Munneke M, Nijkrake MJ, et al. Physical therapy in Parkinson’s disease: evolution and future 
challenges. Mov Disord 2009;24:1–14.
10.  Kalf JG, de Swart BJ, Bonnier MW, et al. Logopedie bij de ziekte van Parkinson. Een richtlijn van de 
Nederlandse Vereniging voor Logopedie en Foniatrie. Woerden: Uitgeverij Lemma, 2008.
11.  Sturkenboom IH, Thijssen MC, Gons-van de Elsacker JJ, et al. Ergotherapie bij de ziekte van Parkinson. 
Een richtlijn van Ergotherapie Nederland. Utrecht: Uitgeverij Lemma, 2008.
12.  Deane KH, Ellis-Hill C, Jones D, et al. Systematic review of paramedical therapies for Parkinson’s disease 
Mov Disord. 2002;17:984–91.
13.  Keus SH, Bloem BR, Verbaan D, et al. Physiotherapy in Parkinson’s disease: utilization and patient 
satisfaction. J Neurol 2004;251:680–7.
14.  Nijkrake MJ, Keus SH, Oostendorp RA, et al. Allied healthcare in Parkinson’s disease: referral, 
consultation, and professional expertise. Mov Disord 2009;24:282–6.
15.  Parkinson’s Disease. National clinical guideline for diagnosis and management in primary and secondary 
care. Sudbury: Lavenham Press, 2007.
16.  Bloem BR, van Laar T, Keus SH, et al. Multidisciplinaire richtlijn voor de ziekte van Parkinson. Alphen aan 
de Rijn: van Zuiden Communications, 2010.
17.  Gage H, Storey L. Rehabilitation for Parkinson’s disease: a systematic review of available evidence. Clin 
Rehabil 2004;18:463–82.
18.  Wade DT, Gage H, Owen C, et al. Multidisciplinary rehabilitation for people with Parkinson’s disease: a 
randomized controlled study. J Neurol Neurosurg Psychiatry 2003;74:158–62.
19.  Guo L, Jiang Y, Yatsuya H, et al. Group education with personal rehabilitation for idiopathic Parkinson’s 
disease. Can J Neurol Sci 2009;36:51–9.
20.  Tickle-Degnen L, Ellis T, Saint-Hilaire MH, et al. Self-management rehabilitation and health-related 
quality of life in Parkinson’s disease: a randomized controlled trial. Mov Disord 2010;25:194–204.
21.  Guttman M, Takahasji J, Torti M. Multidisciplinary team provides better outcome in Parkinson’s disease 
patients compared to standard of care. Mov Disord 2008;21:S511.
22.  van der Marck MA, Bloem BR, Mulleners WM, et al. Rationale and design of the IMPACT study: a cluster 
controlled trial to evaluate cost-effectiveness of multidisciplinary care in Parkinson’s disease. Mov Disord 
2010;25:S290.
23.  Nijkrake MJ, Keus SH, Overeem S, et al. The ParkinsonNet concept: development, implementation and 
initial experience. Mov Disord 2010;25:823–9.
24.  Munneke M, Nijkrake MJ, Keus SH, et al. Efficacy of community-based physiotherapy networks for 
patients with Parkinson’s disease: a cluster-randomized trial. Lancet Neurol 2010;9:46–54.
25.  Grosset KA, Grosset DG. Patient-perceived involvement and satisfaction in Parkinson’s disease: effect 
on therapy decisions and quality of life. Mov Disord 2005;20:616–19.
115
VIEWPOINT ON MULTIDISCIPLINARY COLLABORATION IN PARKINSON CARE
7
26.  Politis M, Wu K, Molloy S, et al. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord 
2010;25:1646–51.
27.  Nisenzon AN, Robinson ME, Bowers D, et al. Measurement of patient-centered outcomes in Parkinson’s 
disease: what do patients really want from their treatment? Parkinsonism Relat Disord 2011;17(2):89-94
“They are all isolated specialists. 
My experience is that they do not 
employ an integrated approach.” 
Caregiver, man, 45 years old,
Dutch focus group discussions, chapter 3 
Published as: 
Wensing M, van der Eijk M, Koetsenruijter J, Bloem BR, Munneke M, Faber MJ. 
Connectedness of healthcare professionals involved in the treatment of patients with 
Parkinson’s disease: a social networks study. Implement Science 2011;6:67.
Measurement of 
multidisciplinary collaboration 
in Parkinson care 
8
118
CHAPTER 8
Abstract
Introduction
Patients with chronic illness typically receive ambulatory treatment from multiple healthcare 
professionals. Connectedness between these professionals may influence their clinical 
decisions and the coordination of patient care. We aimed to describe and analyze 
connectedness in a regional network of healthcare professionals involved in ambulatory 
treatment of patients with Parkinson’s disease.
Methods
Observational study with 104 healthcare professionals who had joined a newly established 
network (ParkinsonNet) were asked to complete a pre-structured form to report on 
their professional contacts with others in the network. Using social networks methods, 
network measures were calculated for the total network and for the networks of 
individual healthcare professionals. We planned to test differences between subgroups 
of healthcare professionals regarding 12 network measures, using a random permutation 
method.
Results
Ninety-six healthcare professionals (92%) provided data on 101 professionals. The 
reciprocity of reported connections was 0.42 in the network of professional contacts. 
Measures characterizing the individual networks showed a wide variation; e.g., density 
varied between 0 and 100% (mean value 28.4%). Healthcare professionals with ≥10 
PD patients had higher values on 7 out of 12 network measures compare to those with 
< 10 PD patients (size, number of connections, two step reach, indegree centrality, 
outdegree centrality, inreach centrality, betweenness centrality). Primary care professionals 
had lower values on 11 out of 12 network measures (all but reach efficiency) compared 
to professionals who were affiliated with a hospital.
Conclusions
Our measure of professional connectedness proved to be feasible in a regional 
disease- specific network of healthcare professionals. Network measures describing 
patterns in the professional contacts showed relevant variation across professionals. 
A higher caseload and an affiliation with a hospital were associated with stronger 
connectedness with other healthcare professionals.
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1. Introduction
Many patients with chronic diseases receive ambulatory treatment from a range of 
healthcare professionals. Teamwork improves clinical performance, outcomes, and 
efficiency of healthcare.1 Potential elements of good teamwork include improved 
coordination of care and integration of a wider range of professional competencies.2 
Contacts between healthcare professionals are crucial in chronic illness care.3 In 
primary and ambulatory care settings, where most chronic illness care is provided, 
healthcare professionals have limited face-to-face contact with each other because 
most are based in office-based practices. In this situation, clinical processes and 
outcomes are determined by distributed decision making, involving many healthcare 
professionals who may or may not share clinical knowledge and coordinate treatment 
delivery. It remains unclear how connectedness between healthcare professionals 
influence ambulatory treatment.
Parkinson’s disease (PD) provides an example of a chronic disease, which is largely 
treated in ambulatory care settings. PD is a common and progressive neurodegenerative 
disorder, which features both cognitive and motor symptoms.4 The prevalence of 
PD is 1.6% in the Dutch population, with values increasing with age up to 4.3% in 
individuals aged 85 years or over.5 PD cannot be cured, but pharmacological 
treatment substantially improves quality of life and functional capacity.4 In addition, 
many patients require allied healthcare, including physical therapy, speech language 
therapy, and occupational therapy.6 Thus, optimal treatment of PD requires a 
collaborative multidisciplinary approach over a long period of time and implementation 
of recommended treatments.7
To optimize multidisciplinary treatment, the ParkinsonNet concept has been 
developed: a professional regional network within the catchment area of hospitals.8,9 
ParkinsonNet aims to enhance PD-specific expertise among allied health providers 
by training a selected number of therapists according to evidence-based guidelines; 
by enhancing the accuracy of referrals to allied health workers by neurologists; by 
increasing patient volumes per therapist via preferred referral to ParkinsonNet therapists; 
and by stimulating collaboration between therapists, neurologists, specialized nurse 
practitioners, and patients.10 ParkinsonNet is a regional network of a selected number 
of motivated healthcare professionals with specific expertise in treating PD patients.
The multidisciplinary networks are composed of a small number of highly motivated 
healthcare providers. Central to the ParkinsonNet concept are: delivery of care according 
to evidence-based guidelines; continuous education and training of ParkinsonNet 
healthcare providers; structured and ‘preferred’ referral to ParkinsonNet therapists by 
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neurologists, enabling each therapist to attract a sufficient number of patients to 
maintain and increase expertise; optimal communication within the network via the 
internet, Meanwhile, more than 65 regional ParkinsonNet networks have been created 
in The Netherlands, now providing full nationwide coverage, with over 1,500 specialty- 
trained healthcare providers providing services. A cluster randomized trial showed 
that implementation of ParkinsonNet networks improved the efficiency of healthcare 
provision compared to usual care, at substantially reduced costs, while health 
outcomes remained unchanged.11
Patterns in the professional contacts of healthcare professionals involved in ParkinsonNet 
may influence clinical processes and outcomes in several ways. Specifically, professional 
contacts may improve the competence of healthcare professionals regarding 
treatment of PD. Higher professional competence is associated with better clinical 
performance, quicker uptake of recommended interventions, and better outcomes 
for patients. It has been proposed that for most individuals, diffusion of innovations 
occurs through personal communication rather than through formal education or 
externally imposed sanctions.12 Specific individuals (sometimes called ‘knowledge 
brokers’) may be crucial for introducing new ideas into a network. It seems reasonable 
to assume that professional competence regarding treatment of PD is highest in 
healthcare professionals who treat ≥10 PD patients and in those affiliated with a 
specialized hospital department. Thus, connectedness with those two types of 
healthcare professionals is expected to contribute to the spread of competence 
among healthcare professionals in the network.
Connectedness between healthcare professionals may also influence the coordination of 
patient care in treatment of PD. Better coordination may be associated with improved 
patient satisfaction and reduced health utilization, including less hospitalizations and 
fewer emergency visits.13 In the absence of a strong formal organization and 
formalized leadership in a regional ParkinsonNet network, coordination of patient 
care is the result of informal social processes, which are characterized by distributed 
decision making. An example of such processes is the pressure on individuals who 
are embedded in highly connected networks to conform to the attitudes and 
behaviors of others in the network.14 Also, individuals tend to link to similar others, 
resulting in networks with individuals who have similar attitudes and behaviors. We 
expected that healthcare professionals would be more embedded in geographically 
defined catchment areas of specific hospitals than in the ParkinsonNet network in a 
region, if this includes more than one hospital.
Furthermore, network studies can identify informal leaders or highly influential 
individuals, who do not necessarily have a formalized leadership position. From a 
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network perspective, these individuals are characterized by a specific position in the 
network, which gives them high social capital, i.e., control over connections.14 It can 
be assumed that healthcare professionals affiliated with a hospital have a central role 
in the treatment of PD, because they typically refer patients to other professionals. 
Thus, we hypothesized that primary care professionals would be less embedded in 
the network, most notably with respect to their prominence and influence in the 
network.
The aim of this study was to examine the connectedness in a newly established 
regional ParkinsonNet of healthcare professionals involved in the treatment of PD 
patients. Our objectives were to examine the feasibility of a new measure; to describe 
the network in terms of a number of measures, which may be related to coordination 
of patient care and the spread of professional competence; and to examine the 
networks of healthcare professionals with ≥10 PD patients and in those affiliated with 
a hospital.
2. Methods
2.1 Study design and population
We performed an observational study involving 104 healthcare professionals in one 
specific region of ‘ParkinsonNet’ in the eastern part of The Netherlands. This network 
had been newly established a few weeks before the study was performed. The region 
has three hospitals, serving 600,000 inhabitants. Participants in the study were 
practicing healthcare professionals from various medical, nursing, and allied health 
professions, who were based in either hospital settings or primary care. The medical 
ethical committee for Arnhem-Nijmegen approved the study.
2.2 Measures
All 104 participants were requested to complete a structured questionnaire during an 
educational meeting, which was organized in the context of the network start-up; an 
email reminder was sent to non-responders. The questionnaire (which is available on 
request) listed all names of the healthcare professionals in the network. Participants 
were asked to tick a box for each name indicating whether this person was known to 
the participant and another box to indicate whether this person was involved in 
professional contacts so far. Knowing each other was defined in the questionnaire as 
‘knowing the face, having talked to each with other, or having heard of.’ Having 
professional contact was defined in the questionnaire as ‘having had professional 
contact about at least one patient with PD who you are treating (including referral 
letters, emails, telephone contact, team meetings).’ In addition, the questionnaire 
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contained questions regarding health profession, number of patients with PD treated 
in one year (dichotomized into less than 10 versus 10 or more patients) as a measure 
for experience, and geographical location in the region (three hospital catchment 
areas were identified).
2.3 Data analysis
Data were entered into a squared data-matrix with the healthcare professionals in the 
rows and columns and values in the cells to indicate presence or absence of a 
connection (values 1 and 0, respectively). As a first step we examined the data with 
respect to missing scores, following published guidelines.15 We examined the 
reciprocity of reported connections as an indicator of the reliability of the data 
collection instrument. Then we replaced missing values of the non-responders with 
the values provided by other individuals on the connection, if available. If no substitution 
was possible, the missing value was replaced with a zero. Missing values regarding 
individual characteristics were not substituted, except that we imputed a value for 
neurologists and specialized Parkinson nurses indicating that they treated more than 
10 patients with PD.
The first stage of data analysis focused on the total network and the area-specific 
networks. Eight network measures were calculated for the networks of ‘knowing each 
other’ and ‘having professional contact’. These network characteristics were expected 
to be relevant for professional competence and coordination of healthcare. The 
second stage of data analysis focused on the networks of the individual healthcare 
professionals (’ego networks’). These individual networks were extracted from the 
total network for each healthcare professionals, including the reported connections 
of the individual with others in the network and the connections between those others. 
Twelve measures were calculated for these individual networks, which were expected 
to be relevant for care coordination and professional competence.
Next, we explored the differences regarding the 12 measures of individual networks 
between subgroups of healthcare professionals as defined by experience in treatment 
of patients PD (< 10 versus ≥10 PD patients, i.e., relatively little experienced versus 
much experience) and clinical setting (primary care versus hospital care or both). 
The cut-off level of 10 patients was based on consensus among the clinical authors 
of this chapter. We hypothesized that healthcare professionals treating many 
Parkinson patients and healthcare professionals in specialized hospital settings 
would have higher values on the listed network characteristics. A random permutation 
test (with 10,000 permutations) was used to derive test differences between subgroups 
statistically. A p-value of 0.05 or less was considered significant. We used Excel to 
store and manage data files and UCINET 6 for descriptions and statistical analysis. 
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Finally, we performed an explorative factor analysis (principal component analysis 
with orthogonal rotation) on the 12 measures of individual networks to explore the 
correlational structure of the network measures. SPSS version 16 was used for this 
factor analysis.
3. Results
A total of 96 of the 104 healthcare professionals provided information on their 
connections (92%): 89 during the regional educational meeting, and seven after the 
email reminder (Table 1). Non-responders included one neurologist, one dietician, 
two occupational therapists, and four physiotherapists. Table 1 provides descriptive 
information on the sample. Ten different disciplines were represented in the regional 
network, with 44 physiotherapists comprising the largest group. About one third 
(n = 35) worked in primary care and about one- half (n = 51) in both primary care and 
hospital settings. The remainder (n = 17) worked only in hospital. Less than one-half 
of the professionals (n = 43) treated more than 10 patients with PD. We found that 
the reciprocity of connections (before imputation of missing values and excluding 
mutually non-existent connections) was reasonably high: 0.57 in the network of 
‘knowing each other’ and 0.42 in the network of ‘professional contact.’
Table 1   Description of healthcare professionals (n = 101)  
N
Professional background
- neurologist (N)
- community geriatrician (O)
- specialized Parkinson nurse (V)
- dietician (D)
- occupational therapist (E)
- social worker (M)
- spiritual counselor (G)
- physiotherapist (F)
- psychologist (P)
- speech-language pathologist (L)
3
1
4
8 
20
1
1
44
3
16
Setting of care delivery
Working in primary care 
Working in hospital 
Working in primary and hospital care
35
17
51
> 10 PD patients under treatment 43
Area
1 
2 
3 
28
32
41
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Figure 1 presents the total network of connections between healthcare professionals. 
Table 2 presents network characteristics of the total- and area-specific networks, 
after imputation of missing values. The network of ‘knowing each other’ included 
more connections than the network of ‘having professional contact’ (1,431 versus 
664). All other network measures also yielded higher values in the network of ‘knowing 
each other.’ Areas one and three showed higher values for network measures 
compared to the total network of professional contacts. The measures for area two 
showed a mixed picture: some were higher, others lower than in the total network. 
Area one had a relatively high outdegree centralization (33.7%), which suggests that 
a few healthcare professionals were highly influential.
Table 3 shows a substantial variation of individual network characteristics for all 
measures in both the network of ‘knowing each other’ and in the network of ‘having 
professional contact.’ For example, the number of others known to the individual 
varied between 4 and 40, and the number of others in this network who can be 
reached in two steps varied between 36 and 99 (in those with at least one connection). 
Consistent with the pattern in the total network, mean and maximum values of the 
network measures were highest in the network of knowing each other.
Figure 1   Visual display of the total network of healthcare professionals in 
ParkinsonNet
Healthcare professionals with ≥10 PD patients in red, those with < 10 PD patients in blue.
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Table 4 shows the same 12 measures in the predefined subgroups. Healthcare 
professionals with ≥10 PD patients had higher mean and maximum values for 8 out of 
the 12 network measures. For one measure, reach efficiency, the difference was also 
significant but lower in professionals with ≥10 PD patients. No statistical difference 
was found for three measures: density, incloseness centrality, and outcloseness 
centrality. Regarding care setting, professionals in primary care had lower values on 
11 of 12 measures compared to professionals who were (partly) based in hospital 
care. The measure for reach efficiency was significantly higher in primary care 
professionals.
Table 2   Description of total and regional networks  
Knowing 
each other
Having professional contact
 Total 
network
Total 
network 
Area 1 Area 2 Area 3
N healthcare  
professionals
101 101 28 32 41
Total number  
of connections (ties)
1431 664 113 91 158
Reciprocity 0.630 0.479 0.614 0.400 0.547
Density 0.142 0.066 0.139 0.092 0.146
Clustering (weighted) 0.360 0.268 0.344 0.253 0.395
Transitivity (3 legs  
in triads with 2 legs)
16.7% 13.3% 16.9% 12.4% 20.9%
Indegree centralization 
of network
25.1% 16.6% 22.6% 10.5% 26.5%
Outdegree centralization  
of network
22.1% 16.6% 33.7% 27.2% 19.2%
Reciprocity: Proportion of all connections that are reciprocated. The measure is used as an indicator of the 
reliability of the measurement of connections.
Density: Proportion of all possible connections that are actually present in a network of a given size.
Clustering: Average density in the local neighborhoods of individuals rather than in the total network. Here it 
is defined as the density in the networks of others connected to an individual (leaving out ego in the 
calculation of density). The average value is weighted for size of network.
Transitivity: Measure related to triads that may indicate balance or equilibrium. If A directs a tie to B and B 
directs a tie to C, then A is also expected to direct to C. Triads are crucial in some social science theories.
Centralization of network: Degree of variance of the total network of (in/out going) connections compared 
to a perfect star network of the same size (which indicates the theoretical maximum of centralization). Higher 
values mean more centralization, thus that positional advantages are unequally distributed.
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Table 3   Description of individual networks 
Lowest and highest values per individual (mean)  
 Knowing each other Having professional 
contact
Size (one-step reach) 4 – 40 (17.4) 0 – 28 (8.9)
Number of connections (ties) 5 – 373 (123.0) 0 – 127 (28.5)
Density 11 – 96% (36.0) 0 - 100% (28.4) 
Two step reach 34 – 99 (83.6) 0 – 84 (46.5)
Reach efficiency 12  – 77% (29.6) 0 – 100% (51.6)
Indegree centrality 2 – 39 (14.2)  0 – 23 (6.6)
Outdegree centrality 0 – 36 (14.2) 0 – 23 (6.6)
Incloseness centrality 23.2 – 38.0 (32.3) 1.0 – 9.7 (8.1)
Outcloseness centrality 1 – 58.5 (38.0) 1.0 – 12.7 (10.6)
Inreach centrality -2 steps 40 – 70 (53) 1 – 55 (36)
Outreach centrality -1 step 1 – 67 (53) 1 – 56 (36)
Betweenness centrality (normalized) 0 – 6.6 (1.1) 0 – 9.5 (1.6)
Size: number of individuals who are connected on one step to an individual, plus the individual.
Density: proportion of connections in an individual’s network of connections of all possible connections 
which are present.
Two step reach: number of individuals that can be reached in 2 steps by an individual.
Reach efficiency: two step reach divided by network size. It indicates how efficient an individual network is 
with respect to reaching others in the total network.
Degree centrality: Number of (in/out) going connections of an individual. Individuals who receive many 
connections may be prominent or have high prestige, while individuals who connect to many others may be 
influential. The measure refers to direct connections to an individual only.
Closeness centrality. Distance of an individual to all others in the network (define by in/outgoing 
connections), here defined as the sum of the lengths of the shortest geodesic paths from an individual to 
others. The measure is standardized by norming against the minimum possible closeness in a network of the 
same size and connection.
Reach centrality: The number of individuals an individual can reach in a specific number of steps in the 
network of in/outgoing connections.
Betweenness centrality: Number of pathways in the network in which an individual is ‘in between’ of two 
other individuals. The measure indicates how frequently an individual is an intermediate between others. The 
maximum would be reached if the individual is the central person in a perfect star network.
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Finally, the explorative factor analysis identified three factors with Eigen value > 1, 
which explained 86% of the variation of scores on 12 network measures across 
individuals. Network measures which load highly on the same factor correlate highly, 
which may reflect a shared underlying dimension. The first factor included network 
size, number of connections, two-step reach, reach efficiency, indegree centrality, 
outdegree centrality, and betweenness centrality (factor loadings > 0.75). The second 
factor included incloseness centrality, outcloseness centrality, inreach centrality, and 
outreach centrality (factor loadings > 0.73). The third factor included density (factor 
loading = 0.91).
4. Conclusions
This study examined the connectedness between healthcare professionals involved 
in the treatment of patients with PD. The high participation rate and reasonably high 
reciprocity of reported connections suggests that the recruitment and the measure 
were feasible. In two of the three geographical sub-areas, we found higher values for 
network density and other network measures compared to the total network, suggesting 
that healthcare professionals were more connected within their geographical area 
than in the total network. Measures related to individual networks of the healthcare 
professionals showed a large variation. The number of patients treated per professional 
appeared to be an important determinant: healthcare professionals with ≥10 PD 
patients yielded higher values on most network measures compared to those with < 10 
PD patients, except for network density and in/outcloseness centrality. Primary care 
professionals yielded lower values for most network measures compared to professionals 
based in hospital settings. We conclude that the analysis of the network of healthcare 
professionals showed relevant variation across individuals and geographical areas.
One strength of this study was the high participation rate, which may be related to 
the fact that completing the questionnaire was integrated in an educational meeting. 
ParkinsonNet provided a special context for this study. We should also mention several 
shortcomings. 
One weakness of our approach is the possibly limited generalizability of our findings, 
which may be restricted to healthcare professionals who participate in a newly 
starting and disease-specific regional network. However, disease-specific networks 
have emerged in different clinical domains. A second limitation was that the measure 
of professional contacts was crude and not validated against a gold standard. 
However, it was straightforward and easy to understand. Third, the distinction between 
three geographic areas within the region was somewhat arbitrary for a few professionals. 
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Finally, the factor analysis suggested that some network measures were highly correlated. 
As the network measures measure different constructs, this does not necessarily 
imply that measures with high correlation reflect some common underlying construct.
In a previous study we examined the communication and collaboration networks 
of 67 healthcare professionals in 10 primary care practices regarding chronic heart 
failure, diabetes, and chronic obstructive pulmonary disease.16 Using a short 
structured measure, we found good agreement between healthcare professionals’ 
reports on receiving and providing information. Networks measures for density and 
degree centralization showed large variation across practices, as did the degree of 
overlap between the three disease-specific networks. A difference with the current 
study is that our previous study focused on professional networks with primary care 
practices, while the current study examined a multidisciplinary network of healthcare 
professionals in a region. Furthermore, ParkinsonNet is an innovative concept, while 
our previous study focused on usual primary care for chronic diseases.
We found that professionals who treated ≥10 PD patients were potentially more 
prominent and more influential in the network, as indicated by their higher indegree 
and outdegree centrality measures. This places them in a position to influence other 
healthcare professionals, and thus spread professional competence in PD treatment 
and enhance the coordination of patient care. Notably, professionals with < 10 PD 
patients had density and closeness centrality measures that were similar to 
professionals with ≥10 PD patients. Network density may be related to acceptance 
and sanctioning of specific behaviors, so this would imply that the speed of uptake of 
new knowledge is not delayed by network characteristics.14 Primary care professionals 
were less connected in the network than professionals based in hospital settings. 
This finding should be interpreted in the context of the newly established network. 
One of the aims of ParkinsonNet is to better integrate primary care professionals in 
the treatment of patients with PD, so it would be interesting to repeat the study in a 
few years.8
Network science provides a set of concepts and methods to study connectedness 
between elements in any system. Network approaches have been applied in many 
scientific disciplines, including neurosciences, molecular life sciences, and public 
health.17-19 Its application in medical care research is relatively new, although the first 
use (concerning the uptake of new treatments by physicians) dates back to 1957.20 
Examples in recent years include studies of opinion networks of long-term care 
specialists and chronic disease networks in primary care.21-22 In medical care 
research, network science offers the tools to conceptualize and measure specific 
network characteristics, which may be related to relevant outcomes. A social network 
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approach may be particularly relevant if actors have imperfect information on their 
behavioral options and expected outcomes.
Communication and collaboration networks of healthcare professionals reflect their 
communication and collaboration behaviors. At the same time, these network 
structures provide opportunities, incentives, and constraints for these individuals 
(and their patients). First, access to healthcare professionals with relevant resources 
(such as clinical knowledge or ability to refer patients) may be influenced by the 
structure of networks. Second, many patient outcomes in chronic illness care can 
only be achieved if the clinical activities of different healthcare professionals are 
intentionally coordinated. Third, a high degree of connectedness enhances imitation 
of behaviors and related social processes, resulting in more homogeneous practice 
patterns. Thus, whether a patient receives safe and effective treatment is not randomly 
distributed in a cohort of patients, but (ceteris paribus) more likely in networks with 
specific network measures.
Future research should focus on the development over time in networks of healthcare 
professionals and on differences between networks in different regions. It should 
also focus on the impact of network measures on clinical treatment and outcomes. 
Future studies should also focus on the networks of individuals with chronic illness 
and include non-professionals who are relevant for their health and well-being.22 
Studies of networks in healthcare could provide relevant information for managers 
and policy makers in healthcare, if it would be clear how network characteristics are 
linked to relevant aspects of clinical treatment. For instance, individuals who have a 
central position in the network could be targeted in order to optimize the outcomes of 
professional networks such as ParkinsonNet. Like in other fields, a network approach 
promises to provide a new perspective on the coordination and delivery of healthcare.
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Abstract
Introduction
ParkinsonNet, a nationwide organization with regionally oriented professional health 
networks in The Netherlands, aims to improve the quality of Parkinson care. Facilitation 
of multidisciplinary collaboration is a key objective of ParkinsonNet. This study examined 
whether the concept enhances multidisciplinary collaboration between healthcare 
professionals involved in Parkinson care.
Methods
A regional network involving 101 healthcare professionals was newly established. 
Participants received two questionnaires. One aimed at documenting direct working 
relationships (‘connections’) between professionals and the other aimed at evaluating 
multidisciplinary team performance. Additionally, thirteen healthcare professionals 
were interviewed to identify barriers and facilitators for multidisciplinary collabora-
tion.’Social network analysis’ focused on sub-networks around three community 
hospitals at baseline and one year after the implementation.
Results
The number of ‘knowing each other’ connections increased from 1431 to 2175 
(52%,p<0.001) and ‘professional contact‘ connections increased from 664 to 891 
(34%,p<0.001). Large differences between sub-networks were found, positive 
changes being associated with a central role of neurologists and nurse specialists 
committed to multidisciplinary care. The perceived team performance did not change. 
Participants experienced problems with information exchange and interdisciplinary 
communication. Generally, participants were unaware of other healthcare professionals 
involved in individual patients and what treatments they provide simultaneously. 
Conclusions
ParkinsonNet partially enhanced multidisciplinary collaboration between healthcare 
professionals involved in Parkinson care. Crucial facilitators of this were a central role 
of nurse specialists and the commitment to collaborate with and refer to expert 
therapists among neurologists. Additional measures are needed to further improve 
multidisciplinary care across different institutions and around individual patients.
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1. Introduction
Western societies age rapidly, which largely explains the rising number of people with 
chronic diseases and multiple co-morbidities.1 In the US, chronic conditions already 
puts neurology healthcare services in high demand.2 An illustrative example is 
Parkinson’s disease (PD), where patients become progressively disabled due to a 
mixture of cognitive, emotional and motor symptoms.3 In 2005 the estimated number 
of PD patients in the 10 most populous countries was between 4.1 and 4.6 million; this 
number is expected to more than double by 2030 to between 8.7 and 9.3 million.4
Conventional therapies provided by a neurologist, like pharmacotherapy or deep 
brain surgery, improve clinical outcomes in PD. Furthermore, the evidence to support 
the effectiveness of allied health interventions as an additional symptomatic treatment 
is growing rapidly.5-6 International studies show that the multifaceted nature of PD 
requires a team-oriented and personalized approach including physicians, nurses 
and therapists, but how such care should be delivered is under debate.7-10 
Insufficient expertise, poor collaboration and inadequate communication are 
recognized as important barriers of multidisciplinary care.11  ParkinsonNet has been 
developed to tackle these barriers by standardizing and integrating the delivery of 
care provided by expert therapists.12The concept consists of professional health 
networks in the catchment areas of community hospitals. Within each network 
selected therapists are trained according to evidence-based guidelines. Neurologists 
are stimulated to refer patients to these skilled professionals. ParkinsonNet has 
nationwide coverage in The Netherlands, with 68 regional networks and 3,000 health 
professionals for an estimated 50,000 patients.12 A cluster-randomized trial showed 
that ParkinsonNet reduced healthcare utilization and costs.13 Furthermore, participants 
improved the adherence to guideline recommendations and treated higher patient 
volumes per year.11
Despite the emphasis on multidisciplinary collaboration in Parkinson care in the 
Netherlands, PD patients experience a lack of collaboration between members of their 
healthcare team.14 This study aimed to quantify the evolvement of multidisciplinary 
collaboration between professionals involved in Parkinson care, to investigate their 
perceived team performance and also to identify barriers and facilitators for multi-
disciplinary collaboration in the first year after the implementation of a new ParkinsonNet 
network.
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2. Methods
2.1 Implementation strategy
A regional network covering the catchment area of three community hospitals was 
newly established in 2011. Participants were selected based on their motivation and 
geographical location.12 All professionals received a two-day course focusing on the 
fundamentals of PD, conventional and allied health therapies, multidisciplinary 
collaboration and communication skills. Additionally, physical therapists, speech- 
language therapists, occupational therapists as well as dieticians received a two-day 
training course based on mono-disciplinary evidence-based guidelines.
To improve the accuracy of dedicated referrals to allied health therapists, neurologists 
and nurse specialists received standardized referral forms with referral criteria. An 
online search engine, the ‘Parkinson healthcare finder’, included information of all 
network participants facilitating neurologists and nurse specialists to direct patients 
to expert therapists in the patients’ immediate environment. Furthermore, collaboration 
was facilitated by semiannual multidisciplinary meetings, an annual national conference 
and an internet-based communication platform.14
2.2 Study design
We used a parallel, mixed-methods design, combining qualitative and quantitative 
methods.15 At baseline and after one year, participants received a questionnaire to 
document their direct working relationships or ‘connections’ with other professionals 
in the network and a questionnaire on perceived team performance. Semi-structured 
interviews with a representative sample of participants were conducted prior to and 
one year after the implementation. The research protocol was submitted to and 
approved by a local ethics committee. 
2.3 Measures
2.3.1 Social Network Analysis
The questionnaire on the direct working relationships listed the names of all participants. 
Health professionals were asked to tick a box for each name indicating whether this 
person was known to the participant and another box to indicate whether this person 
was involved in professional contact. Knowing each other was defined as ‘knowing 
the face, having talked to each other, or having heard of’. Professional contact was 
defined as ‘having had professional contact about at least one patient, including 
referral letters, e-mail, telephone and face-to-face consultation’. 
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2.3.2 Perceived team performance 
The Integrated Team Effectiveness Model provides a multidimensional framework to 
describe healthcare team performance.16 Based on this model, we applied the team 
performance questionnaire with 25 items in three domains; team psychosocial traits, 
team processes and team outcomes.17
2.3.3 Semi-structured interviews
Interviewees were selected based on their profession, geographical location and 
setting to achieve maximum variation in the sample. At baseline and after one year, 
13 professionals were interviewed, using a topic guide to identify barriers and 
facilitators for multidisciplinary collaboration. Verbal consent was provided by all 
interviewees.
2.4 Data analysis
2.4.1 Social network analysis
All participants were assigned to one out of three sub-networks based on their 
geographical location. Each sub-network represented the catchment area of one 
community hospital. All connections between health professionals were entered into 
squared data-matrices; two for ‘knowing each other’ and two for ‘professional 
contact’ at baseline and one year after the implementation, with the professionals in 
the rows and columns, and values in the cells to indicate absence (0) or presence (1) 
of a working relationship. If available, we replaced missing values of non-responders 
with the values provided by other individuals on the connection. If no substitution was 
possible, the missing value was replaced with a zero.18 
Separate and independent analyses were done for both ‘knowing each other’ and 
‘professional contact’ connections. UCINET6, a software package for the analysis of 
social network data, was used to calculate the following network measures in each 
sub-network at baseline and after one year.19-20 First, the ‘number of connections’, an 
absolute measure for the total number of connections between health professionals 
in the sub-network. Second, ‘density’, a relative measure describing the proportion of all 
possible connections that are actually present in a network. A higher density means 
that more professionals know each other or work together. Third, ‘reciprocity’ of 
reported connections as an indicator of the reliability of the data. If person A indicates 
to have worked with person B, does person B confirm the connection with person A? 
2.4.2 Perceived team performance 
Items on the team performance questionnaire provided a score between 0 ‘strongly 
disagree’ to 3 ‘strongly agree’. First, negatively phrased items were mirrored (2, 5, 6, 
7, 8, 14, 15, 16). Second, an overall team performance score and subscale scores for 
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team psycho-social traits (1, 3, 6, 8, 11, 17, 18, 19, 20), team processes (2, 5, 7, 10, 12, 
14, 16) and team outcomes (4, 9, 13, 21, 22, 23, 24, 25) were calculated by averaging 
item scores. The overall team performance score and subscale scores ranged 
between 0 and 3, with a higher score meaning higher levels of perceived team 
performance. We used SPSS 18 to perform an independent student T-test comparing 
baseline scores with values from one year after the implementation. Overall satisfaction 
with multidisciplinary collaboration was measured on a 0 ‘poor collaboration’ to 10 
‘excellent collaboration’ scale.
2.4.3 Semi-structured interviews
The audiotape-recorded interviews were transcribed verbatim. Thereafter, we conducted 
an inductive analysis on barriers and facilitators of multidisciplinary collaboration. 
Inductive analysis involved the conceptualization of themes from the transcripts in 
Kwalitan 5.0. All care aspects were labeled independently by two researchers (ME, 
FN) using the Integrated Team Effectiveness Model as a conceptual framework. This 
was followed by axial coding, involving the classification of codes into recurring 
themes. Constant comparison analysis was used to identify a final set of codes.21 
2.4.4 Triangulation 
We performed parallel data analysis, meaning that the social network analysis and 
the analysis of perceived team performance and interviews were carried out 
simultaneously. Findings were not compared until the interpretation stage giving 
equal weights to both types of data. Through the process of triangulation, relationships 
between qualitative and quantitative data were defined.22
3. Results 
3.1 Participants 
Participants were 101 healthcare professionals from 10 medical, nursing and allied 
health disciplines geographically scattered and based in either hospital, nursing home 
or primary care settings (Table 1). 
3.2 Social network analysis
At baseline 95% (n = 96) and after one year 92% (n = 93) of the participants provided 
data on their direct working relationships. Table 2 shows that the number of ‘knowing 
each other’ connections increased 52.0% from 1431 to 2175 (p <0.001) and 
‘professional contact‘ connections increased 34.2% from 664 to 891 (p <0.001). 
Further analysis on the professional contact connections showed large differences 
between sub-networks. In sub-network 2 and 3 the number of ‘professional contact’ 
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connections increased significantly (p <0.005), unlike sub-network 1, where the number 
of direct working relationships did not change. Figure 1 visualizes the ‘professional 
contact’ connections in sub-network 3. This figure shows the central position and 
large number of connections of neurologists and nurse specialists in the network one 
year after the implementation.
3.3 Perceived team performance
The team performance questionnaire was completed by 74% (n = 76) of the participants 
at baseline and 85% (n = 88) after one year. Overall team performance did not 
change,1.62 (SD 0.33) to 1.67 (0.33). Additionally, all three subscales did not show 
significant changes. The ‘team processes’ subscale received the lowest score [1.29 
(0.41) to 1.35 (0.52)] and ‘team psychosocial traits’ received the highest subscale 
score [1.81 (0.34) to 1.86 (0.36)]. Overall satisfaction with multidisciplinary collaboration 
increased significantly from 4.9 (SD 2.1) to 5.9 (SD 1.7) (p <0.005). This increase was 
significant for primary care professionals; 3.9 (SD 1.9) to 5.5 (SD 2.0) (p <0.005), but 
not for professionals in community hospitals; 5.5 (SD 2.0) to 6.1 (SD 1.6). 
Table 1   Background characteristics of all network participants  
Professional background Total
network
Sub- 
network 1
Sub- 
network 2
Sub- 
network 3
Neurologist 3 1 1 1
Community geriatrician 1 0 1 0
PD nurse specialists 4 1 1 2
Rehabilitation specialist 1 0 0 1
Physical therapist 44 15 15 14
Occupational therapist 19 6 5 8
Speech-language pathologist 16 3 5 8
Dietician 8 1 2 5
Social worker 2 0 1 1
Psychologist 3 1 1 1
101 28 32 41
Setting
Primary practice 41 15 16 10
Community hospital  21 6 5 10
Nursing home 13 4 3 6
Both primary and secondary care 26 3 8 15
101 28 32 41
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3.4 Semi-structured interviews
Participants were interviewed at baseline and one year after the implementation 
(n = 13); three neurologists, three nurse specialists, three physical therapists, one 
occupational therapist, one dietician, one speech therapist and one rehabilitation 
specialist. The coding process produced 42 topics, allocated to the dimensions of 
the Integrated Team Effectiveness Model and divided into barriers and facilitators for 
multidisciplinary collaboration (Figure 2). Interviewees stated that one year after the 
implementation: 
•	 	Nurse specialists play a pivotal role in the coordination of care and providing 
tailored information to patients.
•	 Neurologists are vital in the referral of patients to expert therapists, yet their 
commitment to multidisciplinary care differed between the sub-networks. The 
neurologist in sub-network 1 retired within the first months after the implementation 
and the neurologist in sub-network 2 took up a sceptical position towards multi-
disciplinary health interventions. In sub-network 3 the neurologist managed a 
 multidisciplinary team within the community hospital.
•	 The number of referrals increased in sub-network 3, but lagged behind in sub- 
network 1 and 2.
•	 Interviewees had increased their PD-specific expertise, incorporated guideline 
recommendations in daily practice and increasingly applied a holistic treatment 
approach. Interviewees were generally unaware of other professionals involved in 
individual patients and what treatments they provide simultaneously.
Table 2  Connections in the total network and sub-networks    
Knowing  
each other
Professional contact
 Total network Total network Sub-net-
work 1
Sub-network 2 Sub-network 3
 T0 T1 T0 T1 T0 T1 T0 T1 T0 T1
N health 
 professionals
101 101 101 101 28 28 32 32 41 41
Total number  
of connections 
(ties)
1431 2175 
(p<0.001)
664 891
(p<0.001)
113 112 91 151 
(p<0.005)
158 322 
(p<0.005)
Density 0.14 0.22 0.07 0.09 0.14 0.15 0.09 0.15 0.15 0.20
Reciprocity 0.63 0.60 0.48 0.46 0.61 0.62 0.40 0.48 0.55 0.53
T0 = baseline  
T1 = one year after the implementation
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93.5 Triangulation
Social network analysis and interview data both indicated that the increase in 
professional connections in sub-network 3 is associated with a central role of the 
neurologist and nurse specialist. Moreover, the number of referrals lagged behind in 
the other two sub-networks, where the neurologists retired or did not commit to mul-
tidisciplinary health interventions. Additionally, team performance and interview data 
both showed that team processes need further improvement. Items on the team 
performance questionnaire with the lowest scores were: ‘no work agreements’, ‘no 
clearly defined roles and responsibilities’, and ‘patient data not shared with each 
other’. Interviewees acknowledged an absence of work agreements and indicated 
that communication and information exchange should be improved.
Figure 1   Social network analysis
‘Professional contact’ connections in sub-network 3 one year after the implementation of the network. 
Participants are subdivided in neurologists, nurse specialists and therapists.
Neurologist  Nurse specialist Therapist
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4. Conclusions 
This study showed that the implementation of ParkinsonNet partially enhanced multi-
disciplinary collaboration. Moreover, the quality of this collaboration was facilitated by 
neurologists and nurse specialists committed to multidisciplinary health interventions. 
However, participants felt that one year after the implementation of the network, 
communication and information exchange could still be improved considerably. In 
the following paragraphs, we elaborate on these findings.
Key role for nurse specialists
Our study showed that nurse specialists play a vital role in facilitating regional multi-
disciplinary collaboration. Unfortunately, 55% of all PD patients across Europe have 
no access to specialized nurses.23 International studies confirm that nurse specialists 
have a pivotal role in the coordination of Parkinson care, but also in providing patient 
education and emotional support.24 Moreover, they have a positive effect on patients’ 
sense of well-being and quality of life.25 Hereby, nurse specialists might reduce the 
workload of neurologists, enabling them to focus on their primary medical task. 
Importantly, the American Academy of Neurology predicted that the current shortfall 
of neurologists in the US, estimated at about 11% in 2012, will grow to 19% by 2025.1 
Therefore, neurologists increasingly rely on supervised nurse specialists or physician 
assistants to provide follow-up care, provided that these professionals received 
sufficient neurological training.2 As we showed, an alliance between nurse specialists 
and neurologists improves the quality of care for PD, which might well work similarly 
for other patients, e.g. those suffering from multiple sclerosis, stroke or epilepsy.26 
Neurologists who provide pharmacotherapy as monodisciplinary care has long been 
the gold standard in PD management. The challenge now is to combine conventional 
therapies with allied health interventions within an integrated approach.9 Moreover, 
the European Parkinson’s Disease Association stated that patients have the right to 
be referred to a neurologist with a special interest in PD and who displays a 
commitment to multidisciplinary care.25 However, multidisciplinary care is not a clear 
focus in medical training, and the attitude towards teamwork in healthcare differs 
between physicians.27
To date, neurologists involved in ParkinsonNet are not obliged to participate in the 
training program. Therefore, neurologists who do not attend the training may not be fully 
informed about the effectiveness of allied health interventions. Moreover, neurologists 
are not being held accountable for the number of referrals. Non-commitment among 
certain neurologists might explain the variation in the number of direct working 
relationships between sub-networks in this study.
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ParkinsonNet partially enhanced multidisciplinary collaboration
One year after the implementation of a regional network for PD, communication and 
information exchange across health professionals need further improvement. A longer 
timeframe and additional measures are needed to migrate from a multidisciplinary 
approach towards integrated care. Multidisciplinary care involves several health 
professionals working independently, not collaboratively, each being responsible for 
a specific patient care need. ‘Integrated care’ entails a holistic approach conducted 
by a team of health professionals.9 In this study, multidisciplinary care was largely 
adopted, however integrated care was far from being implemented in daily practice. 
Much can be learned from the Patient-Centered Medical Home approach (PCMH).28-29 
In this model a team of professionals provides care across the continuum of the 
healthcare system. A personalized care plan for each individual patient is at the heart 
of the approach with treatment goals, planned interventions and the identification of 
health professionals responsible for each intervention.28Again, the role of specialized 
nurses in the coordination of the team is essential. PCMH allows for different roles for 
neurologists; some might serve as the principal physician, others as specialist on 
referral to expert therapists.29 Implementation of the PCMH means that patients and 
professionals are both recognized as experts of the disease and as equal partners in 
the healthcare team. For instance, neurologists are experts in the cause and the 
prognosis of the disease and in diagnostic and therapeutic procedures, however 
patients and caregivers know best about day-to-day decisions and experiences with 
the disease. Hence, the role of professionals should change from experts who care 
for patients to enablers who support patients to make their own decisions. Patients 
on their behalf have to learn how to manage their disease and how to interact with the 
healthcare team.
4.2 Strengths 
First, some potential benefits of ParkinsonNet are subjective in nature and until now 
impossible to quantify.30 ParkinsonNet has been evaluated in several studies, however 
variation in the quality of multidisciplinary collaboration was never assessed.12 This 
study shows that social network analysis provides a useful tool to study and visualize 
connections between health professionals.19 This method is applied in many scientific 
disciplines, including neurosciences, molecular life sciences and public health. The 
application in medical research is relatively new, although the first study, concerning 
the uptake of innovations by physicians, dates back to 1957.31The challenge of social 
network analysis is achieving high response rates, as we managed to get in this study. 
Second, we used a mixed-method design to conceptualize the broad spectrum of 
multidisciplinary collaboration in healthcare. This research method is increasingly 
145
MULTIDISCIPLINARY COLLABORATION IN PROFESSIONAL NETWORKS FOR PD
9
utilized in the evaluation of complex health interventions, because it capitalizes the 
strengths of both quantitative and qualitative approaches.15Here, qualitative data proved 
to be valuable in explaining differences between expected and observed results that 
would have been left undetected by quantitative methods alone. 
4.3 Shortcomings
This study was not without shortcomings. First, we solely focused on the professional’s 
perspective and the patient’s view was not included. From previous studies we know 
that PD patients experience a lack of multidisciplinary collaboration within their care.14 
At the time of this study, a valid  instrument to measure patient  experiences in Parkinson 
care was lacking. Care experiences are now widely used to assess the quality of 
Parkinson care from a patient’s perspective and to provide health professionals with 
feedback on their performance.32-33 
Second, there is no valid instrument to measure perceived team performance in PD 
care. Therefore, we used a team performance questionnaire originally developed to 
evaluate teamwork in COPD management. Based on the opinions of two PD experts 
[BB, MM] and one expert in chronic illness care [HJMV] the items on the questionnaire 
were found to be relevant for PD. Illustrative for the applicability in PD care is the 
utilization of the ‘not applicable’ answer category, which was marginally used by 
participants in our study. Unfortunately, the instrument did not capture information on 
the geographical location of participants in the network, meaning that no comparisons 
between sub-networks could be made on perceived team performance.
4.4 Practical implications
As a consequence of this study, neurologists involved in ParkinsonNet will be asked 
to agree on specific terms and conditions, including a commitment to collaborate 
with and refer to specialized therapists. Currently, we are creating a quality of care 
registry to provide information on the level of expertise and quality of care delivered 
by all participants. This registry holds information from health insurance companies 
(hip fractures and costs), health professionals (provided treatment and perceived 
collaboration) and patients (care experiences). The data is publicly available in an 
online ParkinsonAtlas (www.parkinsonatlas.nl), thereby offering transparency on the 
quality of care for each of the 68 participating regions.12 Additionally, the data will be 
used to credit professionals for providing better integrated, less fragmented care.
4.5 Broader impact for other neurological disorders
PD is a debilitating chronic disorder which benefits from a multidisciplinary approach. 
ParkinsonNet might be useful as a framework for the management of other neurological 
disorders, where it is equally important to improve specialized expertise and stimulate 
146
CHAPTER 9
multidisciplinary collaboration between health professionals. Certainly, elements of 
the approach can be applied elsewhere, including the use of disease-specific multi-
disciplinary training and the adoption of a regionally oriented multidisciplinary approach. 
The concept might well serve as a model on how to offer patients access to 
specialized expertise in their immediate environment, and how to gradually develop 
multidisciplinary care. Finally, the concept is beginning to show its merits in other 
countries, including the US, where Kaiser Permanente has recently begun to 
implement the ParkinsonNet approach in its southern regions, with the long-term aim 
of scaling to other regions and other conditions.
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Abstract
Introduction
Our healthcare system faces major threats, as the number of people with multiple chronic 
conditions rises dramatically. Here, we propose the use of Online Health Communities 
(OHCs) as a powerful tool to facilitate high-quality and affordable healthcare for future 
generations. 
Methods
OHCs are internet-based platforms that unite either a group of patients, a group of 
professionals, or a mixture of both. Members interact using modern communication 
technologies such as blogs, chats, forums and wikis. We illustrate the use of OHCs for 
ParkinsonNet, a professional network for Parkinson’s disease whose participants – both 
patients and professionals – use various types of OHCs to deliver patient-centered care. 
Results 
We discuss several potential applications in clinical practice. First, due to rapid advances 
in medical knowledge, many healthcare professionals lack sufficient expertise to address 
the complex healthcare needs of chronic patients. OHCs can be used to share 
experiences, exchange knowledge and increase disease-specific expertise. Second, 
current healthcare delivery is fragmented, as many patients acquire relationships with 
multiple professionals and institutions. OHCs can bridge geographical distances and 
enable interdisciplinary collaboration across institutions and traditional echelons. 
Third, chronic patients lack adequate tools to self-manage their disease. OHCs can 
be used to actively engage and empower patients in their healthcare process and to 
tailor care to their individual needs. Personal health communities of individual patients 
offer unique opportunities to store all medical information in one central place, while 
allowing transparent communication across all members of each patient’s healthcare 
team.
Conclusions
OHCs are a powerful tool to address some of the challenges chronic care faces today. 
OHCs help to facilitate communication among professionals and patients and support 
coordination of care across traditional echelons which does not happen spontaneously 
in busy practice.
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1. Introduction 
Our healthcare system faces major threats. Western societies age rapidly and the 
prevalence of people with multiple chronic conditions rises dramatically.1 Moreover, the 
number of patients with complex healthcare needs outpaces the number of professionals 
with sufficient knowledge and skills to adequately care for these people.2 Finally, 
healthcare threatens to become unaffordable due to overtreatment and costly medical 
advancements.3-4 To guarantee qualitatively and affordable healthcare for future 
generations, disruptive innovations are needed.5 Here, we discuss the use of Online 
Health Communities (OHCs) as a tool to address some of the above challenges. We 
illustrate the use of OHCs for ParkinsonNet, a professional network for PD whose 
participants - both patients and professionals - use various types of OHCs to deliver 
patient-centered care (box 1).6-8 
2. Online Health Communities 
Platforms using social media technologies, such as Wikipedia, Facebook, Linked-in, 
YouTube and Twitter, have become extremely popular among millions of people 
worldwide. These tools have brought new possibilities for co-creation and 
communication between individuals with minimal time and cost restrictions.9 It seems 
logical to apply elements of this revolution to healthcare. As such, social network 
technologies provide an internet-based platform for communication about health 
and disease, for sharing care experiences, and to increase medical knowledge.10-11 
Box 1  The ParkinsonNet concept
What is ParkinsonNet? 
ParkinsonNet consists of regional allied health networks for Parkinson’s disease (PD) in the 
catchment areas of Dutch hospitals. Within each network a selected number of expert 
therapists are trained according to evidence-based guidelines. Neurologists are stimulated 
to refer PD patients to these skilled professionals. Additionally, the concept has nationwide 
coverage in The Netherlands with 66 regional networks and 2200 physicians, nurses, physical, 
occupational therapists, speech-language pathologists and dieticians involved.6
Quality of care 
ParkinsonNet was developed to improve the quality of Parkinson care delivered by allied 
health professionals. The implementation of ParkinsonNet showed a profound reduction in 
healthcare utilization and costs.7 Participants increased their PD-specific knowledge, improved 
the adherence to guideline recommendations, and treated a higher volume of patients per year.8
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By echoing web 2.0 principles into healthcare, we could help patients become 
active participants in their own care and more engaged partners for healthcare 
professionals.12 Moreover, internet-based contacts are a way to expand the possibilities 
for communication outside the few scheduled face-to-face hospital consultations.13
One specific example are OHCs which consist of an internet-based platform that 
unites groups of individuals with a shared goal or similar interest regardless of their 
whereabouts.14 Such a group could include patients with a particular condition (e.g. 
patients with diabetes mellitus type II), a group of professionals with a shared medical 
interest (e.g. diabetologists), or a mixture of both patients and professionals. Members 
might know each other from the ‘real’ physical world, but the strength of OHCs is 
their potential to connect members who would otherwise never have met because 
of geographical distances. Within OHCs, members interact easily using modern 
communication technologies such as blogs, chats, forums and wikis (box 2). An 
illustrative example is PatientsLikeMe, an online platform for patients with life-changing 
conditions who share their experiences and medical data with other patients matched 
for clinical conditions and geographical characteristics. This platform provides 
generic solutions to acquire medical information and peer support for different patient 
groups.15 PatientsLikeMe is currently being used by PD patients who quantify and 
self-report their disease symptoms on a regular basis. This data provides healthcare 
professionals with new insight in variations in symptom severity and understanding 
about the disease progression in PD.16
Platforms using OHC principles are utilized by patients from various ages. Moreover, 
the Health and Welfare Information Portal (ZWIP) combines an electronic health 
record with a communication tool aiming to improve care for frail older people. ZWIP 
potentially enhances patient involvement, coordination of care and collaboration 
among professionals.17 Furthermore, OHCs are utilized in Dutch fertility care. Young 
couples gain access to their medical records containing general and personal 
information and communication tools with peers and their local healthcare team.18 
2.1 Open and closed communities 
OHCs can be classified into open- and closed communities based on the accessibility 
of the community content. The content of open OHCs can be accessed by anyone, 
all members are allowed to contribute to its content, and all information that is 
generated is openly accessible to anyone. Within a closed OHC, the content is visible 
to community members only. Members are allowed to make an active contribution 
after a community manager, an individual who ‘leads’ the community, has granted 
them access. The platform described in this chapter is utilized by several patient 
groups in the field of PD, dermatology, stroke, multiple sclerosis, rheumatoid arthritis, 
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fertility- and cancer care. In the next paragraphs we will elaborate on open en closed 
OHCs utilized in Parkinson care.
2.2 Open Parkinson communities 
The Parkinson community is an open community for all people interested in PD. 
Members are PD patients, caregivers, and healthcare professionals. Table 1 shows 
the different social media applications used within this community. Patients use the 
community forum for online peer support and discussions with healthcare 
professionals. Often, fellow patients provide useful answers, which may alleviate the 
pressure on healthcare professionals. On an open community for breast cancer 
patients, incorrect answers were rapidly corrected by other members.19 A striking 
feature is the wiki which, with the help of several community members, is developing 
into a national encyclopedia for PD. 
2.3 Closed Parkinson communities
The ParkinsonNet community is used to facilitate communication and collaboration 
between healthcare professionals involved in the treatment of PD patients and is 
accessible to ParkinsonNet professionals only (Figure 1). After verifying the 
ParkinsonNet membership the community manager grants access. The community 
forum has been divided into separate discussions for physical, speech, and 
occupational therapists and for interdisciplinary consultation. Other applications 
include; the community blog, where members are informed about ongoing education 
and guidelines; the wiki, containing an up-to-date address list of all ParkinsonNet 
professionals and; the community library, used for sharing presentations of multidis-
ciplinary team meetings. 
Box 2  Social media applications within an OHC
Blog: a blog is a series of messages published in reverse chronological order written by one 
of the community members about e.g. scientific developments or personal care experiences. 
Forum: a forum is used for asynchronous communication with other community members, 
e.g. patients can put questions to professionals or peers.
Library: within a library, documents are shared with all community members, e.g. information 
leaflets, newsletters, scientific articles and guidelines. 
Chat: a chat is a real-time conversation with other community members.
Wiki: within a community wiki, all members are allowed to adapt a certain document, e.g. an 
address list or information leaflet.
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Another example is the closed community of an outpatient Parkinson clinic, which is 
accessible only to patients visiting the clinic and to healthcare professionals who 
work there (Table 1). A distinctive feature of this community is the combination of 
online patient-provider and peer-to-peer communication integrated into one and the 
same community with both patients and healthcare professionals from the same 
clinic involved. In our Parkinson center, we run such an OHC as a service to both our 
patients and the members of our multidisciplinary healthcare team. Access is 
restricted and controlled: to become a member, patients must first send a formal 
membership request. After verifying the patient identification number, the community 
manager grants access. 
The community blog contains information about the treatment facilities that are 
available at our center. Within the community forum, patients are provided with 
facilities for communication with fellow patients and the healthcare team. Future 
patients benefit from previous discussions which remain visible, unless patients wish 
this to be removed. This OHC does not offer individually tailored information, because 
the exchange of information is not private and can be seen by all members. This 
community type has proved to fill the gap between patients’ needs and the support 
our clinic can offer.18 
Figure 1   Schematic overview of the closed 'ParkinsonNet Community'
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Some of our patients are both member of the closed outpatient Parkinson clinic and 
the open Parkinson community. These patients have the opportunity to ask questions 
on both forums. Items in the outpatient clinic are more likely to involve questions to 
our medical team and facts, e.g. treatment options in our clinic, whereas the open 
national forum is more likely to contain peer contact, care experiences and opinions. 
2.4 Personal health communities for PD
A  Personal Health Community (PHC) is a private community governed by individual 
PD patients. Apart from the patient, participants include one or more (ideally all) 
healthcare professionals involved in his care process, and the immediate caregiver. 
The patient is the owner of the community and decides who is granted access to his 
community. The immediate caregiver can act as community manager if the patient is 
unwilling or unable to do so. Once gathered, the patient and the healthcare team 
exchange information and communicate about individual health problems. Like an 
electronic patient record, PHCs offer the opportunity to store all medical information 
in one central place, while allowing transparent communication across members of 
the healthcare team. Hereby, the patient is in the lead as an active and equal partner 
who contributes to his own health.
PHCs differ from other OHCs in two ways. First, PHC functionalities are customized 
and used in a different way. The blogging feature is used as a ‘diary’ to inform other 
members about e.g. side effects of Parkinson medication, the forum for online 
consultation of your healthcare professionals, the library to store medical information 
and the wiki as a specific medical document, like a medication scheme or treatment 
overview. A second difference is ‘two-way authentication’, which adds an extra layer 
of security to the PHC. Patients have to enter their username, password and a security 
code send to their mobile phone.
3. Active users
The following definition of ‘active user’ is applied on our platform: ‘The total number of 
users who performed at least one activity for a given day. Activities include: blog posts, 
blog comments, forum posts, forum replies, library uploads, library downloads, new wiki 
pages, wiki revisions, wiki comments, joining a group, subscribing to content or rating 
a post’.20 Table 1 shows that over a 12 month period 54% of the Parkinson and 
ParkinsonNet community members generated new content or posted a comment. 
Other participants may have visited the community, albeit without an active contribution. 
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Table 1   Social media applications and members of the Parkinson communities  
Parkinson
community
ParkinsonNet 
Community
Outpatient Parkinson clinic Personal health community
Community  
type
Open Closed Closed Closed 
Info A national community for people interested 
in PD for peer-to-peer contact and patient-
professional interaction
Transmural community for ParkinsonNet 
expert therapists for online professional 
interaction
Intramural community of an outpatient 
Parkinson clinic. Supplementary service to  
the existing face-to-face care relationship
A private electronic patient record of individual 
patients to allow personalized medicine
Members PD patients, 
caregivers and healthcare professionals
1.190 (31th Dec 2012)
1.224 (31th Jan 2013)
ParkinsonNet healthcare professionals
1.360 (31th Dec 2012)
1.447 (31th Jan 2013)
The multidisciplinary healthcare team and PD 
patients visiting the Parkinson clinic 
64 (31th Dec 2012)
74 (31th Jan 2013)
One PD patient, his caregiver and healthcare 
professionals involved (e.g. physical therapist, 
neurologists, PCP)
131 patients
70 professionals
(31th Dec 2012)
147 patients  
78 professionals 
(31th Jan 2013)
Active users 2012: 646 (54%) 
Recent month: 
83 (7%)
2012: 737 (54%)
Recent month: 
182 (13%)
2012: 56 (88%) 
Recent month: 
14 (19%)
Data not available due to technical and 
privacy issues
Page views 2012: 241.093
Recent month: 24.671 
2012: 76.,452 
Recent month: 7.568 
2012: 8.376 
Recent month: 1.098
Data not available due to technical and 
privacy issues
Blog Information from physicians and therapists 
on new trials, etiology, diagnosis and PD 
treatment options
Information from ParkinsonNet 
professionals about conferences, team 
meetings, new PD guidelines.
Information on medication, non-motor 
symptoms, research in our clinic,
announcement of maternity leaf local PD 
nurse specialist 
PD patients’ diary about e.g. on/off 
fluctuations, wearing off of, side effects and 
daily experiences
Forum Discussions
between community members about 
medication, symptoms and peer support
Discussions about allied health therapy, 
food and diet and medication
Peer-to-peer contact between PD patients in  
a familiar setting and questions to the local 
healthcare team
Consultation between a patient and his 
professional care team about e.g. side effects
Library Documents on allied health disciplines, 
driving abilities, medication and side 
effects, PD guidelines and scientific papers
Centralized up-to- date information: 
newsletters, presentations, scientific 
papers, 
PD guidelines, clinimetrics, courses
Information on treatment facilities provided  
by our clinic and regional peer contact
Individually tailored information e.g. physical 
exercises, medication schemes or a diary 
Chat No chat available Real time conversation at assigned times 
between ParkinsonNet professionals
No chat available No chat available
Wiki A national encyclopedia for PD on 
diagnosis, symptoms, medication, on/off 
fluctuations, multidisciplinary collaboration, 
etiology and disease progression 
Address list of all ParkinsonNet 
professionals, a   ParkinsonNet calendar 
with e.g. regional ParkinsonNet meetings, 
conferences and symposia
No wiki available E.g. medication or treatment overview
*recent month means ‘January 2013’
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neurologists, PCP)
131 patients
70 professionals
(31th Dec 2012)
147 patients  
78 professionals 
(31th Jan 2013)
Active users 2012: 646 (54%) 
Recent month: 
83 (7%)
2012: 737 (54%)
Recent month: 
182 (13%)
2012: 56 (88%) 
Recent month: 
14 (19%)
Data not available due to technical and 
privacy issues
Page views 2012: 241.093
Recent month: 24.671 
2012: 76.,452 
Recent month: 7.568 
2012: 8.376 
Recent month: 1.098
Data not available due to technical and 
privacy issues
Blog Information from physicians and therapists 
on new trials, etiology, diagnosis and PD 
treatment options
Information from ParkinsonNet 
professionals about conferences, team 
meetings, new PD guidelines.
Information on medication, non-motor 
symptoms, research in our clinic,
announcement of maternity leaf local PD 
nurse specialist 
PD patients’ diary about e.g. on/off 
fluctuations, wearing off of, side effects and 
daily experiences
Forum Discussions
between community members about 
medication, symptoms and peer support
Discussions about allied health therapy, 
food and diet and medication
Peer-to-peer contact between PD patients in  
a familiar setting and questions to the local 
healthcare team
Consultation between a patient and his 
professional care team about e.g. side effects
Library Documents on allied health disciplines, 
driving abilities, medication and side 
effects, PD guidelines and scientific papers
Centralized up-to- date information: 
newsletters, presentations, scientific 
papers, 
PD guidelines, clinimetrics, courses
Information on treatment facilities provided  
by our clinic and regional peer contact
Individually tailored information e.g. physical 
exercises, medication schemes or a diary 
Chat No chat available Real time conversation at assigned times 
between ParkinsonNet professionals
No chat available No chat available
Wiki A national encyclopedia for PD on 
diagnosis, symptoms, medication, on/off 
fluctuations, multidisciplinary collaboration, 
etiology and disease progression 
Address list of all ParkinsonNet 
professionals, a   ParkinsonNet calendar 
with e.g. regional ParkinsonNet meetings, 
conferences and symposia
No wiki available E.g. medication or treatment overview
*recent month means ‘January 2013’
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4. Implementation strategy
Implementation of OHCs in clinical practice takes a collective effort of all healthcare 
professionals involved. However, the community manager plays a vital role during the 
implementation and maintenance of all OHCs. Usually, the community manager of 
an outpatient Parkinson clinic is a local PD nurse specialist. PD nurse specialists are 
key practitioners when it comes to the coordination of care, patient education and 
emotional support.21 However, the community manager appointed in our clinic is a 
marketing and communication expert. The community manager distributes posters, 
information leaflets and ‘business cards’ to patients and healthcare professionals. 
The information leaflet, which is available in every doctor’s office, contains information 
about the aim of the community, login procedures and social media applications 
within the OHC. Other tasks of the community manager are; management and 
maintenance of the community members’ database, generation of content, motivation 
of healthcare professionals and patients to participate and monitoring of the expert 
forum. Lately, the first 10 PD patients received a training on navigation through the 
online outpatient clinic. The community manager of the ‘ParkinsonNet community’ is 
a marketing and communication expert as well. She visited all 68 regional ParkinsonNet 
networks to educate healthcare professionals about OHCs. ParkinsonNet professionals 
are urged to enroll in the ParkinsonNet community as part of their membership. 
Currently, the ParkinsonNet community is the main source of information for the 
professionals in the network. Some information about new guidelines and state-of-art 
courses can only be found within this community. 
In 2011 we introduced the Personal Health Community (PHC) in four Parkinson clinics 
in The Netherlands. During regular home visits patients learn to navigate through and 
utilize the PHC by a local PD nurse specialist. ParkinsonNet organizes workshops to 
engage patients and healthcare professionals in the pilot regions. Additionally, an 
information leaflet, poster and a video to promote the PHC were introduced. Roughly, 
implementation of PHCs includes three phases; a pilot phase concerning patients 
and professionals from the Parkinson clinic only, a second phase in which primary 
care providers are invited and a third phase in which new clinics are included. Our 
first experiences show that PHCs facilitate emotional support, healthcare accessibility 
and improve relationships between professionals and patients.
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5. The added value of OHCs in chronic care 
Based on our first experiences in Parkinson care and the international literature, OHCs 
have four major advantages to improve the quality of chronic care;
5.1 OHCs facilitate the exchange of medical experience and knowledge 
Due to rapid advances in medical knowledge, many healthcare professionals lack 
specific expertise and experience to address the complex healthcare needs of chronic 
patients.1-2 Therefore, healthcare is increasingly organized within specialized networks, 
like ParkinsonNet.22-23 Professional networks enhance information exchange, facilitate 
communication among participants and foster the adoption of new knowledge, such 
as revised guidelines.24-25 Traditionally, these network processes occur largely offline 
during physical encounters, such as medical conferences. However, with the advent 
of modern communication technologies, professional networks can now be supported 
online. Within OHCs, professionals connect and communicate more easily, regardless 
of their working place within the network, and regardless of time. Moreover, OHCs 
can be used to develop disease-specific expertise among all community members, 
patients and professionals, interested in a particular chronic condition.26
5.2  OHCs enhance interdisciplinary collaboration across 
institutions and traditional echelons
Healthcare delivery can become fragmented for chronic patients when they acquire 
relationships with multiple professionals and institutions. Increasingly, chronic care 
has evolved from individual consultations into multidisciplinary teamwork with care 
given by various physicians and therapists, who often work in different departments 
or organizations.27 To manage complex patients with multiple co-morbidities, 
healthcare professionals must collaborate to make coordinated decisions and share 
responsibilities in health outcomes.28 Yet, the collaboration and coordination of care 
should be improved considerably.29 Given their synchronous and asynchronous 
communication capacity, OHCs offer a platform for supporting medical deci-
sion-making and interdisciplinary collaboration across professionals caring for 
complex patients.26, 30-31 OHCs enable communication between community members 
who are not able to have face-to-face interaction at any point in time. Moreover, OHCs 
bridge geographical distances and enable interaction across institutions and 
traditional echelons. An example is the Canadian Virtual Hospice, with information 
and support on palliative and end-of-life care.32 Patients, close family members and 
caregivers interact in several peer-to-peer discussion forums or private messages 
with a team of palliative care experts. Normally, these interactions would not have 
been possible due to physical limitations and geographical distances.
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5.3 OHCs provide a platform to support self-management 
Regularly, patients have a passive role and lack the tools to self-manage their 
condition.33 However, modern patients search the internet for medical information, 
wish to have open communication channels with their physicians and prefer to 
participate in making treatment decisions.34 Self-management refers to the efforts to 
enhance patient participation and assisting patients to gain control over their lives.35 
The concept is associated with improved communication between patients and 
clinicians, and it enhances quality of life.36 Supporting patients with chronic diseases 
like type 2 diabetes, arthritis, and asthma to self-manage their condition helps to 
improve the quality and safety of care and reduces costly and inappropriate use of 
healthcare resources.37-38 Increasingly, the internet is used to support self-manage-
ment and actively engage patients in treatment decisions.39 Chronic patients using 
online communication tools become more knowledgeable, feel better socially 
supported and empowered and have improved behavioral and clinical outcomes 
compared to non-users.40-41 Examples that include OHC-principles are patient 
participation in online peer support groups and access to Personal Health Records.16, 
42 Personal Health Records allows patients to have access to medical records, control 
their own online information and enable individualized health communication.43
5.4 OHCs have the ability to improve patient-centered care 
Patient centeredness is defined as ‘providing care that is responsive to individual 
patient preferences, needs, and values, and ensuring that patient values guide all 
clinical decisions’.44 Contrary to some perceptions, patient centeredness is not just 
about being nice to patients, but engaging them to become active participants in 
their care.45 The concept is known for its advantages in terms of reduced healthcare 
utilization and improved efficiency, patient-doctor communication, treatment 
compliance and health outcomes.46-48 OHCs enhance patient-centered care by 
improved access to personalized information, emotional support and patient-partici-
pation.16,42, 49 PHCs are essentially patient-centered, while they engage patients in 
their care process and tailor care to their individual needs. Professionals have the 
opportunity to benefit from patient peer-to-peer conversations which take place in 
OHCs by knowing that they have more effectively addressed their patients’ needs.50 
Blog and forum items often involve aspects of patient-centered care; like information 
and emotional support needs, patients’ willingness to participate in treatment 
decisions or an experienced lack of continuity of care.
163
IMPROVEMENT OF PATIENT-CENTERED CARE USING ONLINE HEALTH COMMUNITIES
10
6. Barriers for implementation in clinical practice
Why do only a few innovations become part of routine practice and why do most fail 
to survive beyond the pilot phase? To answer this question, full understanding of the 
clinical and technological barriers and incentives for achieving behavior change in 
practice is needed.51-52 The following barriers to internet technologies may be at play. 
First, the implementation of internet innovations can radically affect healthcare 
delivery and the professionals’ daily work processes, requiring considerable time 
and willingness to learn.53 Doctors may be hesitant to adopt technologies that imply 
an interruption of their traditional practice patterns. The requirement of additional time 
is a prominent barrier to physician technology acceptance.54
Second, the implementation of OHCs into clinical practice demands a paradigm shift 
in control and power, out of the hands of those who deliver care, into the hands of 
those who receive it.14 Professionals should no longer regard patients as passive 
objects, but rather as equal, participatory partners who contribute to their own health. 
Thus, OHCs require a change in the mindset of both professionals and patients. Not 
surprisingly, in the age of Facebook young clinicians may struggle to maintain 
professional distance on the one hand and have close, meaningful relationships with 
their patients on the other hand.55
Third, besides behavioral change, safety and financial issues have to be solved.56 To 
ensure a safe and secure environment, the Dutch government authorizes PD patients 
to apply their personal verification code, normally used to complete and submit a tax 
return form to the tax authority while using our OHC platform. Healthcare professionals 
are only allowed to access closed communities via their unique, electronic identity. 
Additionally, for OHCs to become integrated into everyday use, new and viable 
business models are needed. To utilize OHCs in daily practice is time consuming, 
however, they may also substitute usual ways of care delivery. Generally, healthcare 
is reimbursed by face-to-face interactions and offline medical services. Bearing this 
in mind, we would like to introduce the term ‘blended health’, analogous to blended 
learning, which combines face-to-face contact with the possibilities of online tools. 
The intended result is a healthcare system not driven by technology, but using 
technology as a tool to facilitate patient-centered care.
More and more, innovations in healthcare are based on internet technologies and the 
willingness of PD patients to participate in such interventions is growing.57 Generally, 
health related internet use is associated with age and level of education.58 The 
European Union investigated the level of internet access within the 27 member states. 
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Household internet access ranged from 45% in Bulgaria to 94% in The Netherlands.59 
Therefore, internet access is assumed to be a minor limitation in the adoption of 
OHCs in The Netherlands. 
7. Conclusions
OHCs are a powerful tool to address some of the challenges chronic care faces 
today. A challenge now is to perform an in-depth evaluation of our platform which is 
simultaneously being designed, developed, and deployed.60 Further evaluation 
should address user needs, risks, benefits and cost implications before OHCs can 
be fully adopted in daily practice.61-62 We expect that innovations like OHCs can help 
to facilitate high-quality and affordable healthcare for future generations. Chronic 
care demands an integrated approach tailored to the needs of individual patients to 
optimize outcomes. In the absence of a formal team structure, OHCs help to facilitate 
communication among professionals and patients and support coordination of care 
across traditional echelons which does not happen spontaneously in a busy practice. 
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CHAPTER 11
Abstract
Introduction
Fragmentation of care, complexity of diseases and the need to involve patients actively 
in their individual health care led to the development of the personal health community 
(PHC). In a PHC, patients can –regardless of the nature of their condition– invite all 
professionals that are involved in their health care process. Once gathered, the patient 
and health care team can exchange information about the patient’s health and 
communicate through several functionalities, in a secured environment. This study 
aimed to explore the use, first experiences and potential consequences of using 
PHCs in healthcare.
Methods 
Eighteen respondents, consisting of women experiencing infertility (n = 5), persons 
with Parkinson’s disease (n = 6), a gynecologist, a fertility doctor, a fertility nurse, three 
Parkinson’s specialist nurses and a neurologist.
Results
First experiences with PHCs showed that patients use their PHC differently, depending 
on their condition and people involved. Various (potential) advantages for future health 
care were mentioned relating to both organizational aspects of care (e.g. continuity of 
care) and the human side of care (e.g. personal care). Patient involvement in care was 
facilitated. Disadvantages were the amount of work that it took and technological 
issues.
Conclusions 
Using PHCs leads to promising improvements in both the organization of care and 
care experience, according to the participants in this study. They indicate that patients 
with different diseases and in different circumstances can benefit from these 
improvements. The PHC seem to be an online tool that can be applied in a personalized 
way. When (technically) well facilitated, it could stimulate active involvement of patients 
in their own health and health care. It warrants further research to study its effect on 
concrete health outcomes.
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1. Introduction
Current health care faces some serious challenges. Due to complexity of diseases, 
health care services are increasingly distributed across multiple clinicians in different 
specializations and institutions.1,2 Health care has evolved into multidisciplinary 
teamwork of various physicians, nurses and other care providers, who often work in 
different departments and organizations.3 This poses challenges not only for health-care 
professionals, but also for individual patients, as it demands a more active role in the 
organization of their own health care.4,5 Policy is therefore more and more focused on 
transforming patients from their current (often) passive position to engaged individuals 
who actively participate in their own health network.6 Additionally and importantly, many 
patients also express the wish to be more actively involved.7,8 However, current 
healthcare is not prepared to respond to these developments adequately for several 
reasons. First, health care is primarily organized from the health care provider’s 
perspective, instead of the patient’s. Secondly, the complex care pathway that an 
individual patient has to deal with is generally poorly organized. In most cases, no one 
really leads the process and adequate communication between the different healthcare 
providers could be improved.9 Thirdly, so far, interventions to activate patients and put 
them in the heart of the health system are not yet well developed.5,10–12
Reflecting these developments and challenges, the online personal health community 
(PHC) was developed. A PHC can – in fact – be defined as the patient’s own ‘online 
hospital’. Online, he or she can gather all different health-care professionals from 
different health care organizations, which are relevant for his or her health. With the 
patient in the lead, all members of the community can share information about the 
patient’s health and communicate with each other about this information through 
several functionalities in the PHC, including blogs and forums. This way, the PHC could 
be a tool to deal with some of the aforementioned difficulties in current health care.
The PHC resembles initiatives that have been developed in recent years, such as 
www.patientslikeme.com, NHS’ Healthspace, personal health records (PHR) and 
some electronic health record (EHR) systems. Most of these initiatives provide 
patients a tool to have insight into their own medical data.13–18 On the website www.
patientslikeme.com, patients can discuss their medical data online with ‘patients-like-
them’.17 However, the concept of the PHC also differentiates itself on multiple aspects. 
First, the PHC puts the individual patient in the heart of the health system, 
acknowledging the multiple and personal contexts of individuals’ lives. Second, the 
PHC makes the complex patient’s network transparent for both the patient and his or 
her health care providers. Third, to have access to the PHC, health-care professionals 
need consent from their patient. This is ethically more justifiable than the often occurring 
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model of implied consent, in which the record can be accessed by anyone who 
claims to have a relationship with the patient.14 Finally, in many of the aforementioned 
systems, patients missed the opportunity to communicate with others, and in 
particular health-care professionals, about their medical data.15,16 Combining medical 
data with the possibility to communicate with others seems required to meet self- 
management goals and is possible within PHCs.19
Although many studies are conducted into the development, implementation and 
use of PHRs and EHRs, for example, to our knowledge, there is no information about 
the consequences for health-care professionals and patients using PHCs.15 The aim 
of this study is therefore to qualitatively evaluate the use and the potential consequences 
of using PHCs for patients and health-care professionals. The research question is 
threefold: (i) How do patients and health-care professionals use the PHCs in daily 
practice; (ii) what are their first experiences; and (iii) what are their expectations 
(regarding the (dis)advantages) of using PHCs for future health care? A qualitative 
research design can ideally answer this question, because one can go in-depth to 
capture the complexity of data.20
2. Methods
We used a phenomenological approach to explore experiences and possible 
advantages and disadvantages related to the concept of PHC. Phenomenology is a 
qualitative methodology that aims to explore the participants’ lived experience and 
that reveals the meanings of the experience to the respondents’ care.21–24 Phenomeno-
logical analyses do not discover causes.21 The goal is to clarify the meaning of a 
certain phenomenon: in this study the PHC.
2.1 The personal health community
The PHC is provided on a secured Dutch website offering an online platform for 
health-care professionals, caregivers and patients to communicate, share information 
and exchange knowledge within online health communities.1 
A PHC is an online space owned by the patient. It offers the possibility to store and 
share medical information. The information consists of diaries written by the patient, 
forums for asynchronous communication, uploaded files with medical information 
1 The online communities described in this thesis migrated to different platforms in the last couple of 
years: https://www.mijnzorgnet.nl/ (2009-2013), http://www.mijnparkinsonzorg.nl/ (2014) and http://
www. parkinsonconnect.nl (2014- …). Mijnzorgnet.nl is still available as a personal health record  utilized 
by different patient groups.
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and third party applications (e.g. forms, tools for decision support, questionnaires). 
The patient can invite people who are relevant for his/her health to become a member 
of the PHC, for instance a GP, medical specialist, psychologist, family members and 
friends. Members have access to all personal information and communication 
possibilities. This allows transparent communication across all members of the 
health care team, including the patient. All activities in the community are logged. 
This way, the patient can see who ‘entered’ his or her community at what time. The 
PHC offers the possibility for the patient to be in the lead and to contribute to his or 
her own health care. When first visiting the online platform, patients register using 
their personal DigiD, which is an identification and authentication method provided 
by the Dutch government to ensure safe access to all (semi-) governmental 
institutions. After making a profile, patients can start their own PHC. Health-care 
professionals need to use their national electronic identification for health-care 
professionals, called UZI, to register and log onto the website. Thereafter, they can 
accept their patients’ invitations to join their PHCs. Registration is free of charge and 
untraceable to the individual user.
2.2 Setting
We performed this qualitative study aimed at exploring the experiences and possible 
advantages and disadvantages related to the concept of PHC in two patient 
populations, that is, suffering from infertility and Parkinson’s disease (PD). Each 
population and related care context will now be briefly described.
2.2.1 Dutch infertility care
Infertility is defined as any form of reduced fertility with a prolonged time of unwanted 
non-conception. Infertility care is multidisciplinary in its nature and receiving treatment 
in more than one hospital is not uncommon. Several medical disciplines are involved 
in infertility care, such as nurses, clinical embryologists, psychologists and 
gynecologists. Moreover, other medical conditions, such as Diabetes Mellitus, could 
influence fertility treatment protocols and effects, which asks for collaboration 
between different medical specialists. In The Netherlands, couples with impaired 
fertility can be referred by their GP to every gynecologist for further assessment of 
their fertility problem, for intra-uterine insemination (IUI) and ovulation induction (OI) 
as the first treatment possibilities. In vitro fertilization (IVF), including intracytoplas-
matic sperm injection (ICSI), is only performed in 13 IVF-licensed hospitals in The 
Netherlands: eight university hospitals, four general hospitals and one private clinic 
(tertiary health care). In some hospitals without an IVF-licensed laboratory, physicians 
can start up and monitor IVF cycles and refer the patient to an IVF-licensed hospital 
for the oocyte retrieval and/or embryo transfer. Overall, treatment for infertility is often 
lengthy, and the emotional impact of being infertile on patients is usually large.25-26
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2.2.2 Dutch Parkinson care
PD is a complex and debilitating disease. Patients become progressively incapacitated, 
not only because of the typical motor symptoms (e.g. bradykinesia, rigidity and 
tremor), but also because of a wide variety of non-motor symptoms (such as 
swallowing problems and bowel disorders). Conventional therapies, such as phar-
macological treatment and stereotactic deep brain surgery (DBS), offer only partial 
and temporary relief, particularly in more advanced stages.27 More and more, 
professionals are convinced that a multidisciplinary team approach is desirable for 
most PD patients.9 In The Netherlands, the lead physician is a neurologist, whereas 
Parkinson specialist nurses and a variety of allied health-care professionals, physical 
therapists, speech language pathologists and occupational therapists are regularly 
involved in treatment of PD patients.9
Ethical approval for the study was obtained from the Ethics committee of the Radboud 
University Nijmegen Medical Centre.
2.3 Data collection
The experiences with PHCs were investigated in infertility- and Parkinson care, as 
these two populations were the first users of PHCs on our platform. By including both 
populations, it was possible to apply the principle of ‘sample diversification’ to obtain 
results that are relevant to a broader range of settings.28 Both conditions share 
common characteristics, such as the multidisciplinary character and the impact on 
the patient’s life. However, both have also important differences, such as mean 
patients’ age (respectively, 20–40 years versus 60–80 years), other types of care 
providers and/or experiences with the Internet. The inclusion of these two conditions 
can contribute to the transferability of our findings.
2.3.1 Inclusion and exclusion criteria
The first author approached all health-care professionals (n = 10) for an interview, 
who joined at least one PHC between the 1st of September and the 1st of December 
2011, which were one gynecologist, one fertility doctor, one fertility specialist nurse, 
four Parkinson’s specialist nurses, one physical therapist, one occupational therapist 
and one neurologist. Seven professionals agreed on participating in this study (the 
infertility professionals, three Parkinson’s specialist nurses and one neurologist). 
Subsequently, a selection of these professionals (one gynecologist and three 
Parkinson’s specialist nurses) were asked to invite their patients into this study from 
whom they were joining the PHC, to prevent double invitations as much as possible. 
Then, potential participants received information by telephone about the aim and the 
procedure of the qualitative study from the first author, after which they could give oral 
consent. The five infertile patients who had started a PHC on the 1st of September 
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2011 all agreed on participating in the study. In addition, six of the ten PD patients 
who started a PHC in the period between the 1st of September and 1st of December 
2011, gave consent to participate as well. The most frequently mentioned reason for 
not participating for both patients and health-care professionals was lack of 
experience with the PHC. Table 1 shows the background characteristics of all 
interviewees. By involving patients and health-care professionals, data triangulation 
was reached, which increases the validity of this study.
2.3.2 Interviews
The first author performed semi-structured face-to-face interviews with all participants 
(i.e. patients and health-care professionals: n = 18) who agreed to participate in the 
study. The location of the interview depended on the participants’ preference: their 
home (n = 11), the hospital (n = 5) or by Skype in an online face-to-face meeting 
(n = 2). The interviewer was not involved in the patients’ clinical care and did not 
speak before with the health-care professionals about the PHC. The interviews were 
conducted according to a semi-structured interview guide, which was based on 
literature and developed specifically for the purpose of this study. One interview 
guide was developed for patients and one for health-care professionals (Table 2). 
During the interviews, techniques such as open-ended and reworded questions were 
used to clarify meanings and to explore new issues that had been brought up. 
Furthermore, the interviewer encouraged participants to talk freely and to describe 
their answers in depth. The interviews lasted 30– 70 min, were digitally recorded, and 
transcribed verbatim. Data were analyzed concurrently with the data collection. 
Insights obtained through analysis guided the further interviews. Data saturation 
within the patient population was reached, as the last two interviews with patients did 
not bring new information forward. Data saturation was not reached within the 
healthcare professional population. However, the maximum number of health-care 
professionals who participated in the PHCs and agreed to take part in the study, were 
interviewed.
2.4 Reflexivity
The interviewer (JA) was aware that her personal experiences due to her medical 
education could influence the data collection and analysis. The safeguards included 
an independent assessor doing the verbatim transcription and the independent 
analysis of the transcripts by two researchers (JA and FV), resulting in researcher 
triangulation, which will be further outlined below.
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Table 2  Interview guide for semi-structured interviews with patients and professionals  
 Patient Health care professional
General What is the course of your condition What is your profession?
What is the type of treatment
How many health-care professionals 
and clinics are involved and how is 
your relationship with them?
What do you find important in the 
relationship with your care provider?
What do you find important in the 
relationship with your patients?
PHC What was the reason to create a 
personal health community?
Why did you decide to participate 
in the personal health community of 
your patient?
How long ago did you start? How long ago did you start?
Expectations What were your expectations?  
And were these expectations met? 
Why (not)?
What were your expectations?  
And were these expectations met? 
Why (not)?
Experiences How much do you use your PHC? How much do you use the PHC of 
your patients?
Who is currently participating?  
Who did you invite or wanted to 
invite? Why these people?
In how many PHCs do you 
 participate?
Could you give some examples of 
information you uploaded? Could 
you give examples of questions you 
posted?
What have you actively  contributed 
to these PHCs (e.g. answering 
 questions, uploading information)?
Could you explain in what way the 
PHC is (dis)advantageous for you 
and your health?
Could you explain in what way the 
PHC could be (dis)advantageous for 
patients’ health?
How do you experience the contact 
with your health-care professionals in 
the PHC?
How do you experience the contact 
with your patients in the PHC?
Did you talk about the PHC during  
a consultation with your doctor in the 
hospital?
Did you talk about the PHC during  
a consultation with your patient?
Quality of 
care1
Do you think that the introduction  
of a PHC could improve dimensions 
of quality of care?
Do you think that the introduction  
of a PHC could improve dimensions 
of quality of care?
Accessibility? Accessibility?
Equitability? Equitability?
Efficiency? Efficiency?
Timeliness? Timeliness?
Effectiveness? Effectiveness?
Safety? Safety?
And why/how? And why/how?
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2.5 Data analysis
Data were analyzed according the phenomenology methodology.21 The aim of the 
data analysis was to understand the complexity of meaning of the PHC to patients 
and healthcare professionals. The methodology comprised of four stages: (i) Two 
researchers (JA and FV) independently extracted inductively meaningful units 
relevant to the research question (i.e. open coding). (ii) The units from the several 
interviews were then clustered and themes determined (i.e. axial coding).29 (iii) The 
Table 2  Continued    
 Patient Health care professional
Patient- 
centeredness 
of care2
Do you think that the introduction  
of a PHC could improve patient 
centeredness of care? 
Do you think that the introduction  
of a PHC could improve patient 
centeredness of care?
Regarding Regarding
Accessibility of care Accessibility of care
Communication Communication
Information provision Information provision
Patient involvement Patient involvement
Continuity and transition of care Continuity and transition of care
Respect for patient’s values Respect for patient’s values
Competence and knowledge Competence and knowledge
Emotional support Emotional support
Care organization Care organization
And why/how? And why/how?
Future 
perspectives
 
What do you think that the PHC 
could contribute to future health care  
in relation to …
What do you think that the PHC 
could contribute to future health care  
in relation to …
your role in your disease  
management
the role of your patient
role of your care provider the role of you as a care provider
patient-doctor relationship task division between different 
health-care Professionals
your quality of life patient-doctor relationship
What are the conditions to meet 
these future perspectives?
What are the conditions to meet 
these future perspectives?
1  Dimensions based on framework for quality of care of World Health Organization (2006).38
2  Dimensions based on patient centeredness framework, respectively in infertility of van Empel et al. (2010) 
and in Parkinson’s disease of van der Eijk et al. (2011)39,40.
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themes were contextualized (i.e. checked for consistency with the whole interview to 
maintain the context) and attributed a code. Eidetic reduction was applied, meaning 
that the researchers have expressed what is essential about the specific expressions 
used by the participant.21 (iv) Primary themes and subthemes were determined, their 
interaction and the meaning of their interaction(i.e. selective coding).19 As the analysis 
evolved, the two researchers discussed the emerging themes and codes. Points of 
discussion were reflected upon and any discrepancies were discussed until consensus 
was reached. The analysis gave insight into the experiences and possible advantages 
and disadvantages related to the concept of PHC, which will now be discussed.
3. Results
In line with our research question we first discuss how health-care professionals and 
patients (are planning to) use PHCs, focusing specifically on the latter. Secondly, 
based on first experiences with PHCs, we focus on the future expected advantages 
and disadvantages of using PHC’s for health care. We do this by making a distinction 
between PD- and infertility care and between patients and health-care professionals 
and taking the participants altogether.
3.1  Composition and use of the PHC dependent on individual 
patient’s context
“I have diabetes and therefore I regularly visit – amongst others – the internist. And I’m 
also having treatment at the reproductive medicine department. Furthermore, I have a 
general practitioner, who in general never knows how I’m doing. He receives a letter 
from a physician, but that’s all he knows about me. So I really thought that maybe this 
[PHC] is a way to gather all these different people. Maybe this way I can get a total 
picture [of my health].” (Respondent 3, patient)
Bringing together different medical disciplines and getting a complete picture of the 
patient’s condition(s) and ongoing treatment(s) is one of the reasons patients 
mentioned to start a PHC. This did not only apply for patients suffering from multiple 
conditions (as in the quote), but also for patients with singular diseases that involved 
several health-care professionals. The number of professionals invited in a patient’s 
PHC was strongly dependent on the type of condition the patient was suffering from 
and the related number of professionals involved in the patient’s care. All patients 
stated that they would only invite a professional to their PHC if trust and medical 
expertise were present. The number of people invited depended also on the patient’s 
personal preference who to invite: for instance, some patients did not want to invite 
all their health care professionals and whereas some wanted to invite family members. 
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From the interviews it appeared that this preference varied across participants. A 
schematic overview of the PHC/ online health network of two respondents is 
presented in Fig. 1.
Besides the variation in the number of invited participants in PHCs, there was also a 
variation among respondents in the way they used the different functionalities in the 
PHC. This depended on their personal needs. For instance, a PD patient preferred to 
ask medical- related questions and used primarily the forum, whereas an infertile 
patient wanted to see her lab results and used the ‘library’ function. This variation in 
use is shown in Table 3. Nevertheless, it is clear that most patients and professionals 
made use of the ‘diary’ and the ‘forum’ and to a lesser extent of the ‘library’ and 
‘patient file’. Both patients and professionals stated that these functions were less 
developed and could be valuable in future use. 
3.2  (Future) advantages and disadvantages of using PHCs based 
on first experiences
Based on first- and short-term experiences, both patients and professionals 
mentioned a number of advantages and disadvantages of using PHCs in future. 
These (dis)advantages are discussed from three perspectives: (i) PD versus infertility; 
(ii) patients versus health-care professionals; (iii) across all participants altogether.
3.2.1 PD versus infertility
Particularly PD patients and health-care professionals expected that using the PHC 
could lead to better tuning, exchanging and collaboration between health-care 
professionals. It is more transparent who is involved in the individual patient’s care. 
Furthermore, they expected that professionals and patients can contact each other 
more easily. This could result in ‘shorter communication channels’.
“The main interesting part [of the PHCs] is in the first place that one another can find 
each other more easily; the consultation format could take place more easily. Also 
among different medical disciplines. That someone, a client, has a question and that 
all persons who’re involved in the treatment team, could be contacted at once. That’s 
to my opinion the most interesting part. I notice that [by using it]. Patients prefer this as 
well. In the past, many mistakes have been made in this particular care aspect.”(Re-
spondent 17, professional)
“To me it appears to be a win-win situation. You can consult each other easily, 
communication channels are shorter. In addition, it becomes more easily to get 
feedback about the follow-up of your patient.” (Respondent 16, professional)
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Figure 1   Two examples of PHC composition representing a patient’s online  
health network
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This patient was under fertility treatment at one IVF clinic. She had no other health problems. 
She appreciated the possibility to interact with a clinic’s gynecologist, her lead fertility physician 
and fertility specialist nurse for emotional support and tailored information provision.
This PD patient had many health-care professionals involved in his health: for PD, but also for 
other co-morbidities (cardiological, urological). He preferred to have them all in his PHC for 
several reasons. He appreciated the possibility to ask questions to his health care providers. He 
also expected some health-care professionals to interact with each other about, for instance, 
interaction between medication he got prescribed. He preferred to have his son in his PHC, 
because his son, working in health-care, could advise him and keep track of everything happening 
in his PHC.
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Lead fertility 
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Parkinson’s disease patients and health-care professionals see many advantages 
from an organizational perspective of care, while, contrastingly, patients and 
professionals in fertility care mentioned merely advantages related to the care 
experience, including emotions and experiences from a psychosocial perspective 
(i.e. human factors). The latter group underlined that the PHC made health care more 
personalized. For instance, it improved the patient–physician relationship. Mostly, 
infertility respondents found it advantageous that patients could post a message to 
the medical team at any time of the day, also outside office hours, reducing stress.
“The idea that at all times you find yourself in a secure [online] environment: at the 
moment that you need help, you’re worrying about something, you encounter problems 
or if you have a comment about something. That you can always express these 
thoughts at any time, that’s great.” (Respondent 13, patient)
You can only contact the secretariat [of the hospital] between 9 and 10 a.m. or between 
9 and 11 a.m. But then I lost some blood in the middle of the day. I stressed out and I 
could not phone the hospital, because you may only call in case of emergencies. This 
wasn’t really an emergency but you’re not feeling comfortable. I immediately placed a 
message in my PHC and I received response from the doctor right away. I found that 
perfect.“ (Respondent 4, patient)
Participants from both conditions argued that the possibility of asking questions 
online 24 h per day contributed to the continuity of care. Also other PHCs components 
led to more continuous care flows, which will be discussed in the next paragraph.
3.2.2 Patients versus health-care professionals
By comparing the views of patients and health care professionals regarding the 
advantages and disadvantages of PHCs, it becomes clear that especially patients 
thought that healthcare professionals could stay more up to date about the situation 
and condition of their patient.
“I want to invite my general practitioner, my physical therapist, my neurologist. That 
they all can have a look in my PHC to see how I’m doing.” (Respondent 10, patient)
Participation in a PHC provides health-care professionals with the possibility to follow 
the situation of their patient at a distance (e.g. occurrence of complications or in case 
of temporary treatment elsewhere). It contributed, according to patients, to continuity 
of care.
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Additionally, patients indicated the possibility to ask specific questions online to their 
own health care professionals about their own situation, as an advantage. This 
advantage could often not be met  in public or general health forums, where everyone 
can read along and healthcare professionals answer merely in general terms. Also, 
through the different medical disciplines participating in the PHC, patients could 
easily have access to different views of conditions and treatments. According to the 
patients, this could result in (i) more complete information, which enables them to 
make an informed choice about their own health care and (ii) professionals could 
tune their views on medical advises to the views of others. This was partly agreed on 
among the participating professionals. In the current PHCs ,not much medical data 
was stored yet, which seemed a prerequisite to achieve the aforementioned advantages.
“My fertility physician recommended to lose weight, while my internist gave me the 
advice to stop doing that, because of my stressful life at the moment, because I 
already have to monitor all these hormones and blood sugars. It would be great if both 
doctors could agree on the best strategy. In reality this seems often very difficult to 
establish.” (Respondent 3, patient)
The possibility of asking questions to their own medical team online provided patients 
also with another advantage: They did not have to call or visit the hospital anymore 
for every question. The PHC offered the possibility to get a quick response on simple 
but urgent questions. This possibility gave patients much relief and (emotional) support.
In contrast to these more ‘practical’ advantages, primarily derived from patient 
interviews, health care professionals put more emphasis on the impact of using 
PHCs on current health care with respect to the change of ‘traditional’ roles of their 
profession but also from patients. For instance, they mentioned that they have to get 
used to patients ‘owning’ their own records. Another example is that by using PHCs, 
they have to take into account not only the physical condition, but to a larger extent 
also the mental condition. They mentioned that they are getting to know their patient 
in another way, which could result in a changing relationship between patients and 
the medical team.
“The [relationship] changes enormously. If patients meet me, then they have a really 
special doctor in front of them and I think that the patient is also special to me. You see 
the patient from a different perspective, because you’re continuously investing time in 
that person. In a ‘normal’ consultation it happens step wisely and you don’t see your 
patients so often. And now [with the PHC] you could have contact almost every day 
and you could follow how the patient is doing from day to day. I think that the relationship 
with the medical team really changes.” (Respondent 13, professional)
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Both patients and professionals also mentioned disadvantages of using the PHC. 
Patients, for instance, do not want to be confronted with their condition all the time, 
which the PHC might bring about. For optimal use of the PHC, it asks for routine and 
discipline and patients are not sure whether they could fulfill this task. One patient 
was anxious that different views expressed in the PHC could make him insecure.
Professionals mentioned having much work pressure and using the PHC would 
come on top of that. As a prerequisite for the implementation, they suggested that 
more time should be scheduled for using the PHC next to their tasks.
Finally, particularly PD patients and professionals uttered their concerns about the 
technological difficulties of the PHC. Through these difficulties (e.g. size letter type, 
visual organization of website) the PHC is not accessible or user friendly to everyone.
3.2.3 Other expectations of PHCs in future health care across all participants 
All participants argued that – independent from the condition – a PHC could contribute 
to an increased patient’s insight into his or her own health and health care.
“I really like the idea that a patient gets much more insight into his own illness and in 
the way how different disciplines handle his disease.” (Respondent 16, professional)
“Yes, you receive information from different perspectives and you can get a quick 
answer in an easy way which makes your treatment better. You get more insight into 
your treatment. Particularly the number of health-care professionals (…)”. (Respondent 1, 
patient)
By using PHCs, patients get more involved into their own treatment and it increases 
the rate of active involvement of patients in their own health care. By asking questions 
and receiving (your own) medical information, the patient could be more in the lead.
“That is also a little bit of autonomy; that you can see your own medical data.” 
(Respondent 3, patient)
Furthermore, the respondents stated that it is beneficial that all information is collected 
and accessible for the patient and all relevant health-care professionals. This is, for 
instance, convenient when the patient forgets easily, has changed from health-care 
professional(s), wants to use it as a reference work, or wants to check if nothing has 
been forgotten.
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“It’s such an emotional rollercoaster and we both are very busy working. I was like – by 
the way I’m not a diary person – we have to write things down that when our [fertility] 
treatment is not successful, we have a sort of script of the treatment cycles before. 
Maybe something went wrong and so on.” (Respondent 4, patient)
Different views were given on the characteristics of patients who could benefit the 
most of PHCs when added to their usual care. Some said that it could be very 
convenient for autonomous patients who prefer to have the lead in their own care 
process, whereas others stated the opposite.
“The transition of data and thinking along is maybe something a critical and autonomous 
patient would do more naturally. The PHC could support this.” (Respondent 1, patient)
“For those patients who are less involved, it’s of course easier and less confronting to 
ask their questions in their PHC, than in a face-to-face encounter with their doctor.” 
(Respondent 4, patient)
One PD patient mentioned that PHCs are beneficial for patients who are recently 
diagnosed with a condition, because they have many questions to ask. Contrastingly, 
other PD patients put forward that the PHC should be offered in a later phase of the 
condition, because in the beginning there is too much to deal with already. Other 
characteristics that were mentioned: PHCs are suitable (i) when a greater geographical 
distance exists between patient and physician, (ii) when a patient has a great number 
of health-care professionals, (iii) when a patient has a condition and follow-up of 
treatment is important (e.g. repetitive laboratory results), (iv) when patients have a 
health problem hard to talk about to others, (v) when patients have complex care, and 
(vi) when patients have co-morbidity. In short, a great variation of characteristics was 
repetitively mentioned. All participants agreed that computer and Internet skills are 
required for using the PHC adequately.
4. Discussion
This study qualitatively evaluated the use of and first experiences with the PHC. 
Interviews with patients and health-care professionals showed that patients designed 
their PHC differently, suiting their own individual situation. It depended on the type of 
condition, the number of people involved in their care and their individual needs. The 
(potential) advantages outnumbered the disadvantages and related to both 
organizational aspects of care (e.g. better transition and continuity of care), and 
patient care experiences (e.g. more personal care, reducing stress). The PHC features 
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and the aforementioned advantages could possibly be a facilitator for the societal 
need for more personalized care (the acknowledgement of the broader context of an 
individual patient and not only the disease) and active participation of patients (in 
terms of self-management).30 This could, for instance, facilitate general practitioners 
or other health-care professionals in overseeing the complexity of their patients. The 
basis for this implication is threefold.
First, a PHC is person-specific. This is in contrast with PHRs, which are often bound 
to one specific disease/patient population (e.g. Diabetes, IVF patients).31-32 These are 
not suitable anymore when looking at the above-mentioned future health care 
perspectives. As the participants in this study underlined, the personal contexts of 
individual patients’ lives and the web of relationships and interactions they have with 
the medical and social environment, ask for a more generic system, such as the 
PHC. In the PHC ‘disease experts’ (e.g. physicians) and ‘personal context experts’ 
(e.g. the patient, family) can be integrated. This integration could take place in the 
PHC. Hence, different types of patients could benefit from the PHC by using it in an 
individualized way; and hereby facilitating personalized care at the same time. This 
does not mean that only patients with chronic diseases or co-morbidity could benefit. 
Every individual person has an important broader personal context that goes beyond 
his or her medical condition.33 For instance, some of this study’s women experiencing 
infertility did not suffer from another condition. However, because of the impact of 
their infertility, they appreciated the continued communication with their health care 
providers outside traditional face-to-face care.
Second, in many EHR and PHR projects no clear role and position of the patient was 
defined.34 In the PHC the patient is in the lead as he/she is the owner of the PHC and 
has access to and can manage (parts of) his/her medical records, anticipating more 
involvement in care. Based on our data, it seemed that patients felt to be more actively 
involved by using the PHC. In particular, this could account for patients who are not 
autonomous naturally. Carefully, our study suggests that the PHC could strengthen 
the participation in care from a variety of patients, but maybe particularly those who 
need some help. The professional participants in this study indicated this change of 
the patient’s role. Though, first the technological difficulties of the PHC need to be 
resolved.
Third, the PHC offers the possibility of both sharing medical data and communication 
between patient and health-care professionals. This combination was missing in 
other HER and PHR systems.14 Many participants in this study valued this possibility 
enhancing patient participation in deciding personal health choices. Also, professionals 
thought that it could improve the collaboration between different health care providers, 
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reducing fragmentation of care. However, this feature was not fully exploited in this 
study. Not much data was stored yet in the PHCs. Systematically integrating medical 
data into the patient’s PHC from the providers’ electronic medical records could 
provide a solution for this.
4.1 Future research
As aforementioned, this study is based on short-term experiences of patients and 
healthcare professionals with PHCs. The Medical Research Council (MRC) developed 
a framework for the evaluation of complex interventions. This framework includes as 
a first step that identifying the potential consequences of a complex health service 
activity (such as the PHC) in a first pilot study can provide important information for 
future evaluations.35-36 Hence, the current study could also be considered a first pilot 
study. To the best of our knowledge, this is the first paper to describe such a health 
care concept including its first evaluation in which we collected insight into the 
directions for future research. These directions consist, for instance, of (a) elaborating 
the research among a broader population (i.e. more respondents and involvement of 
more different conditions) to investigate long-term experiences and affirmation or 
rejection of results; (b) investigating if the potential organizational consequences for 
health care (e.g. improvement in continuity of care) and patients’ care experiences 
result in an improvement of quality of care (in cost-effectiveness, safety etcetera); and 
(c) studying the implementation of the PHC into health care. Despite the promising 
future perspectives, an adequate implementation strategy is needed acknowledging 
all barriers, possibly hampering its future success.14,15
4.2 Limitations of the study
In our experience, the phenomenological qualitative approach was very useful for the 
exploration of meanings of experiences with the ‘phenomenon’ of the PHC. It provided 
in-depth insight in patients’ and professionals’ views. Efforts were made to ensure the 
trustworthiness of the qualitative data.36 To enhance credibility, we performed 
investigator triangulation, reduced possible bias from the personal experiences of 
the interviewer, and selected carefully meaningful units.37 There are, however, three 
limitations related to participant selection and the number of respondents.
First, for our study aims, we were dependent on selecting participants who had 
already gained some experience with a PHC. Given the nascent stage of the PHC, 
there is a possibility that these participants were typical ‘early adopters’ and might 
thus not be fully representative for the general population. However, as participants 
consisted of both patients and professionals from two types of conditions, we tried to 
minimize this bias. 
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Second, some patients only just started using their PHC and did not have the time yet 
to explore all its possibilities. Their current view could thus change over time. Nevertheless, 
we found it also very valuable to explore participants’ expectations based on these 
early experiences to get a grasp of what a PHC could contribute to future care.
Third, qualitative research is often criticized for its sample size. The number of 
interview participants in this study may seem small, but this is not necessarily a 
shortcoming. As our study achieved data saturation within the patient group, the 
patient sample was sufficient in size and more interview participants would not have 
altered the results. The only shortcoming with respect to the sample size is the small 
number of different health-care professionals. Another potential limitation is that a few 
interviews were performed using Skype, which means that interviewer and participant 
were not in the same room. However, both sound and video were used during these 
interviews. Hence, both verbal and non-verbal communication could be ‘recorded’, 
which is one of the most essential elements of interviewing.
5. Conclusions
Using PHCs in health care could lead to promising improvements in both the 
organization of care and care experience, according to the patients and healthcare 
professionals involved in this study. They indicated that patients with different conditions 
(i.e. PD and infertility) and in different individual patient-related circumstances (e.g. 
different number of healthcare professionals involved, level of autonomy, stage of 
disease) could benefit from these improvements. The PHC seems to be an online tool 
that can be applied in a personalized way. When (technically) well facilitated, it could 
stimulate active involvement of patients in their own health and health care. It warrants 
further research to study its effect on concrete health outcomes.
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“As a patient, I need and expect full disclosure 
of all information related to my condition (whether good or bad). 
For me, knowledge about the disease is power, I cope best 
when I have all the facts. I also appreciate providers 
who exhibit kindness, genuine concern and good will.” 
Woman with Parkinson’s disease, 66 years old
NPF patient centeredness study (chapter 5) 
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Chapter 1  General introduction
Chapter 1 introduces the concept of patient-centered care in the context of patients 
with Parkinson’s disease (PD). Patient centeredness means providing care that is 
respectful of and responsive to individual patient preferences, needs and values, and 
ensuring that patient values guide all clinical decisions’. PD is an illustrative example 
of a chronic disorder associated with a multitude of disease-related complications 
(e.g. depression, falls, digestive complaints and sleep problems). Moreover, patients 
become progressively disabled due to a mixture of cognitive, emotional and motor 
symptoms. Particularly elderly patients are confronted with not just PD, but typically 
with one or more comorbid conditions. Given the complex nature of the disease, 
delivering patient-centered care to PD patients is challenging. Preferably, Parkinson 
care is provided by a collaborative team of physicians, nurses, psychosocial caregivers 
and allied health experts.’Patient-centeredness’ implies that patients are invited to 
participate within this team. This thesis provides a starting point in the definition, 
measurement and improvement of patient-centeredness in Parkinson care.
Chapter 2  Viewpoint on patient centeredness in Parkinson care
Chapter 2 provides a viewpoint on patient-centered care. Modern medicine has become 
highly advanced and heavily professionalized in the 20th century. The downside of 
this achievement is that healthcare is characterized by a provider- centered model, 
with an emphasis on the diagnosis and treatment of diseases, but which is not 
sufficiently sensitive to individual patient’s needs. Disease-centered care is a legacy 
of past efforts to treat infectious diseases and acute illnesses, but does not account 
for the increasing numbers of chronic patients who require continuous care across 
different healthcare settings and providers. To date, most chronic patients assume a 
passive role, partially because this is the conventional approach to medicine, but 
also because they lack the tools and support mechanisms to gain a more central 
‘participatory’ position within their own healthcare team. Patient centeredness has 
become popular as an alternative approach to organize healthcare in the 21th century. 
The concept means that patients and healthcare professionals should both be 
recognized as disease experts. Neurologists are experts in the cause and the 
prognosis of the disease and in diagnostic and therapeutic procedures, however 
patients know best about day-to-day decisions and experiences with the disease.  
Consequently, the relationship between professionals and patients has to be 
redefined into a ‘partnership’, instead of the professional being the expert and the 
patient simply following instructions. This transition has been visualized in a TEDx 
lecture entitled ‘From God to Guide’. Within this partnership, the role of professionals 
should change from experts who care for patients to enablers who support patients 
to make their own decisions. Patients on their behalf have to learn how to manage 
their disease and how to interact with the healthcare team.
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Chapter 3  Definition of patient centeredness in Parkinson care
In chapter 3 we explore the unmet needs of PD patients and caregivers. Eight focus 
group discussions involving 40 PD patients (mean age 62 years, Hoehn & Yahr stage 
1-3) and 20 caregivers (mean age 63 years) were organized to explore the experiences 
in relation to patient-centered care. The key elements of patient centeredness – as 
defined by the Picker Institute – were used as a framework for discussion and 
qualitative analysis. Patients and caregivers both desired more emotional support 
from healthcare professionals, and wanted more active involvement in clinical 
decision making, but currently lacked sufficient information to do so. Participants 
missed the tools to find professionals with specific PD expertise and identified a lack 
of collaboration between healthcare professionals. 
Chapter 4  Measurement of patient centeredness in Parkinson care
Patient experience questionnaires are increasingly recognized as an essential part of 
quality of care assessment. In Chapter 4, we used our disease-specific model of 
patient-centered care to compose a questionnaire that would capture patient 
centeredness by assessing care experiences. The questionnaire was sent to 1112 
Dutch PD patients of which 895 (82.0%) completed the survey. Data analyses 
included calculating scores for overall patient centeredness [scoring range 0-3], 
subscale experiences [0-3] and item quality improvement [0-9]. Face, content and 
construct validity and reliability were assessed. After the validation procedure, the 
Patient centeredness Questionnaire for PD (PCQ-PD) addressed 46 care aspects in 
six subscales of patient centeredness. The internal consistency of the instrument, 
expressed in Cronbach’s α per subscale, ranged from 0.62 to 0.84. The overall patient 
centeredness score was 1.69 (SD 0.45). ‘Emotional support’ (1.05, SD 0.90) and 
‘tailored information’ (1.18, SD 0.57) subscales received the lowest experience 
ratings. Dutch PD patients are under-informed about Parkinson medication and the 
treatment options offered by allied health experts. ‘Access to medical records’ 
obtained the highest quality improvement score (5.44).
These joint experiences together represent a disease-specific model of patient- 
centered care, including six core domains; emotional support (1), tailored information 
(2), empathy & professional expertise (3), accessibility of care (4), patient involvement 
(5) and continuity & collaboration (6).
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Chapter 5  Improvement of patient centeredness in Parkinson care
In chapter 5 we aimed to validate the PCQ-PD for use in US based populations, to 
assess the level of patient centeredness in North American Parkinson centers and to 
demonstrate the PCQ-PD’s potential as a quality improvement instrument. We 
applied a cross-cultural validation procedure to the Dutch version of the PCQ-PD and 
carried out a multicenter study in 20 Centers of Excellence. Data analyses included 
calculating case mix-adjusted scores per center. Each center received a feedback 
report on their performance and a survey to evaluate the effects of the report. The 
PCQ-PD was completed by 972 PD patients (median 50 per center, range 37-58). 
Significant differences between centers were found for all subscales, except for 
emotional support (p<0.05), yet the PCQ-PD turned out to have a limited discriminative 
power. The information subscale (1.62, SD 0.62) and collaboration subscale (2.03, 
SD 0.58) received the lowest experience ratings. 14 centers (88%) who returned the 
evaluation survey claimed that patient experiences could help to improve the quality 
of care. Nine centers (56%) used the feedback to change elements of their care 
delivery process. 
Chapter 6  The individual formerly known as patient
Chapter 6 provides a provocative viewpoint on outdated nomenclature in healthcare. 
In 1993, the pop musician Prince changed his stage name to the Love Symbol ( ). 
Because this symbol was unpronounceable, the media referred to him as ‘The Artist 
Formerly Known As Prince, TAFKAP’. Prince felt that his former name no longer 
applied to his new artistic interests. By analogy, we should consider to change the 
word ‘patient’. Patient is derived from the Latin word ‘patientia’, which means patience, 
The PCQ-PD is a valid instrument to measure patient experiences in Dutch Parkinson 
care. Application of the instrument revealed the level of patient centeredness in 
The Netherlands, summarized best as a compelling call for the provision of more 
tailored information and additional support to cope better with the disease.
The PCQ-PD is a valid instrument to measure care experiences in the United States 
and Canada. North American PD patients are under-informed about critical care 
issues and experience a lack of collaboration between healthcare professionals. 
Feedback on patients’ experiences facilitated Parkinson centers to improve their 
delivery of care. These findings create a basis for collecting patients’ experiences 
in a repetitive fashion, intertwined with existing quality of care registries.
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suffering, endurance or forbearance. Those terms were applicable to the medical 
care that was delivered centuries ago. If you were ill, waiting patiently was the best 
option, suffering was inevitable, and much endurance was needed. This behavior no 
longer fits 21st century medicine. Contemporary patients search the Internet for 
medical information, wish to have open communication channels with their physicians 
and want to be regarded as humans with a health problem, and not as carriers of a 
disease. Changing the nomenclature will not prevent people suffering from their 
disease. However, new active labels may underscore the importance of considering 
patients as partners in the healthcare process. Though, it is difficult to find alternatives. 
For the time being, we propose the word TIFKAP: ‘The Individual Formerly Known As 
Patient’. 
Chapter 7   Viewpoint on multidisciplinary collaboration  
in Parkinson care
Neurologists play a vital role in Parkinson care. However, conventional management 
strategies, including drug treatment and stereotactic deep brain surgery, offer only 
partial and temporary relief. In Chapter 7 we stated that a collaborative team approach 
combining neurological management with a team of allied health experts, psychosocial 
caregivers and nurse specialists is the optimal way to control the broad symptom 
complex, although strong evidence to support this belief is lacking. International 
studies on multidisciplinary care are heterogeneous in terms of design, intervention 
and outcomes, while the evidence regarding the direction and duration of the 
treatment effects remains inconclusive. Pending more evidence, we should optimize 
the delivery of multidisciplinary Parkinson care. Insufficient expertise, poor collaboration 
and inadequate communication are recognized as important barriers for delivery of 
high-qualitative multidisciplinary care. ParkinsonNet has been developed to tackle 
these barriers by standardizing and integrating the delivery of care provided by expert 
therapists. To date, it is unclear to what extent ParkinsonNet enhances multidisciplinary 
collaboration. An additional challenge is to involve patients more closely in the network, 
empowering them to participate in the management of their disease.
Chapter 8   Measurement of multidisciplinary collaboration  
in Parkinson care
PD patients typically receive care from multiple healthcare professionals across 
different primary and secondary care settings. In chapter 8, we applied social network 
analysis to quantify and visualize ‘connections’ between healthcare professionals 
involved in Parkinson care. 104 healthcare professionals who joined a newly established 
ParkinsonNet network were asked to complete a pre-structured questionnaire to 
report on their professional contacts with others in the network. Social network 
analysis provided 12 network measures for the total network and for the networks 
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of individual professionals. Ninety-six healthcare professionals (92%) returned the 
questionnaire. Measures characterizing the individual networks showed a wide variation; 
e.g., density varied between 0 and 100% (mean 28.4%). Healthcare professionals 
with ≥10 PD patients had higher values on 7 out of 12 network measures compared 
to those with <10 patients (e.g. number of connections). Primary care professionals 
had lower values on 11 out of 12 network measures compared to professionals who 
were affiliated with a hospital.
Chapter 9  Multidisciplinary collaboration in professional networks
Facilitation of multidisciplinary collaboration is a key objective of ParkinsonNet. In 
chapter 9 we examined whether the concept enhances multidisciplinary collaboration 
between health professionals involved in Parkinson care. A regional network involving 
101 professionals was newly established. All participants received two questionnaires 
at baseline and one year after the implementation. One aimed at documenting 
professional connections between participants and the other aimed at evaluating 
the perceived team performance. Thirteen participants were interviewed to identify 
barriers and facilitators for multidisciplinary collaboration. Social network analysis 
focused on sub-networks around three community hospitals. The number of ‘knowing 
each other’ connections increased from 1431 to 2175 (52%, p <0.001) and ‘professional 
contact‘ connections increased from 664 to 891 (34%, p <0.001). Large differences 
between sub-networks were found, positive changes being associated with a central 
role of neurologists and nurse specialists committed to multidisciplinary care. 
Participants experienced problems with information exchange and interdisciplinary 
communication. Generally, participants were unaware of other healthcare professionals 
involved in individual patients and what treatments they provide simultaneously.  
Social network analysis is a feasible method to quantify and visualize connections 
between healthcare professionals involved in Parkinson care. Validated network 
measures showed relevant (and undesired) variation across professionals. A higher 
caseload and an affiliation with a hospital were associated with stronger connected-
ness with other healthcare professionals.
ParkinsonNet partially enhanced multidisciplinary collaboration between professionals. 
Crucial facilitators of this were a central role of nurse specialists and the commitment 
to collaborate with and refer to expert therapists among neurologists. Additional 
measures are needed to further improve multidisciplinary care across different 
institutions and around individual patients.
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Chapter 10   Improving collaborative and patient-centered care 
using online health communities
In chapter 10 we propose the use of online health communities as a tool to enhance 
collaborative and patient-centered care. Online health communities are internet-based 
platforms that unite either a group of patients, a group of professionals, or a mixture 
of both. Members interact using modern technologies such as blogs, chats, forums 
and wikis. Chapter 10 illustrates the use of online health communities for ParkinsonNet, 
whose participants use different types of communities to enhance multidisciplinary 
collaboration. Additionally, several applications in clinical practice are discussed. 
First, due to rapid advances in medical knowledge, many healthcare professionals 
lack sufficient expertise to address the complex needs of chronic patients. Online 
health communities can be used to share experiences, exchange knowledge and 
increase disease-specific expertise. Second, healthcare delivery is fragmented, as 
many patients acquire relationships with multiple professionals and institutions. 
Online health communities can bridge geographical distances and enable interdisci-
plinary collaboration across institutions and echelons. Third, chronic patients lack 
adequate tools to self-manage their disease. Online health communities can be used 
to engage patients in their care process and to tailor care to their individual needs.
Chapter 11   Improvement of patient-centered care using Personal 
health communities 
A personal health community is a private community governed by individual patients. 
Apart from the patient, participants include the caregiver and one or more (ideally all) 
health professionals involved. Once gathered, personal health communities offer an 
opportunity to store all medical information in one central place, while allowing 
transparent communication across members of each patient’s healthcare team. In 
chapter 11 we implemented personal health communities in the management of PD 
and fertility care. Eighteen respondents, consisting of women experiencing infertility 
(n = 5), PD patients (n = 6), a gynecologist, a fertility doctor, a fertility nurse, three PD 
nurse specialists and a neurologist were interviewed. First experiences with personal 
health communities showed that patients use their community differently, depending 
on their condition and professionals involved. Bringing together different healthcare 
providers and obtaining a complete picture of the team and ongoing treatments are 
Online health communities provide a useful tool to address some of the challenges 
chronic care faces today. Online health communities facilitate patient-centered care, 
enhance communication among health professionals and patients, and support 
 coordination of care across institutions.
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reasons for patients to start a personal health community. Patients favor the possibility 
to interact with professionals for emotional support and to obtain medical information. 
Potential advantages for future care are related to both patient  centeredness and 
organizational aspects of care. Disadvantages included the time needed to participate, 
and technological issues. 
Several patient groups can benefit from personal health communities. The approach 
potentially improves the continuity and patient-centeredness of care. When (technically) 
well facilitated, the concept stimulates active patient involvement in their own health 
and healthcare. It warrants further research to study its effect on concrete health 
outcomes.
“I wish I could have direct access to my physician 
when I need to discuss an urgent matter related 
to my condition. An e-mail or telephone number would 
be very helpful. I promise not to abuse it.“
Woman with Parkinson’s disease, 65 years old
Patient centeredness study, chapter 5 
General discussion
13
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In this chapter the main findings of this thesis will be reported by answering the eight 
research questions defined in the general introduction (chapter 1, page 17). Thereafter, 
the findings will be positioned in the context of the current literature on patient- centered 
care, followed by implications for clinicians and researchers. This thesis ends with a 
final conclusion.
1. Main findings
1.1 How should patient centeredness in Parkinson care be defined? 
Modern medicine has become highly advanced and heavily professionalized in the 
20th century. The downside of this achievement is that healthcare is characterized by 
a provider-centered model, with an emphasis on the diagnosis and treatment of 
diseases, but which is not sufficiently sensitive to individual patient’s needs.1 Dis-
ease-centered care is a legacy of past efforts to treat infectious diseases and acute 
illnesses, but does not account for the increasing numbers of chronic patients who 
require continuous care across different healthcare settings and providers. To date, 
chronic patients assume a passive role, partially because this is the conventional 
approach to medicine, but also because they lack the tools and support to gain a 
central role within the healthcare team.2 
Patient-centered care has been defined by the National Academy of Medicine as 
“providing care that is respectful of and responsive to individual patient preferences, 
needs, and values, and ensuring that patient values guide all clinical decisions”.3 
Although the evidence to support patient-centered care is growing, this is still a 
young field, and the ideological base of this concept is better developed than its 
evidence base.4-7 Terminology might be a hampering factor; ‘patient centeredness’ 
refers to multiple different care aspects and different processes in the medical 
consultation. Therefore, it is important to operationalize the concept more accurately 
in measurable elements.8 As a first step, we explored the care experiences of 40 PD 
patients (mean age 62 years, Hoehn & Yahr stage 1-3) and 20 caregivers (mean age 
63 years) in eight focus group discussions (chapter 3). The key elements of patient 
centeredness as defined by the Picker Institute and the World Health Organization 
were used as a framework for discussion and qualitative analysis.9-10 We identified 
various unmet needs among PD patients and caregivers. Many of these care aspects, 
such as respect for patient’s preferences and the need for information, are generic 
and recognizable for all patients with chronic conditions. Though, we concluded that 
the experiences shared in the discussions together represent a disease-specific 
model of patient-centered care, including 46 care aspects in six core domains; emotional 
support, information, empathy & professional expertise, accessibility of care, patient 
involvement and continuity & collaboration.
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1.2   Which patient-centered care initiatives have thus far been 
tested in Parkinson care?
In chapter 2, we reviewed the international literature for patient-centered care 
initiatives tested in Parkinson care. A taxonomy of ‘patient focused quality interventions’ 
was used to classify 18 studies.11 These studies included: patient education programs, 
face-to-face and online support groups, decision aids to facilitate patient involvement 
in treatment choices, the introduction of PD nurse specialists, telemedicine 
consultations, incorporation of the patient’s most troublesome symptoms in an 
individualized treatment plan and evaluation of treatment success from the patient’s 
perspective. These interventions together cover all six core domains of patient 
centeredness by a broad focus on providing better emotional support and tailored 
information; implementation of tools that allow better access to healthcare; active 
patient involvement and self-management; and reduction of healthcare fragmentation. 
We concluded that most patient-centered care initiatives were aimed directly at 
patients, without the involvement of healthcare providers.
1.3  How should patient centeredness in Parkinson care be measured? 
Patient experience questionnaires are increasingly recognized as a reliable way to 
assess the level of patient centeredness.12 A suitable instrument to measure pa-
tient-experiences in Parkinson care is lacking. We used our disease-specific model 
of patient centered care to construct a questionnaire that measures the quality of 
care from a patient perspective (chapter 4). The questionnaire was sent to 1112 
Dutch PD patients from six different centers, and face, content and construct-validity 
and reliability were assessed. 895 patients (net response 82.0%) completed the 
questionnaire. The patient centeredness questionnaire for Parkinson’s disease 
(PCQ-PD) addresses 46 care aspects in six subscales of patient centeredness. We 
found that the PCQ-PD is a valid instrument to measure care experiences in The 
Netherlands. Additionally, we performed a cross-cultural validation procedure on the 
Dutch version of the PCQ-PD to test its applicability in the United States and carried 
out a multicenter study in 20 North American Parkinson centers (chapter 5). The 
PCQ-PD was completed by 972 US and Canadian PD patients (median 50 per center, 
range 37-58). Significant differences between centers were found, yet the PCQ-PD 
turned out to have a limited discriminative power. We concluded that the PCQ-PD is 
a valid instrument to measure patient experiences in the US, with comparable 
measurement properties as found in the Dutch cohort. 
1.4   What is the level of patient centeredness in Dutch and  
North American Parkinson care?
This question was addressed in chapters 3, 4 and 5. Dutch focus group discussions 
showed that PD patients desire emotional support from their healthcare providers 
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and want more active involvement in clinical decision making, but lack sufficient 
information and support to do so (chapter 3). Participants missed the tools to find 
professionals with Parkinson expertise and identified a lack of collaboration between 
members of their healthcare team. Application of the PCQ-PD confirmed the 
qualitative findings; the ‘emotional support’ and ‘information’ subscales received the 
lowest experience ratings (chapter 4). Patients felt under-informed about Parkinson 
medication and about the various treatment options offered by allied health 
professionals. In the United States and Canada, the ‘information’ and ‘continuity & 
collaboration‘ subscales received the lowest experience ratings (chapter 5). Patients 
were unaware of possible interdisciplinary consultations between healthcare 
providers and were not informed about discussions regarding their treatment. Both 
Dutch and American patients report moderate to high scores on empathy, participation 
and accessibility of care. However, both patient groups experience insufficient 
collaboration, are under-informed about critical care issues and desire more support 
to learn how to cope with the disease.
1.5   Does feedback on care experiences improve patient 
centeredness in Parkinson care?
In chapter 5, 20 North American Parkinson Centers of Excellence received a feedback 
report on the quality of care as experienced by their own patients. The report included 
patient centeredness scores anonymously benchmarked against other Parkinson 
centers. Quality improvement scores promoted the identification of care aspects with 
the highest priority for improvement for each center. After three months, center repre-
sentatives (medical directors and research coordinators) received a survey to 
evaluate the impact of the feedback report. We found that feedback on patients’ 
experiences facilitated healthcare providers to initiate quality interventions within their 
own center. Three months after receiving the report, half of the centers had changed 
specific elements of their care delivery process, indicating the leverage of care 
experience data to change an organization towards the needs of patients. We will 
further discuss these findings in paragraph 2.2.1.
1.6   How should multidisciplinary collaboration between health 
professionals involved in Parkinson care be measured?
Parkinson care is preferably provided by a collaborative team of neurologists, nurses, 
psychosocial caregivers and allied health experts (chapter 7). ParkinsonNet, a 
nationwide organization with regionally oriented professional health networks, aims 
to improve the quality of Parkinson care.13 Facilitation of multidisciplinary collaboration 
between healthcare professionals is a key objective of the approach (see paragraph 
2.2).13 In chapter 8, we applied social network analysis to study multidisciplinary 
collaboration between health professionals involved in Parkinson care.14-15 A regional 
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ParkinsonNet network involving 101 professionals from 10 medical, nursing and 
allied health disciplines based in either hospital, nursing home or primary care 
settings was newly established. All participants were asked to complete a 
questionnaire to report on their professional contacts with others in the network. 
Data-analysis showed that social network analysis is a feasible method to quantify 
and visualize direct working relationships between healthcare professionals. Network 
measures describing patterns in the professional contacts showed relevant and 
undesired variation across healthcare professionals. In chapter 9, we combined 
social network analysis with data from other sources to understand the broad 
spectrum of multidisciplinary collaboration in Parkinson care. In the evaluation of 
complex health interventions, such as ParkinsonNet, mixed method analysis 
capitalizes the strengths of both quantitative and qualitative data.16 Interview data 
proved to be valuable in explaining differences between expected and observed 
results, for example by the identification of barriers that hampered regional 
collaboration. These results would have been left undetected by quantitative methods 
alone. 
1.7   Does the implementation of ParkinsonNet improve multi-
disciplinary collaboration between health professionals involved  
in Parkinson care?
Despite the emphasis on multidisciplinary care, Dutch PD patients still experience a 
lack of collaboration between healthcare providers (chapters 3 and 4).17 Therefore, 
we examined the evolvement of multidisciplinary collaboration in a newly established 
ParkinsonNet network (chapter 9). Over a 12-month period, we evaluated team 
performance and conducted semi-structured interviews with ParkinsonNet 
professionals. We found that neurologists and nurse specialists hold key positions in 
the network. Neurologists are vital in the referral of patients to expert therapists, yet 
their commitment to multidisciplinary health interventions differed between the 
networks. Nurse specialists are the main point of contact for both professionals and 
patients and coordinate regional care. One year after the implementation, team 
processes needed further improvement. Health professionals reported that ‘no work 
agreements were made’, ‘there are no clearly defined roles and responsibilities’, and 
‘patient data is not shared with each other’. Participants experienced problems with 
the exchange of medical information, especially across institutions. Generally, 
participants were unaware of other professionals involved in individual patients and 
what treatments they provide simultaneously. We concluded that ParkinsonNet 
partially improved multidisciplinary collaboration; connecting professionals does not 
necessarily entail improved teamwork among disciplines. 
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1.8   Does the implementation of online health communities improve 
collaborative, patient-centered care?
We implemented online health communities to facilitate patient centeredness and to 
enhance collaboration between healthcare professionals involved in Parkinson care 
(chapters 10 and 11). Online health communities are internet-based platforms that 
unite either a group of patients, a group of professionals, or a mixture of both.18 
Members interact using modern technologies such as blogs, chats, forums and 
wikis. We implemented an online health community in our Parkinson expert center in 
Nijmegen (chapter 10). This community is accessible only to patients visiting our 
clinic and to health professionals who work here. A distinctive feature is the 
combination of online patient-provider and peer-to-peer communication integrated 
into one and the same platform with both patients and professionals from the same 
clinic involved. The community contains information about available treatment 
facilities and patients are provided with facilities for communication with fellow 
patients and the healthcare team. Results show that this community fills the gap 
between patients’ needs and the support our clinic can offer. 
Thereafter, we implemented an online health community in each regional ParkinsonNet 
network. These communities facilitate asynchronous communication among healthcare 
professionals, bridge geographical distances and support coordination of care 
across institutions (chapter 10). Within these communities, members are informed 
about multidisciplinary team meetings, ongoing education and guidelines. Healthcare 
professionals utilize regional communities to increase their expertise by sharing 
experiences and knowledge with other experts involved in the regional network. 
Personal health communities are online health communities that personalize care at 
an individual patient level (chapter 11). Within these private communities, participants 
include; the patient, his immediate caregiver and professionals involved in his care 
process. A personal health community offers the opportunity to store all medical 
information in one central place, while allowing transparent communication across 
members of each individual patient’s healthcare team. Patients who started a 
personal health community favored the option to interact with easy accessible health 
experts for emotional support and medical information. Both patients and 
professionals expect this community to improve the continuity of care. Personal 
health communities potentially improve all six core domains of patient centeredness. 
However, for online communities to become integrated into clinical practice, several 
behavioral, financial and technical issues have to be solved (chapter 10-11).
212
CHAPTER 13
2. Interpretation of findings
Patient-centered care initiatives in Parkinson’s disease should focus on providing 
better emotional support, offering tailored information and improving multidisci-
plinary collaboration. This conclusion was made based on the actual healthcare 
experiences of thousands of patients in The Netherlands, the United States and 
Canada. Importantly, patient centeredness implies that care has to be responsive to 
individual preferences and values.1 In this respect, our efforts in chapters 4 and 5 – 
with application of a patient-experience questionnaire to a large cohort yielding an 
average experience score – may sound contradictory, as this only offers insight in the 
average quality of care as perceived by mainstream patients, but it does not clarify 
individual needs and priorities. On the contrary, knowledge of such average 
(group-based) care experiences did facilitate healthcare providers to change their 
care delivery process into a more patient-centered manner (chapter 5). Here, I will 
elaborate on both the individual patient level (paragraph 2.1) as well as the patient 
population level (paragraph 2.2) to promote patient-centered Parkinson care.
2.1 Providing patient-centered care at an individual patient level
This thesis does not include original research on the patient-physician relationship. 
However, the implementation of patient centered care should include interventions 
that affect the interaction between individual patients and physicians.19 The National 
Academy of Medicine stated that ‘healthcare should establish a partnership among 
practitioners and patients to ensure that decisions respect patients’ wants and 
preferences and that patients have the education and support they need to make 
decisions and participate in their care.’20 This statement transforms the role of 
physicians from one characterized by authority to one that includes an alliance with 
individual patients.21 We found that patient-centered care initiatives tested in PD 
primarily aimed at patients, without the involvement of clinicians (chapter 2). However, 
to establish a partnership, doctors have to assume alternative communication and 
listening skills, and have to recognize individual patients’ expertise and preferences.22-
23 Education into these elements of patient centeredness should ideally start in the 
first year of medical school, but this is certainly not ubiquitously present in medical 
schools. In 2012 the RadboudUMC introduced a mission statement including 
participatory and personalized healthcare as a prominent characteristic of their care 
delivery process and new curriculum for medical students.24 Furthermore, we should 
consider the option of pre-selecting students before they enter medical school based 
on patient-centered values; such as sincere commitment to patients well-being and 
willingness to collaborate in a team of different, but equal health professions. 
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PD patients wish to gain more control over their health and want to govern decisions 
about their treatment (chapters 3, 4 and 5). Shared decision making and self-man-
agement are activities that enable this appeal.25-26 In paragraph 2.1.1 and 2.2.2, I will 
explore these methods in Parkinson care.
2.1.1 Shared Decision Making 
PD patients wish to be informed and want to participate in treatment decisions about 
their care (chapter 3). International studies confirm that the majority of patients prefer 
making shared decisions with physicians, and this number increased to 71% in 
studies from 2000 to 2012.27 If patients realize that there are more options available, 
they are more eager to become informed about the benefits and risk of the different 
options.28 In this regard, neurologists could apply Shared Decision Making (SDM) to 
all medical decisions for which there is no preference or superiority for one particular 
treatment over other treatments, including refraining from further treatment.29 
Unfortunately, SDM is not common in current clinical practice.30  Traditionally, 
physicians make decisions on behalf of their patients.31 Moreover, evidence-based 
guidelines, used as the gold standard in medical decision making, do not account for 
patient preferences.6 
Overall, patients vary in their wishes and abilities to participate in their care. Age and 
cognitive capacity play a major role in the ability to understand information and make 
treatment decisions. Even in newly diagnosed patients with PD, cognitive measures 
are impaired, in particular immediate memory and executive function.32 Impairment in 
understanding treatment consent as well as impairment in organizing information 
necessary to make complex decisions are present even in PD patients without 
dementia.33 Additionally, it may be difficult for clinicians to judge the extent to which 
patients wish to be involved in understanding their health problems, in knowing each 
option available to them, and in making shared decisions.34 For instance, older 
patients may prefer to be informed, without actively taking part in the decision.35 
Therefore, healthcare professionals should be supported to carefully explore patients’ 
decision making capacity and desired degree of control to facilitate greater 
participation by chronically ill elders who wish to become more involved in their 
care.36 Healthcare professionals would gain by asking one simple question to their 
patients: ‘what role do you want to play in making decisions about your health?’.37
Decision aids facilitate SDM by presenting the evidence, contra-indications and 
financial factors for each treatment option.38 These tools generate positive effects, 
including improved patient-physician communication and a larger number of 
decisions consistent with patients’ values.39 Stimulated by positive experiences with 
SDM in the literature40-43, our research group developed two decision aids, each 
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aiming to facilitate a specific treatment choice that many patients face during the 
course of their disease. The first relates to the choice for the early pharmacological 
treatment in young de novo patients. The online decision aid presents the evidence, 
side effects and patient experiences of Levodopa treatment and dopamine agonists.44 
The second decision aid relates to the advanced treatment options for patients in the 
late stage of PD, when response fluctuations and dyskinesias can no longer be 
managed with oral medication.45 Three options are then available: deep brain stimulation, 
intraduodenal levodopa infusion, or subcutaneous apomorphine infusion.46 Each 
treatment has its own risks and benefits, indications and contra- indications, financial 
issues and impact on quality of life. There is a variable amount of evidence to support 
the choice for each of the strategies. The decision aid makes an unbiased comparison 
between all three options and facilitates a choice that best fits the preferences of an 
individual patient.
2.1.2 Self-management support
An important element of patient centeredness is the promotion of self-management.47 
Self-management involves collaborative goal-setting, treatment planning and 
assisting patients to gain control over their lives.48 The approach is associated with 
improved self-efficacy, reduced medication side-effects and decreased psychosocial 
problems.49-50 Self-management is particularly useful to patients with a chronic 
disease, such as diabetes, chronic obstructive pulmonary disease and long-term 
neurological conditions, such that people can live with their chronic condition for 
most of the time without professional support.51-52 Parkinson care oftentimes does not 
recognize the importance of self-management, as we showed that it does not meet 
the need for information, participation and psychological support in coping with the 
disease (chapters 3 and 4). In chapter 3, we described several promising self-man-
agement interventions tested in Parkinson care, including education programs and 
patient support groups. These interventions enhanced patients’ self care knowledge, 
quality of life, self-effacy and psychosocial well-being.53-59 Unfortunately, broader 
implementation of such programs in clinical care is lacking behind.    
Online health communities facilitate self-management in Parkinson care, but we did 
not find positive and sustained effects in our study (chapter 10-11). International 
studies show that chronic patients using online communication tools become more 
knowledgeable, feel better socially supported and empowered, and have improved 
behavioral and clinical outcomes compared to non-users.60-61 An online self- 
management program for people with heart disease, chronic lung disease and type 2 
diabetes improved patients’ self-efficacy and decreased disease symptoms.62-63 The 
intervention included an individualized exercise program; medication overviews; 
methods for managing negative emotions; fatigue management; a weekly action 
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plan and interactive feedback from healthcare professionals. Other examples include 
online peer support groups and access to personal health records.64-65 The latter 
allows patients to have access to their medical record and enable individualized 
health communication.66 Notwithstanding, simply implementing a personal health 
record is by itself not enough to support self-management, unless it promotes 
communication about things that matter to patients, helps patients to understand 
their illness, and facilitates patient involvement.21 In that respect, the Dutch 
‘ParkinsonNeXt’ project (a large public-private partnership, supported by a European 
development grant) is worth mentioning, as a future direction to support self-man-
agement. ParkinsonNeXT aims to develop innovative products to facilitate patients in 
maintaining an independent life, such as apps that facilitate the measurement of vital 
functions at home, facilitation of timely medication intake and interactive treadmills 
and stationary bicycles that can be used within the patients’ own home.
2.2  Patient-centered care at a patient population level 
Patient-centered care provided by a team of neurologists, therapists and nurse 
specialists is the optimal way to manage PD, but how such care should be delivered 
is under debate (chapter 7).67 Two team-oriented approaches are described in this 
thesis. In the Netherlands, ParkinsonNet provides care by a restricted number of 
healthcare providers who collaborate within regionally coordinated networks in the 
catchment areas of community hospitals (chapter 8-9).13,68 Within each network 
selected therapists are trained according to evidence-based guidelines. Neurologists 
direct referrals towards expert therapists in the network to increase their caseload.13 
This concept has been recognized by neurologists in leading medical journals.69-71 An 
alternative approach is offered by Parkinson expert centers around the world (chapter 
5). Most of these centers deliver a comprehensive outpatient approach - such as the 
North American Centers of Excellence  - in which both the evaluation and treatment 
delivery are offered by healthcare teams within one center.72 In the following 
paragraphs, I will elaborate on the adoption of patient-centered care by Parkinson 
expert centers (2.2.1) and ParkinsonNet networks (2.2.2).
2.2.1 Parkinson care delivered by expert centers
Strengthening the impact of feedback on patient care experiences 
In chapter 5 we carried out a multicenter study in 20 North American Centers of 
Excellence. All centers received a feedback report from actual patient experiences, 
benchmarked anonymously against other centers. Quality improvement scores 
facilitated health professionals to launch improvement initiatives within their own 
center. Three months after receiving the report, half of the centers had changed 
specific elements of their care delivery process. However, such feedback did not 
encourage all centers to improve; some centers discussed the report within their 
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medical team, but did not know how to convert the feedback into a practicable action 
plan. Increasing the desire to change and improving the ability to translate feedback 
into an optimal improvement strategy are necessary future steps.73-74 Furthermore, the 
content and timing of feedback is important.75 Long term conditions such as PD, 
require audits and feedback at regular intervals (perhaps six monthly or yearly), 
provided to various levels of staff, in both verbal and written formats, and should 
include explicit targets to accomplish behavioral change.76-77 Other interventions 
include experience based co-design, which involves gathering experiences from 
patients as well as professionals, organizing joint patient-professional meetings to 
agree on areas for improvement, and implementing actions that will improve the 
service or care pathway.78 
Online health communities used by Parkinson expert centers
The Radboudumc’s Parkinson center runs an online health community as a service 
to both our patients and the members of our multidisciplinary healthcare team 
(chapter 10). The community provides a combination of online patient-professional 
and peer-to-peer communication integrated into one platform with both patients and 
professionals from our clinic involved. This community has also been implemented in 
our fertility clinic and improved the patient centeredness of care.79 The use of online 
communities in addition to usual care has rapidly gained popularity in expert centers. 
For instance, Cleveland Clinic and The Johns Hopkins hospital have established an 
online community as part of their day-to-day services.80-81 Online communities 
improve patient centeredness by enhanced patient empowerment and the option to 
tailor care more appropriately to the needs of patients.82-83 Sustained activity and 
long-term adoption remains difficult: many internet interventions lack the ability to 
maintain usage in the long term.84-85  An important barrier is the lack of viable business 
models.86 Moreover, Internet innovations radically affect care delivery and the 
professionals’ daily work processes, requiring considerable time and willingness to 
learn.87 Doctors may be hesitant to adopt technologies that interrupt their traditional 
practice patterns. Moreover, the requirement of additional time is a prominent barrier 
to physician technology acceptance.88 
2.2.2 Parkinson care delivered by regional professional networks 
ParkinsonNet only partially improved multidisciplinary collaboration in Parkinson 
care. In the absence of a formal team structure, neurologists and nurse specialists 
are key figures in facilitating collaboration within a geographical region, where 
professionals work in different institutions and in different echelons of healthcare. In 
the next paragraphs, I will elaborate on these findings.
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The role of neurologists and PD nurse specialists
Neurologists are key figures in the network, however their commitment towards mul-
tidisciplinary health interventions regionally differed (chapter 9). Recently, all 
ParkinsonNet neurologists were asked to consent to specific terms and conditions, 
including a commitment to collaborate with and refer to specialized allied health 
therapists. This should alleviate the quality of multidisciplinary care, though evidence 
on the impact is currently lacking. Additionally, nurse specialists gained an important 
position in providing patient-centered care.89 Nurse specialists have a positive effect 
on patients’ sense of well-being and quality of life.90-91 Moreover, an alliance between 
nurse specialists and neurologists improves the quality of care, which might well work 
similarly for other neurological patients, e.g. those suffering from multiple sclerosis, 
stroke or epilepsy.92 The American Academy of Neurology predicted that the current 
shortfall of neurologists in the United States, estimated at about 11% in 2012, will grow 
to 19% by 2025.93 Therefore, training supervised physician assistants has become an 
important strategy to master the workload of neurologists.93-94 ParkinsonNet recently 
developed a guideline for nurse specialists and importantly all regional networks now 
have at least one specialized nurse involved. 
Towards an integrative approach 
No standard template exists to organize a team oriented approach in Parkinson 
care.95 The impact of the disease and the severity of symptoms vary substantially 
between patients and across disease stages; consequently, the nature of the 
management team should be variable and tailored to the specific needs of each 
patient.96 Nurse specialists are a crucial factor within the team89-91, but further 
composition is flexible and may differ on an individual patient level.97 A patient in the 
late stage, who suffer from an increasing number of disabilities, needs a more 
comprehensive care team compared to a patient in the early stage.98 Considering the 
heterogeneous clinical presentation and diverse personal priorities, an individually 
tailored integrated team approach seems preferable over a one-size-fits-all concept, 
but evidence to support this assumption is lacking (noting that is very difficult to 
design studies that can reliably measure the effect of such personalized interventions).67 
The Patient-Centered Medical Home (PCMH) applied in the United States is a 
promising example of a integrated approach.99-101 It is a primary care model designed 
to improve the continuity, accessibility, and coordination of care.102 The PCMH 
includes an non-hierarchical expert team providing care across the continuum of the 
healthcare system. A individualized treatment plan is at the heart of the approach, 
with treatment goals, planned interventions and the identification of professionals 
responsible for each intervention.99-100 Moreover, patient priorities are part of the 
treatment plan and treatment success is evaluated from the patient’s perspective. 
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Although the PCMH reduced emergency department and hospital admissions in two 
studies103-104, controversy remains as to whether the PCMH model has been 
successful.102 By the application of elements of the PCMH, ParkinsonNet could 
improve their care services to PD patients (box 1). 
Box 1  Adoption of the Patient Centered Medical Home concept102
Elements of PCMH
		Performance measurement and  
quality improvement: continuous quality 
 improvement, measure patient-
experiences, report performance.
		Care coordination and care transitions: 
coordinate transitions of care, track refer-
rals, arrange follow-up.
		Patient-centered access: appointments, 
24/7 clinical advice and electronic 
 access.
		Care management and support: shared 
decision making, medication management, 
care planning and self-management 
support.
		Team-based care: continuity, team care 
approach with clinical and non-clinical 
team members.
		Population health management: 
 comprehensive health assessments,  
use of patient information and clinical 
data for population management.
Adopted by ParkinsonNet?
Partially adopted, by the development and 
implementation of the PCQ-PD (chapters 4 
and 5).
Partially adopted, by standardized referral 
forms, the ‘Parkinson healthcare finder’ and 
PD nurse specialists (Chapter 8).
Partially adopted, by the development of 
online and personal health communities 
(chapter 10-11).
Partially adopted, by the development of  
two decision aids (General discussion, 
Paragraph 2.1).
Largely adopted, however now we have to 
make the transition towards an integrated, 
comprehensive approach  
(general discussion, paragraph 2.3).
In 2014 ParkinsonNet started a quality 
 registry which will be used for this purpose 
in the upcoming years 
(General discussion, paragraph 3).
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3. Implications
3.1 Implementation of a national quality of care registry 
Patients’ experiences are at the core of future quality of care assessment.105-106 To 
leverage the utility of the data, care experiences should be collected in a repetitive 
fashion and intertwined with data from other sources. This will allow for comparisons on 
the patient’s view with the provided treatment, clinical outcomes and costs.107 Recently, 
a registry has been developed in The Netherlands, containing information about the 
quality of Dutch Parkinson care.13 This registry combines data from healthcare claims 
(hip fractures, costs), healthcare professionals, and patients (care experiences, quality 
of life). The data will become publicly available to enable direct comparisons across 
regional networks, provided that the validity of the data has been demonstrated and it 
offers genuine and reliable insights in care delivery and outcomes.108 For this purpose 
an interactive online map has been developed (http://www.parkinsonatlas.nl/), that 
provides a starting point for the visualization, interpretation and reduction of undesired 
variation in medical practice.109-110 A  comparable registry has been implemented in the 
Parkinson Centers of Excellence, containing information about individual patients, provided 
treatments, co-morbid conditions and clinical outcomes, to identify best practices and 
positive health outcomes associated with specific treatment approaches.111-114
3.2 Introduction of value-based care
Patient-centered care involves services across primary and secondary care settings, 
which are, in The Netherlands, reimbursed separately in a fee-for-service system.115 
This payment model rarely accounts for individual patient preferences and 
professionals are penalized for failing to meet treatment targets.116 Therefore, new 
payment models are needed to reimburse the integrated care pathway of patients 
across existing silos. Michael Porter, a professor at Harvard Business school, 
introduced the ‘value chain model’; a chain of activities that a company operating in 
a specific industry performs in order to deliver a valuable product or service.117 
Porter’s model can be applied to medicine.118-119 ‘Value-based care’ means that all 
professionals are collaboratively responsible for the outcomes in terms of achieving 
and maintaining good health, for each invested Euro or Dollar.118 Useful indicators to 
reward ‘value’ are patient reported outcome measures such as patient-experiences, 
quality of life, the extent to which patients’ preferences are being taken into account, 
and patients achieving the outcomes that are important to them. In that respect, the 
Dutch quality registry might eventually become an important driver for value-based 
care, clarifying where good care is delivered for a good price. In the United States, 
accountable care organizations utilize the principles of value-based care; physicians 
in both hospitals and primary care settings have financial incentives to lower costs 
and to improve their level of patient-reported outcomes.120 
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3.3 Implications for clinicians
•	 In order to improve the patient-centeredness of Parkinson care, healthcare providers 
should focus on providing better emotional support, offering tailored information 
and improving the multidisciplinary team performance (chapter 3,4 and 5).
•	 PD patients wish to gain more control over their health and want to govern 
decisions about their treatment. Shared decision making and self-management 
support are promising activities that enable this appeal (General discussion 
paragraph 2.1). 
•	  The level of patient centeredness can by assessed by measuring the patients’ 
care experiences. The PCQ-PD is a questionnaire developed and validated in the 
Netherlands and the United States specifically for this purpose, addressing 46 
care aspects in six subscales of patient centeredness. Feedback on patient care 
experiences facilitate healthcare providers to enhance patient centered care 
(chapter 3, 4 and 5).
•	 The ParkinsonNet approach partially improves multidisciplinary collaboration 
among health professionals involved in Parkinson care. In the absence of a formal 
team structure, neurologists and nurse specialists are key figures in facilitating 
patient-centered care (chapter 9).
•	  An integrative team approach aligns best with the patient centeredness philosophy, 
including a non-hierarchical team guided by an individualized treatment plan, 
while patients are engaged as part of the healthcare team (General discussion 
paragraph 2.1).
•	 Internet interventions may improve collaborative, patient-centered care. Online 
health communities enhance asynchronous communication among professionals 
and supports coordination of care across institutions and traditional echelons. 
When technically well facilitated these interventions stimulate patient involvement 
in their own health and healthcare (chapter 10 and 11).
3.4 Implications for researchers
•	 Continued development of the PCQ-PD should focus on: responsiveness to 
change and test-retest reliability121-122; the minimal important difference, representing 
the smallest improvement considered worthwhile by patients123; gathering 
experiences of patients and staff and then bringing them together to develop 
service improvements124-125; developing a short form of the PCQ-PD to increase its 
applicability for routine measurements. 
•	 The PCQ-PD was recently completed by more than 4000 patients in 21 
ParkinsonNet regions. This project has not been described in this thesis. 
Data-analysis could focus on the discriminative power of the PCQ-PD. The 
PCQ-PD detected significant differences between North American Parkinson 
centers, yet turned out to have a limited discriminative power. These results 
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suggests that patients’ experiences can be used for feedback, but should not be 
utilized to list Parkinson centers in a consecutive order.126 
•	 Social network analysis is a feasible method to quantify and visualize direct 
working relationships between health professionals involved in Parkinson care. 
Mixed method analysis combining quantitative and qualitative measures should 
be applied to understand the whole spectrum of multidisciplinary collaboration in 
Parkinson care (chapters 8 and 9).
•	 Further development of online health communities should address user needs, 
privacy, and the development of viable business models.127 It warrants further 
research to study the effect of online health communities on concrete health 
outcomes (chapters 10 and 11). 
4.  Final conclusion
Our current healthcare system is organized in a provider-centered manner, with an 
emphasis on the diagnosis and treatment of diseases, which is not sufficiently 
sensitive to individual patient’s needs. The alternative approach is patient-centered 
care. Despite the promising opportunities of patient centeredness, its uptake into 
routine clinical practice is lagging behind. Therefore, the current challenge is to 
achieve long-term behavioral change via the development and implementation of 
patient-centered innovations. A collaborative approach aligns best with the pa-
tient-centeredness philosophy, including a non-hierarchical healthcare team guided 
by an individualized treatment plan, while patients are engaged as part of the team. 
The essence of patient centeredness is a partnership between patients and 
healthcare professionals. Healthcare professionals have to recognize that to best 
serve their patients, they must learn to see things through their eyes, discover their 
needs and recognize what really matters to them.
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Nederlandse samenvatting
Hoofdstuk 1  Introductie
In hoofdstuk 1 wordt het onderwerp van dit proefschrift, patiëntgerichte zorg voor 
mensen met de ziekte van Parkinson, geïntroduceerd. Patiëntgerichtheid betekent 
het zoveel mogelijk afstemmen van zorg op de specifieke eigenschappen en reële 
wensen van de patiënt. De ziekte van Parkinson is is een illustratief voorbeeld van een 
chronische ziekte die gepaard gaat met veel comorbiditeiten. Patienten worden in 
toenemende mate beperkt door motorische, cognitieve en emotionele symptomen. 
De complexiteit van deze ziekte vereist een patientgerichte, multidisciplinaire aanpak 
waarbij de patiënt als partner betrokken wordt bij het behandelteam. Dit proefschrift 
biedt een aanzet tot een defintie, het betrouwbaar meten en het verbeteren van pa-
tientgerichte zorg voor mensen met de ziekte van Parkinson.
Hoofdstuk 2   Visie op patiëntgerichte zorg voor mensen met de 
ziekte van Parkinson
In hoofdstuk 2 beschrijven wij onze visie op patiëntgerichtheid. Gezondheidszorg is in de 
twintigste eeuw steeds geavanceerder en professioneler geworden. Vanuit technologisch 
oogpunt is de zorg in Westerse landen buitengewoon goed. Een keerzijde van het huidige 
systeem is dat de zorg rondom dokters is georganiseerd en de nadruk ligt op 
diagnostiek en behandeling van ziektes; een aanpak die onvoldoende gevoelig is 
voor individuele behoeften van patiënten. Patiënten hebben een passieve rol en 
nemen in het behandelteam geen centrale plaats in. Deze aanpak volstond bij de 
bestrijding van infectieziekten en acute situaties, maar voldoet niet meer aan het 
toenemend aantal chronische patiënten die zorg nodig heeft van meerdere zorg -
verleners vanuit verschillende zorginstellingen. 
Patiëntgerichtheid is een alternatieve benadering om de gezondheidszorg anders te 
organiseren. Het concept gaat uit van het principe dat zowel de zorgverlener als de 
patient ziekte experts zijn. Een arts heeft kennis van de etiologie en pathofysiologie 
van ziektes en kent de diagnostische en therapeutische overwegingen, maar een 
patient is de ervaringsdeskundige. De relatie tussen arts en patient kan daarom het 
best omschreven worden als een ‘samenwerkingsverband’, in plaats van de zorgverlener 
te zien als de enige expert en de patiënt die simpelweg zijn instructies opvolgt. 
Binnen dit samenwerkingsverband moeten patienten worden ondersteund in het 
ontwikkelen van kennis, vaardigheden en vertrouwen om zelf beslissingen te nemen 
en meer regie over hun ziekte te krijgen.
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Hoofdstuk 3   Definitie van patiëntgerichte zorg voor mensen met  
de ziekte van Parkinson
In hoofdstuk 3 hebben we onderzoek gedaan naar wensen, behoeften en knelpunten 
in de zorg voor mensen met de ziekte van Parkinson. In acht groepsdiscussies met 
40 patiënten (gemiddelde leeftijd 62 jaar, Hoehn & Yahr ziektestadium 1-3) en 20 
mantelzorgers (gemiddelde leeftijd 63 jaar) vroegen we deelnemers naar hun 
ervaringen met de zorg. Het model van patiëntgerichtheid van het Picker instituut 
werd gebruikt als leidraad tijdens de discussies en de data-analyse. Zowel patiënten 
als mantelzorgers hebben meer behoefte aan emotionele steun van zorgverleners en 
willen actiever worden betrokken bij beslissingen over hun behandeling. Hiervoor 
missen zij echter de juiste informatie en steun van hun zorgverleners. Patiënten weten 
niet hoe zij zorgverleners moeten vinden die gespecialiseerd zijn in de ziekte van 
Parkinson. Daarnaast gaven patienten aan dat de samenwerking tussen zorgverleners 
sterk kan worden verbeterd. 
Hoofdstuk 4   Meten van patiëntgerichte zorg voor mensen met  
de ziekte van Parkinson
Het meten van patiëntervaringen vormt een essentieel onderdeel van kwaliteitsmetin-
gen in de zorg. In hoofdstuk 4 hebben we het model van patiëntgerichtheid voor de 
ziekte van Parkinson uit hoofdstuk 3 gebruikt om een patiëntervaringen vragenlijst op 
te stellen. De vragenlijst werd verstuurd naar 1112 patiënten, waarvan 895 (82%) de 
vragenlijst hebben ingevuld. De mate van patiëntgerichtheid werd bepaald door een 
totale patiëntgerichtheid score [0-3], subschaal scores [0-3] en een verbeterscore 
per vraag [0-9] te berekenen. De vragenlijst werd getest op inhouds- indruks- en 
constructvaliditeit en betrouwbaarheid. Na het validatieproces bestond de ‘CQ-index 
ziekte van Parkinson’ uit 46 vragen in zes domeinen van patiëntgerichtheid. De samen hang 
van het instrument uitgedrukt in Cronbach’s α per subschaal werd vastgesteld op 
0.62 tot 0.84. De patiëntgerichtheid score voor de totale populatie was 1.69 (SD 0.45). 
‘Emotionele steun’ (1.05, SD 0.90) en ‘informatievoorziening’ (1.18, SD 0.57) lieten de 
laagste subschaal scores zien. Patiënten gaven aan niet goed geïnformeerd te zijn 
over medicatie en behandelopties van paramedische disciplines. ‘Toegang tot het 
medisch dossier’ was het item met de hoogste verbeterscore (5.44). 
Deze patientervaringen vormen samen een ziektespecifiek model van patiëntgericht-
heid voor de ziekte van Parkinson bestaande uit zes domeinen; emotionele steun, 
informatievoorziening, patiëntparticipatie, empathie & deskundigheid, toegang tot 
zorg en continuïteit & samenwerking.
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Hoofdstuk 5   Verbeteren van patiëntgerichte zorg voor mensen met 
de ziekte van Parkinson 
In hoofdstuk 5 hebben we de mate van patiëntgerichtheid in Amerikaanse ziekenhuizen 
onderzocht en hebben we vastgesteld of patiëntervaringen kunnen worden gebruikt 
om de kwaliteit van zorg te verbeteren. We voerden eerst een onderzoek uit om de 
toepasbaarheid van de patientervaringen vragenlijst in Amerika te testen. Daarna 
werd de vragenlijst uitgezet in 20 gerenommeerde Parkinsoncentra in de Verenigde 
Staten en Canada. De mate van patiëntgerichtheid werd per centrum bepaald door 
het berekenen van casemix gecorrigeerde scores. Ieder centrum ontving een 
feedback rapport en een vragenlijst om de effecten van het rapport te evalueren. De 
Patient Centeredness Questionnaire for Parkinson’s Disease (PCQ-PD) werd ingevuld 
door 972 patiënten [mediaan 50, range 37-58]. Er werden significante verschillen 
aangetoond tussen de centra op alle subschalen, m.u.v. ‘emotionele steun’ (p<0.05), 
echter bij een laag discriminerend vermogen van de vragenlijst. ‘informatievoorzie-
ning’ (1.62, SD 0.62) en ‘samenwerking’ (2.03, SD 0.58) lieten de laagste subschaal 
scores zien. 14 centra (88%) gaven aan dat patientervaringen de kwaliteit van zorg 
kunnen verbeteren. Negen centra (56%) gebruikten de feedback om hun zorgverlening 
aan te passen. 
Hoofdstuk 6  The individual formerly known as patient
In 1993, veranderde de popmuzikant Prince zijn artiestennaam in the Love Symbol 
( ). Omdat het symbool niet goed uit te spreken was, werd in de media gerefereerd 
naar ‘The Artist Formerly Known As Prince, TAFKAP’. Prince was van mening dat zijn 
voormalige artiestennaam niet meer voldeed aan zijn nieuwe artistieke interesses. 
De CQ-index ziekte van Parkinson is een valide instrument om in Nederland 
 patiëntervaringen van mensen met de ziekte van Parkinson te meten. Onderzoek 
bij een grote groep patiënten liet een gebrek aan betrouwbare informatie zien en 
behoefte aan emotionele steun bij het leren omgaan met en accepteren van de 
ziekte. 
De PCQ-PD is een valide instrument om patiëntervaringen te meten in Amerikaanse 
parkinsoncentra. Amerikaanse en Canadese patiënten geven aan niet goed 
 geïnformeerd te zijn over belangrijke aspecten van hun zorg en ervaren een gebrek 
aan samenwerking tussen zorgverleners. Deze patientervaringen werden gebruikt 
om de kwaliteit van zorg te verbeteren.
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Naar analogie van deze naamsverandering, zouden wij moeten overwegen om het 
woord ‘patiënt’ niet meer te gebruiken. Patiënt is afgeleid van het Latijnse woord 
‘patientia’, wat geduld, lijden en afwachten betekent. Deze woorden zijn van 
toepassing op de medische zorg van eeuwen geleden. Als men ziek werd was lijden 
onvermijdelijk en kon men niet veel anders dan geduldig afwachten. Dit past niet 
meer bij de huidige tijd. Patiënten zoeken op Internet naar medische informatie, 
vragen om toegang tot hun medische dossier en willen meebeslissen over 
behandelopties. Daarnaast willen ze gezien worden als een mens met een gezond-
heidsprobleem en niet als dragers van een ziekte. Het veranderen van terminologie 
zal uiteraard niets bijdragen aan het voorkomen van enig menselijk lijden, maar een 
actiever label zou wel het belang benadrukken van het betrekken van de patiënt als 
partner in het zorgproces. Een alternatief verzinnen is lastig. Voorlopig stellen we 
daarom het woord TIFKAP voor; ‘The Individual Formerly Known As Patient’.
Hoofdstuk 7   visie op multidisciplinaire zorg voor mensen met  
de ziekte van Parkinson
Neurologen spelen een essentiële rol in de zorg voor mensen met de ziekte van 
Parkinson. Neurologische interventies, zoals medicatie en diepe hersenstimulatie, werken 
slechts gedeeltelijk en tijdelijk. Een multidisciplinaire aanpak waarbij neurologische 
zorg wordt gecombineerd met een team van paramedici, psychosociale zorgverleners 
en verpleegkundigen is de optimale manier om de ziekte van Parkinson te kunnen 
behandelen. Wetenschappelijk bewijs hiervoor blijkt echter beperkt. Internationale 
studies verschillen erg in opzet, interventies en uitkomsten. Te weinig kennis, inadequate 
communicatie en samenwerking zijn belangrijke barrières van multidisciplinaire zorg. 
In Nederland is ParkinsonNet ontwikkeld om deze problemen aan te pakken. Parkinson- 
Net draagt bij aan de kwaliteit van zorg, echter het is tot op heden niet aangetoond of 
ParkinsonNet ook bijdraagt aan betere samenwerking tussen zorgverleners. Daarnaast 
worden Parkinsonpatiënten nog onvoldoende betrokken bij hun zorg en vervullen zij 
geen actievere rol in het zorgproces. 
Hoofdstuk 8   Meten van multidisciplinaire zorg voor mensen met  
de ziekte van Parkinson
In hoofdstuk 8 introduceren wij de term ‘connectiviteit’ om werkrelaties tussen 
zorgverleners te kwantificeren en te visualiseren. Aan 104 deelnemers van een nieuw 
regionaal ParkinsonNet netwerk werd een vragenlijst voorgelegd om werkrelaties tussen 
zorgverleners in het netwerk in kaart te brengen. 96 zorgverleners (92%) vulden de 
vragenlijst in. ‘Social network analysis’ liet een grote variatie in connecties zien tussen 
zorgverleners in het netwerk; Zorgverleners die jaarlijks meer dan 10 Parkinson-
patiënten behandelen scoorden hoger op 7 van de 12 uitkomstmaten in vergelijking 
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met zorgverleners die minder dan 10 patiënten behandelen (bijv. ‘Aantal connecties’). 
Eerstelijns zorgverleners scoorden lager op 11 van de 12 uitkomstmaten in vergelijking 
met zorgverleners die werkzaam zijn in een verpleeghuis of ziekenhuis. 
Hoofdstuk 9   Multidisciplinaire samenwerking in netwerken voor  
de ziekte van Parkinson 
Een van de doelstellingen van ParkinsonNet is het faciliteren van multidisciplinaire 
samenwerking tussen zorgverleners betrokken bij de behandeling van de ziekte van 
Parkinson. In hoofdstuk 9 hebben we onderzocht wat ParkinsonNet bijdraagt aan het 
verbeteren van multidisciplinaire samenwerking. Hiervoor werd een nieuw regionaal 
netwerk met 101 zorgverleners geïmplementeerd. De deelnemers ontvingen twee 
vragenlijsten bij de start van het netwerk en een jaar na de implementatie. Een 
vragenlijst documenteerde de connecties of werkrelaties tussen zorgverleners, de 
ander had tot doel de multidisciplinaire teamprestatie te evalueren. 13 deelnemers 
werden geïnterviewd om belemmerende en bevorderende factoren van multidiscipli-
naire samenwerking te achterhalen. Social network analysis was gericht op drie 
subnetwerken rondom regionale ziekenhuizen. ‘Ik ken deze zorgverlener’ connecties 
namen toe van 1431 tot 2175 (52%, p <0.001) en ‘ik heb samengewerkt met deze 
zorgverlener’ connecties namen toe van 664 tot 891 (34%, p <0.001). Er werden grote 
verschillen tussen de subnetwerken aangetoond. Een centrale positie van een 
betrokken neuroloog en Parkinsonverpleegkundige is essentieel om het aantal 
werkrelaties te laten toenemen. ParkinsonNet deelnemers ervaren problemen met 
communicatie en informatieoverdracht naar zorgverleners die werkzaam zijn op 
andere locaties. Zorgverleners weten vaak niet welke andere professionals betrokken 
zijn bij hun patiënt en welke behandelingen zij gelijktijdig aanbieden.
Social network analysis biedt een bruikbare methode om werkrelaties tussen zorg- 
verleners te kwantificeren en te visualiseren. Zorgverleners die een groter aantal 
patiënten behandelen en een dienstverband in het ziekenhuis betrekken zijn sterker 
verbonden met andere zorgverleners in het netwerk.
ParkinsonNet draagt deels bij aan het verbeteren van multidisciplinaire samen-
werking. Een neuroloog die zich heeft gecommitteerd aan een multidisciplinaire 
aanpak en een parkinson verpleegkundige als spin in het web zijn belangrijke 
succesfactoren. Aanvullende maatregelen zijn nodig om de samenwerking in het 
netwerk rondom individuele patienten te verbeteren.
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Hoofdstuk 10   Verbeteren van patiëntgerichte samenwerking met 
online zorgcommunities 
In hoofdstuk 10 wordt het concept van Online zorgcommunities geïntroduceerd als 
hulpmiddel om patiëntgerichte samenwerking te faciliteren. Zorgcommunities zijn 
ontmoetingsplaatsen op het Internet voor groepen patiënten, groepen zorgverleners 
of beiden. Deelnemers communiceren met elkaar door middel van blogs, chats, 
forums and wikis. Hoofdstuk 10 beschrijft hoe communities worden ingezet binnen 
ParkinsonNet. Daarnaast worden mogelijke toepassingen van communities 
besproken gebaseerd op internationale studies. De hoeveelheid medische kennis 
neemt snel toe, waardoor zorgverleners vaak de expertise missen die nodig is om 
complexe chronische patiënten te behandelen. Online zorgcommunities kunnen 
worden gebruikt om ervaringen en kennis te delen en om de expertise te vergroten. 
Daarnaast is de gezondheidszorg gefragmenteerd, omdat veel patiënten zorg nodig 
hebben van diverse zorgverleners op verschillende locaties. Online communities 
bieden de mogelijkheid deze afstanden te overbruggen en kunnen samenwerking 
tussen de eerste en tweedelijn faciliteren. Als laatste missen chronische patiënten de 
hulpmiddelen om meer regie te kunnen voeren over hun ziekte. Online communities 
worden ingezet om patiënten actief te betrekken bij hun zorg en om zorg beter af te 
stemmen op individuele behoeften. 
Hoofdstuk 11   verbeteren van patiëntgerichte samenwerking met 
persoonlijke zorgcommunities
Een persoonlijke zorgcommunity (PZC) is een afgeschermde ontmoetingsplaats op 
het Internet voor individuele patiënten. Naast de patiënt, zijn de mantelzorger en een 
of meerdere (liefst alle) betrokken zorgverleners deelnemer van de PZC. In de PZC 
kan medische informatie centraal worden opgeslagen en kunnen deelnemers 
onderling met elkaar communiceren. In hoofdstuk 11 hebben we de eerste ervaringen 
van gebruikers onderzocht met betrekking tot de ziekte van Parkinson en voortplan-
tingsgeneeskunde. 18 mensen werden geïnterviewd, waaronder vijf vrouwen die een 
fertiliteitbehandeling ondergingen, 6 mensen met de ziekte van Parkinson, een 
gynaecoloog, een fertiliteitarts, een fertiliteitverpleegkundige, een neuroloog en drie 
Parkinsonverpleegkundigen. De interviews lieten zien dat de PZC verschillend wordt 
gebruikt, afhankelijk van de aandoening en het aantal en soort deelnemers. Redenen 
Online zorgcommunities bieden de mogelijkheid om problemen in de chronische 
zorg aan te pakken. Communities worden ingezet om patientgerichte, multi-
disciplinaire samenwerking te faciliteren en om communicatie in de zorg te verbeteren 
over de muren van instellingen heen.
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voor patiënten om deel te nemen waren het samenbrengen van zorgverleners en 
overzicht creëren over het behandelteam en lopende behandelingen. Patiënten 
waarderen de mogelijkheid om steun en informatie te kunnen vragen aan hun eigen 
zorgverleners. Verschillende voordelen voor de toekomst worden genoemd; het 
verbeteren van de continuïteit van zorg en de mogelijkheid om zorg beter af te 
stemmen op individuele behoeften. Nadelen zijn de hoeveelheid tijd die een PZC kost 
in de dagelijkse praktijk en technische implementatieproblemen.
Verschillende patiëntenpopulaties kunnen profiteren van PZCs. Deelnemers gaven 
aan dat PZCs de continuïteit en patiëntgerichtheid van de zorg kunnen verbeteren. 
Wanneer de PZC (technisch) goed wordt gefaciliteerd stimuleert het patiënten om 
een actievere rol te spelen in hun zorg. Vervolgonderzoek moet uitwijzen wat de 
effecten van de PZC zijn op concrete uitkomstmaten.
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Appendix 1: Patient-Centered Questionnaire
Patient-Centered Questionnaire 
for Parkinson’s Disease (PCQ-PD)
Questionnaire on patient experiences with care 
provided to people with Parkinson’s disease
Quality of care through patients’ eyes
This questionnaire is developed by the National Parkinson Foundation, 
The Radboud University Nijmegen Medical Centre (The Netherlands) 
and the UF Center for Movement Disorders & Neurorestoration
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Information about the questionnaire
This questionnaire focuses on your experiences with care regarding Parkinson’s 
disease during the past year. Your answers will help to improve healthcare to what’s 
important to you as a patient.
 
We appreciate your time in completing this questionnaire. Participation in this study 
is voluntary. All information is confidential. Your healthcare providers will not be able 
to see your answers. 
Instructions for filling out the questionnaire
Please answer the questions by marking them with an x in the square to the left of the 
best answer. Your answers will be analyzed by a computer. An x outside of these 
squares will not be detected! 
 x = correct
x = incorrect
If you want to change your answer, put brackets around that choice and put an x in 
the square of your final choice: 
(x ) = the answer you do not want to choose 
 x = your final answer
It is important that the questions are completed by the person named on the cover 
letter, 
if needed, you can ask your caregiver or a family member for assistance. It will take 
you approx. 20 minutes to complete the questionnaire. Completing part C is optional.
There are no “right” or “wrong” answers. Your views and experiences are what matter. 
After you have completed the questionnaire, it can be returned using the enclosed 
reply envelope (no stamp required). For questions or comments, please call [Name], 
telephone number [number] or send an e-mail to [e-mail address]. 
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Part A. Background questions 
The following questions are about your gender, age and health status. 
1. What is your year of birth?
2  Are you a man or a woman? 
 Man
 Woman
3. What is your neurological diagnosis?
 I have Parkinson’s disease
 I have a Parkinsonism (e.g. MSA or PSP)
 I do not know
 I have another diagnosis:
4. In what year did you perceive the first Parkinson’s disease symptoms?
5. In what year have you been diagnosed with Parkinson’s disease?
6 What is the highest level of education you completed?
 Less than high school graduate
 High school graduate or equivalent       
 Attended a college, but no degree
 Completed a technical or community college (e.g. associate’s degree)
 College or university degree or higher
7. What is your living situation?
 At home
 Skilled care facility
 Other 
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8. Do you have a regular care partner?
 No
 Yes, spouse/ partner
 yes, other relative
 yes, paid caregiver
 Yes, other 
9.  Did you visit one of the following healthcare professionals related  
to Parkinson’s disease during the past year? 
You may mark more than one square! 
 Neurologist
 Primary Care Physician
 Physical therapist
 Occupational therapist
 Speech-language pathologist
 Psychosocial caregiver/ social worker
 other, namely;
10.  Overall, how do you rate the quality of healthcare for your Parkinson's 
disease that you have received in the past year? 
 Excellent
 Very good
 Good
 Fair
 Poor
11. In general, how would you describe your own physical health?
 Excellent
 Very good
 Good
 Fair
 Poor
12. In general, how would you describe your own mental health?
 Excellent
 Very good
 Good
 Fair
 Poor
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13.  Which statement describes your current disease stage best? 
Please mark one square only
 Parkinson symptoms only affect one side of my body.
  Parkinson symptoms mildly affect both sides of my body but I have no problems 
with my balance.
  There are mild to moderate signs of Parkinson's disease on both sides of my  body 
and I have problems with my balance. I am physically independent.
 I am severely limited. However, I am still able to walk or stand without assistance.
 I am bound to a wheelchair or bedridden, unless I receive assistance.
 
14. Were you born in the United States, Canada or somewhere else?
 Yes, born in the US
 Yes, born in Canada
 No, born somewhere else 
15. What is your primary language that you speak at home? 
 English 
 Spanish 
 French 
 Some other language
16. Are you of Hispanic or Latin origin or descent? 
 Yes, Hispanic or Latin
 No, not Hispanic or Latin
17. Do you consider yourself…?
 White 
 Black or African-American
 Asian 
 Native Hawaiian or other Pacific Islander
 American Indian or Alaska Native
 Other
18.  Were you covered with a health plan or health insurance during  
the past year?
 Covered
 Not covered
 I do not know
244
PATIENT CENTEREDNESS QUESTIONNAIRE – PARKINSON’S DISEASE (PCQ-PD)
19.  If covered, in which manner? 
You may mark more than one square
 Health insurance through your or someone else’s employer or union
 Medicare, a government plan that pays health care bills for people aged 
       65 or older and for some disabled people
 Medicaid or any other state medical assistance plan 
 Health insurance that you purchased directly
 Health insurance from some other source
 I do not know
Part B. Your experiences with healthcare 
The following questions focus on your experiences with healthcare during the  
past year. Certain questions may not apply to you, or you may not have experienced 
certain care aspects. Please answer these question with “not applicable”. 
Part B1: Providing information 
While answering part B1, it is not important how you have obtained the information; 
face-to-face, a brochure, internet, your clinic’s website, from health professionals 
or peers.
1.  Do you know what a regional or national Parkinson’s disease patient 
organization can do for you?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
2.  Do you know where to find adaptive equipment, home care and facilities for 
Parkinson’s disease?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
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3. Do you know where to find reliable information about Parkinson’s disease?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
4. Do you know about the possibilities of peer support (groups)?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
5. Have you been informed about medication use and possible side effects?  
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
6.  Have you been informed whether or not your Parkinson medication and/ or 
treatment is covered by your health insurance?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
7.  Did one of your healthcare professionals contact you after you started a 
new medication regimen?  
e.g. to ask about your response or possible side effects
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
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8.  Do you know about the possibilities of alternative health therapies as  
an additional treatment to your disease? 
e.g. acupuncture or massage 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
9.  Do you know about advanced treatment options? 
e.g. deep brain stimulation surgery, Apokyn or a duodopa pump
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
 
10.  Do you know about Parkinson’s disease and the ability to drive a car? 
e.g. the influence of medication on your driving skills or changes in vision 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
11.  Do you know how to find healthcare professionals who are specialized  
in Parkinson’s disease? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
12.  Do you know about the treatment options for Parkinson’s disease provided 
by different healthcare professionals? 
Treatment by a physical therapist (e.g. prevent loss of mobility), occupational 
therapist (e.g. assistance in everyday activities), speech-language pathologist 
(communication and swallowing). 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 No need/ N.A. in the past year
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Part B2: Communication and collaboration among
13.  Did you have onehealthcare professional with whom you could make the 
most important health decisions?
 No
 Yes
 I don’t know
14.  Was someone made responsible for the coordination of your care? 
‘Someone’ can be a physician, physician assistant, nurse practitioner, but also 
yourself, your partner or a family member.
 No
 Yes
 I don’t know
15.  Were all your healthcare professionals aware of each others’ involvement 
in your treatment?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 I don’t know
16.  Did your healthcare professionals make mutual agreements about  
your treatment?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 I don’t know
17. Did you get conflicting information from your healthcare professionals? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
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18.  Were you informed about what your healthcare professionals discussed 
with each other regarding your treatment?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
19.  If you requested a second opinion in the past year, did your physician 
cooperate?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 Not applicable to the past year
20.  In your opinion, did your Primary Care Physician/ family doctor refer you to 
the neurologist in a timely manner? 
 No
 Yes
 Not applicable to the past year
21.  Did your neurologist and the physician assistant/ nurse practitioner 
collaborate? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 Not applicable to the past year
22.  If several physicians were involved in your treatment simultaneously,  
did these physicians collaborate?  
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 Not applicable to the past year
 I do not know
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Part B3: Accessibility of care
23.  In general, was the length of time you had to wait before you could visit 
your healthcare professionals a problem for you?
 Not a problem
 Not much of a problem
 A moderate problem
 A serious problem
24. In general, was the time spent in the waiting room a problem for you? 
 Not a problem
 Not much of a problem
 A moderate problem
 A serious problem
25.  Did you have one person assigned to you, whom you could contact for 
questions, problems or a complaint?
 No
 Yes
 I do not know/ I haven’t tried
26. Did you have e-mail access to your healthcare professionals?
 No 
 Yes
 I do not know/ I haven’t tried
27. Did you have telephone access to your healthcare professionals?
 No 
 Yes
 I do not know/ I haven’t tried
28.  In general, did your healthcare professionals answered your questions in  
a timely manner? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 I do not know/ I haven’t tried
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Part B4: Empathy and PD expertise 
29. Did your healthcare professionals listen carefully to you? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 
30. Did your healthcare professionals take enough time with you?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
31. Did your healthcare professionals explain things clearly?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
32.  Did your healthcare professionals seem competent to you regarding  
the treatment of Parkinson’s disease? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
Part B5: Patient involvement 
The following questions focus on the way your health professionals empowered 
you to make your own decisions in the past year.
33. Did you have access to your own medical record during the past year? 
 No
 Yes
 I do not know/ I haven’t tried
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34.  Did you have the opportunity to authorize who had access to your medical 
record during the past year? 
 No
 Yes
 I do not know/ I haven’t tried
35.  Did you have the opportunity to choose  the healthcare professionals by 
whom you wish to be treated? e.g. being able to see the physician you 
requested to see 
 No 
 Yes
 I do not know/ I haven’t tried
36.  Did you have the opportunity to schedule appointments with your 
healthcare professionals at a time you preferred?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 I do not know
37.  Did your healthcare professionals adapt the treatment to your personal 
situation and preferences?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
38.  Were you encouraged to participate in decisions about your treatment  
with your healthcare professionals? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
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Part B6: Emotional support by your health professionals
The following questions are about your caregiver and the opportunity to bring up 
issues that relate to the impact of Parkinson’s disease on your personal situation 
and daily life in the past year.
39. Did your healthcare professionals payattention to your caregiver?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 Not applicable to my situation 
40.  Did your healthcare professionals actively involve your caregiver  
in decisions about your treatment? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 Not applicable to my situation
41.  If you were diagnosed with Parkinson’s disease in the past year, were you 
supported by your healthcare professionals directly after the diagnosis 
was first communicated to you? 
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 Not applicable to the past year
42.  Were you supported by your health professionals in coping with the 
consequences of Parkinson’s disease? e.g. acceptance of disease 
progression
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 I chose not to disclose 
 Not applicable to the past year
253
PATIENT CENTEREDNESS QUESTIONNAIRE – PARKINSON’S DISEASE (PCQ-PD)
43.  Were you supported by your health professionals if you had to deal with 
personal relationship changes due to Parkinson’s disease?
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 I chose not to disclose 
 Not applicable to the past year 
44.  Were you supported by your health professionals if you had problems 
related to your job due to Parkinson’s disease? e.g. maintaining your job/ 
coping with income loss.
 No, not at all
 Yes, to some extent
 Yes, to a moderate extent
 Yes, to a great extent
 I chose not to disclose
 Not applicable to the past year
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- National Parkinson congress, oral and poster presentation
- Movement disorders congress, Dublin, poster presentation
- University of Florida, Gainesville, oral presentation
- National Parkinson Foundation, Miami, oral presentation
- DICA-congress, Amsterdam
- Quality registries congress, Stockholm, oral presentation
- World Parkinson congress, Montreal, oral presentation
- ParkinsonNet Jaarcongres
2009
2009
2010
2010
2011
2011
2012
2012
2012
2013
2013
2013
2009-2015
0.3 ECTS
0.2 ECTS
1.0 ECTS
1.0 ECTS
0.3 ECTS
0.4 ECTS
1.0 ECTS
1.4 ECTS
0.4 ECTS
0.2 ECTS
1.0 ECTS
1.2 ECTS 
2.0 ECTS
d) Other
- Employment MijnZorgnet ontwikkeling BV
- ParkinsonNet, Coordinator patient-centered care
- TU Twente, onderzoekssgroep evaluatie E-health interventies
- Maandelijkse refereerlunch Neurologie RadboudUMC
- Maandelijkse refereerlunch IQ healthcare, RadboudUMC
- Journal club IQ Healthcare, RadboudUMC
2009-2012
2012-2014
2009-2012
2009-2014
2009-2014
2009-2014
0.5 ECTS
1.0 ECTS
1.0 ECTS
1.4 ECTS
TEACHING ACTIVITIES
e) Lecturing
- Visiting lecturer Hogeschool van Arnhem en Nijmegen (HAN) 2010-2014 2.8 ECTS
Total 28.7 ECTS
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Ik ben veel dank verschuldigd aan alle mensen die een rol hebben gehad in de 
totstandkoming van dit proefschrift. Een aantal wil ik hier speciaal noemen: 
Geachte prof. dr. Bloem, beste Bas, 6 jaar geleden mailde je mij; “Martijn, Ik heb 
een wereldbaan voor je. Bel me even terug!” En een wereldbaan werd het! Hoogtepunten 
waren het onderzoek in de Verenigde Staten en mijn presentatie op het Wereld Parkinson 
Congres in Montreal. Ook liet je me naar Stockholm vliegen om jou als spreker te 
vervangen. Daarmee sprak je een enorm vertrouwen in mij uit. Met jouw aanstekelijk 
enthousiasme ben je een fijne leermeester en een onuitputtelijke inspiratiebron. Op 
cruciale momenten wist jij me te motiveren en sprak jij de juiste woorden. Onze samen- 
werking eindigt niet met dit proefschrift:”You can check out, but you can never leave.” 
Geachte dr. Munneke, beste Marten, met veel bewondering kijk ik naar hoe jij met 
ParkinsonNet de wereld hebt veroverd. Jouw strategisch inzicht kent geen grenzen, 
je weet altijd de juiste mensen met elkaar te verbinden en met veel flair betreedt je de 
wereld van ministeries en zorgverzekeraars. Waar ik beren op de weg zag, zag jij 
kansen. Met jouw hulp kon ik die kansen vervolgens verzilveren. 
Geachte dr. Faber, lieve Marjan, een wetenschapper in hart en nieren, van jou heb 
ik geleerd hoe je wetenschappelijk onderzoek gedegen uitvoert, analyseert en opschrijft. 
Ik bewonder jouw bescheidenheid en loyaliteit. Altijd kon ik bij jou terecht en nooit 
hoefde jij daar iets voor terug. Ik vond het een voorrecht om je beter te leren kennen 
en door jou begeleid te mogen worden. 
Waarde leden van de manuscriptcommissie prof. dr. Kremer, prof. dr. Roos en 
prof. dr. Nijhuis - van der Sanden, veel dank voor de beoordeling van dit proefschrift. 
Zes jaar geleden begon ik als ‘vlieg aan de muur’ bij MijnZorgnet. Ik dank alle collega’s 
voor deze inspirerende tijd. Coby Nogarede was voor mij niet alleen bedrijfsleider, 
maar ook een vertrouwenspersoon. Betty Jansen zorgde voor een bijna huiselijke 
sfeer in de kantoortuin. Het vrijdagmorgen ontbijt, het Nespressoapparaat en de 
fruitmand deden de rest. Wanneer Jan Oord begon met praten zakte mijn hartslag 
met 10 slagen per minuut en wist ik dat alles goed zou komen. Discussies met 
prof. dr. Kim Putters, Eelco den Breejen en Femke Vennik zette mij keer op keer 
aan het denken, omdat zij MijnZorgnet vanuit een geheel ander perspectief wisten te 
belichten.
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Het is onmogelijk alle ParkinsonNet collega’s te bedanken zonder daarbij iemand 
tekort te doen. Bij ParkinsonNet werken stuk voor stuk mensen met een gouden hart 
voor de zorg; van de jonge talenten die mensen met de ziekte van Parkinson een 
warm hart toedragen tot en met de seniors van het eerste uur, ik ben ze dankbaar 
voor hun collegialiteit, enthousiasme en inspiratie! 
Pieter, de gehele promotieperiode was jij mijn collega, vanaf de eerste weken bij mijn 
MijnZorgnet tot de laatste dag bij ParkinsonNet. Bijna iedere week lopen wij hard 
door het Goffertpark. Zo bleef jij mijn verbindingslijn met het RadboudUMC. Je kent 
mijn onderzoek van A tot Z, stelt kritische vragen en weet dingen vaak scherper te 
verwoorden dan ik. Ik vind het super dat jij mijn paranimf wil zijn. 
Twee talentvolle onderzoekers draag ik een bijzonder warm hart toe. Annemijn Aarts, 
bij MijnZorgnet was jij mijn ‘promoveerbuddy’. Ik besprak niet alleen artikelen en 
 onderzoeksdesigns met jou, maar ook lief en leed. Zo zochten we samen buiten op 
een bankje mijn verlovingsring voor Karen uit. Jan Kremer fietste langs, remde af voor 
een praatje, maar trok snel weer op toen hij onze betrapte gezichten zag. Frouke 
Nijhuis, door jou maakte ik na mijn overstap naar de afdeling neurologie een zachte 
landing en nog altijd kan ik op je rekenen. 
 
Twee studentassistenten hebben mij veel werk uit handen genomen. Ten eerste, 
Sara Al Shamma die mij bijstond met het uitwerken en analyseren van de focusgroep 
interviews. Ten tweede, Inez Ummels die mij hielp met het handmatig invoeren en 
analyseren van honderden vragenlijsten. 
Ik dank dr. Bart Post, prof. dr. Michel Wensing en prof. dr. Bert Vrijhoef voor de 
samenwerking en gezamenlijke publicaties. Voor statistische ondersteuning heb ik 
gebruik gemaakt van de expertise van prof. dr. George Borm, Jan Koetsenruijter 
en Jan Hendriks. Dankzij Janine Liefers werden vragenlijsten automatisch ingescand 
en was handmatig invoeren verleden tijd. 
Ik heb met neurologen samengewerkt, waarbij de patiëntgerichte aanpak verweven 
zit in hun DNA. Jeroen van Vugt, Lucille Dorresteijn en Jorrit Hoff vroegen patiënten 
deel te nemen aan mijn focus groep interviews en zette als eerste mijn patiëntervaringen 
vragenlijst uit. Wijnand Rutgers en Teus van Laar behoorden tot de voorlopers die 
online communities op hun afdeling implementeerden. 
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Ik dank alle mensen met de ziekte van Parkinson, partners en familieleden voor 
hun bijdrage aan dit onderzoek. Met bewondering en respect kijk ik naar uw aanpas-
singsvermogen en strijdvaardigheid bij het leren omgaan met een chronische ziekte 
die alle fronten van het leven raakt.
The National Parkinson Foundation provided a research grant for performing the 
 ‘patient-centeredness study’ in the United States. I’m especially grateful to Peter 
Schmidt and Jorge Zamudio who invited me in their office in Miami. This ‘kick-off 
meeting’ boosted my self-esteem and provided me with tips and tricks for getting this 
project done. I owe my special gratitude to Michael Okun who invited me in Gainesville 
to test the applicability of the patient experience questionnaire to US patients. Also 
special thanks to Amanda Eilers, who arranged all the interviews with patients, 
caregivers and health professionals. Additionally, all medical directors and research 
coordinators should be acknowledged for their participation in this study. 
Jorn, twee jaar geleden gooiden wij beiden het roer om door geneeskunde te gaan 
studeren. We doorliepen samen de premaster en lopen nu coschappen. Soms vroeg 
ik me af waar ik in godsnaam aan begonnen was. Jij hield me binnenboord en sleepte 
me door twee hertentamens heen. Ronald Goorden, bedankt voor het vertrouwen 
en de kans om deze droom te verwezenlijken. Cogroep 183, ik ben trots op jullie!
Je kunt hele proefschriften volschrijven over patiëntgerichtheid, hoe je het definieert, 
hoe je het meet, hoe je het implementeert. Je kunt ook een keer naar mijn huisarts 
gaan. Jürgen ten Berge, jij hebt mij geleerd wat patiëntgerichtheid werkelijk betekent 
en hoe ik zelf als dokter zou willen zijn.
Het Radbal basketbalteam wil ik bedanken voor de ontspanning op de dinsdagavond. 
Ik zie weer uit naar de halve liters Weizenbier na afloop, de toernooitjes en de BBQ 
poolparty bij Johnny van Rie.
Marc, Mariëlle, Lucas, Sanne, Berry, Ine, Christiaan, Lianne, Jeroen, Janske, Huib, 
Carlijn en Bram, ons Genootschap ontstond 15 jaar geleden tijdens de studie. Ik ben 
dankbaar voor deze vriendschap, van de onbezorgde weekendjes weg tot de steun 
die we aan elkaar hebben in mindere tijden.
Daan, Arjan, Bram, Frans en Bas, onze vriendschap gaat terug tot in de vorige 
eeuw, maar we blijven elkaar volgen in iedere fase van het leven. Bram, jij weet mij 
keer op keer een spiegel voor te houden en me te stimuleren om mijn hart te volgen. 
Daan, een half jaar geleden ontving ik deze voicemail: “Dit is een proefschrift 
motivatie bericht voor Dokter Dr. Drs. M. van der Eijk. Heel veel succes vandaag, zet 
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hem op, doe het rustig aan, je bent er bijna, ga zo door, mijn held. Einde proefschrift 
motivatiebericht.” Vanaf dat moment wist ik; jij wordt mijn paranimf. 
Lieve Familie Cnossen, in het bijzonder Gerri en Jelle, ik ben dankbaar voor het warme 
nest op de Zuivelweg in Doetinchem. Jelle, meerdere keren kon ik na een discussie 
met jou terug naar de tekentafel om een artikel aan te passen. Bedankt dat je er nooit 
omheen draait. Helaas heb ik jouw stelling over de ideale vrouwelijke lichaamsvormen, 
wegens te weinig raakvlak met mijn onderzoek, niet opgenomen in dit proefschrift.
Lieve Pa, bedankt voor je wijze adviezen en het vertrouwen bij alle keuzes die ik 
maak. Anja, jij hebt over al mijn Engelse teksten de taalkundige eindredactie gevoerd. 
Hiervoor ben ik je eeuwig dankbaar! Ik dank ook mijn broers en hun partners, in het 
bijzonder Erik-jan, jij laat mij in mijn dromen geloven en geeft mij het gevoel dat alles 
altijd wel goed zal komen. Jouw ‘broederliefde’ is onvoorwaardelijk en eindeloos.
Karen, wij laten zien dat we samen alles kunnen overwinnen. Als iets niet gaat zoals 
wij dat van tevoren hadden bedacht, dan verzinnen we altijd weer een nieuw plan. Ik voel 
me door jou gesteund in alles wat ik doe, je bent er altijd voor mij en je geeft mij de 
ruimte die ik nodig heb. Niet door te promoveren, maar door jou groei ik boven mezelf 
uit. Ik prijs me gelukkig dat ik jou mijn vrouw mag noemen. 
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